Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005785	p-ck-mbm	ug/l (ug/l)	27530	63798	0.03%
3005785	p-ck-mbm	— (—)	6349	9333	100.00%	Distribution not available
3005785	p-ckmbm	ug/l (ug/l)	282	361	0.00%
3005785	s-ck-mbm	— (—)	29	30	100.00%	Distribution not available
3005785	p-kreatiinikinaasi,mb-alayksikkö,massa	ug/l (ug/l)	27	36	0.00%
3005785	p-ck-mb	ug/l (ug/l)	25	25	0.00%
3005785	s-ck-mbm	ug/l (ug/l)	25	32	0.00%
3005785	b-cardiac,ckmb	— (—)	10	10	100.00%	Distribution not available
3005785	p-ckmbm	— (—)	9	9	100.00%	Distribution not available
3005785	b-cardiac,ckmb	ng/ml (ug/l)	6	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other septicaemia

2731

12629

2.33

315.83

2.8

2.3

8.02

7.29

ug/l

0.66

2332

10838

Infections, IBD-co-morbidities

1049

2048

4.08

315.02

2.5

1.9

8.53

11.24

ug/l

1.73

909

1819

Bacterial infection, other or unspecified

3584

16727

2.08

313.70

2.8

2.3

7.19

7.37

ug/l

0.19

2979

14471

Asthma, unspecified (mode)

3210

12487

2.16

311.71

2.7

2.0

5.71

7.66

ug/l

8.58

2751

10975

Spinal stenosis

3571

14374

2.10

311.39

2.7

2.2

5.82

8.19

ug/l

8.77

3032

12422

Stroke, excluding SAH

4210

16985

1.98

308.99

2.6

2.3

6.78

7.51

ug/l

1.44

3646

14548

Emergency coronary revascularization (for ACS)

5472

15168

3.00

307.65

2.9

2.3

10.57

6.60

ug/l

25.20

4974

12786

Implicit bacterial Sepsis

3235

12733

2.61

307.65

3.1

2.3

8.38

7.10

ug/l

1.61

2737

10942

Heart failure, not strict

6853

16849

3.18

307.65

2.9

2.1

10.33

6.78

ug/l

15.46

6072

14725

Valvular operations

2306

3475

9.90

307.65

2.6

1.9

19.50

6.58

ug/l

73.05

2227

2894

Hypothyroidism, levothyroxine purchases

1078

1246

5.22

307.65

2.3

1.3

7.67

3.38

ug/l

5.73

961

1085

Anaemias

1305

1177

8.01

307.65

2.5

1.3

9.86

3.37

ug/l

10.05

1171

1025

Calcific aortic valvular stenosis, diagnosis (helper)

3144

11184

3.32

307.65

2.8

2.4

9.89

6.64

ug/l

15.67

2875

9308

ILD medications

6943

22262

1.78

307.65

2.5

2.2

8.35

7.10

ug/l

2.83

5990

19381

Major coronary heart disease event excluding revascularizations

6465

15246

3.40

307.65

3.1

2.1

10.74

5.87

ug/l

24.40

5769

12928

Abdominal and pelvic pain

6366

18008

1.85

307.65

2.6

2.1

6.00

8.40

ug/l

14.57

5554

15617

Headache

3906

14790

2.34

307.65

2.8

2.0

5.56

7.83

ug/l

6.63

3379

12926

Hypertensive Heart Disease

1905

5954

2.95

307.65

2.8

2.2

6.16

7.62

ug/l

3.68

1627

5039

Dizziness and giddiness

5170

20624

2.18

307.65

2.8

2.2

5.75

7.59

ug/l

8.05

4431

17972

Asthma, excluding more controls

4249

11610

2.04

307.65

2.6

1.9

6.17

7.28

ug/l

3.29

3714

10230

Cardiovascular diseases

3340

4093

4.74

307.65

2.3

1.4

9.08

3.17

ug/l

23.27

2994

3507

Myocardial infarction, without ST-elevation

4299

14105

3.36

307.65

3.2

2.3

9.22

6.98

ug/l

6.88

3757

11965

Dyspnoea

7150

22807

2.63

307.65

2.9

2.1

6.49

7.52

ug/l

3.15

6198

19756

Myocardial infarction

5141

11128

3.92

307.65

3.1

2.0

11.96

5.93

ug/l

25.68

4576

9362

Explicit Sepsis

3089

13595

2.38

307.65

2.8

2.2

7.84

6.95

ug/l

1.03

2636

11687

Angina pectoris

5309

12403

3.29

307.65

3.1

2.0

8.18

5.84

ug/l

10.04

4754

10451

Other heart diseases, wide

7896

13501

4.04

307.65

2.6

1.8

10.62

5.44

ug/l

35.66

7095

11579

Coronary atherosclerosis

6836

13278

3.88

307.65

2.9

1.9

10.38

5.90

ug/l

26.53

6163

11237

Hypothyroidism (congenital or acquired)

1082

1251

5.21

307.65

2.3

1.3

7.67

3.38

ug/l

5.75

963

1089

Statin medication

4158

9666

2.55

307.65

2.4

1.9

9.65

5.78

ug/l

11.06

3693

8243

Disorders of lipoprotein metabolism and other lipidaemias

5834

18804

2.08

307.65

2.5

2.2

7.87

7.31

ug/l

1.06

5027

16423

Hypertension

4852

12869

2.26

307.65

2.4

2.0

8.51

7.38

ug/l

2.02

4318

11224

Other arrhythmias

4668

11660

3.37

307.65

2.7

1.8

7.84

5.54

ug/l

6.61

4110

9950

Bacterial Sepsis

3585

13979

2.53

307.65

3.0

2.3

8.36

7.03

ug/l

1.93

3035

12047

Pacemaker

2978

12344

2.70

307.65

3.2

2.4

10.83

6.72

ug/l

7.32

2645

10320

Codeine

5918

16780

2.03

307.65

2.5

2.1

6.50

7.87

ug/l

4.42

5124

14717

Diseases of arteries, arterioles and capillaries (FINNGEN)

2388

2339

8.54

307.65

2.8

1.5

11.12

3.66

ug/l

31.21

2175

1952

Concussion

2794

10756

2.37

307.65

2.7

2.0

5.54

8.52

ug/l

12.81

2393

9469

Operations 2 for CAVS

3144

11184

3.32

307.65

2.8

2.4

9.89

6.64

ug/l

15.67

2875

9308

Inflammatory bowel disease treatment related agents

6973

23366

1.77

307.65

2.6

2.2

8.15

7.15

ug/l

1.93

6066

20239

ILD medications: prednisolone, methylprednisolone, prednisone

6904

22118

1.84

307.65

2.5

2.2

7.99

7.11

ug/l

1.69

5959

19258

Calcific aortic valvular stenosis, including rheumatic fever

3150

11218

3.31

307.65

2.8

2.4

9.90

6.64

ug/l

15.82

2880

9341

Abnormalities of breathing

6675

13976

3.07

307.65

2.7

1.9

6.69

8.01

ug/l

3.69

5791

12051

Non-rheumatic valve diseases

5177

8769

5.21

307.65

2.7

1.9

12.72

5.91

ug/l

55.46

4739

7423

Fever of other and unknown origin

3712

14670

2.53

307.65

2.9

2.1

7.62

8.04

ug/l

0.38

3202

12777

Other intervertebral disc disorders

5137

17281

1.91

307.65

2.4

2.2

6.00

8.23

ug/l

11.45

4514

15033

Atrial fibrillation and flutter with reimbursement

2556

2413

8.07

307.65

2.9

1.5

10.64

3.63

ug/l

21.75

2320

2015

Septicaemia

3019

13796

2.30

307.65

2.8

2.3

7.93

7.30

ug/l

0.61

2578

11858

Haemorrhage from respiratory passages

2360

9169

2.60

307.65

2.8

2.0

8.49

8.25

ug/l

0.14

2021

7805

Abnormalities of heart beat

2366

8567

2.99

307.65

2.9

1.9

6.70

7.62

ug/l

0.84

2049

7279

Calcific aortic valvular stenosis

3151

11192

3.33

307.65

2.8

2.4

9.94

6.64

ug/l

16.10

2882

9316

Pain, not elsewhere classified

1766

6672

2.89

307.65

3.1

2.0

6.20

8.18

ug/l

2.30

1554

5812

Ischaemic heart disease, wide definition

7448

14441

3.72

307.65

2.9

1.9

10.69

5.88

ug/l

30.15

6721

12290

Continuous positive airway pressure

1076

2500

4.05

307.65

2.2

1.6

11.03

5.33

ug/l

6.31

848

2125

Pain in throat and chest

7352

13766

3.61

307.65

2.8

1.9

6.91

8.06

ug/l

2.93

6439

11874

Any gastric operation

4630

12212

1.98

307.65

2.4

2.1

7.48

7.40

ug/l

0.07

3951

10740

Implicit Sepsis

5998

19568

2.63

307.65

2.9

2.2

8.66

7.01

ug/l

3.69

5117

17032

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1990

3350

3.12

307.65

2.3

1.8

7.25

10.00

ug/l

4.50

1771

2978

Symptoms and signs involving the digestive system and abdomen

6305

18009

1.83

307.65

2.5

2.1

5.99

8.40

ug/l

15.04

5488

15618

Heart failure and coronary heart disease

3145

8427

3.27

307.65

3.6

2.1

9.47

5.45

ug/l

11.59

2748

6929

Symptoms and signs involving the circulatory and respiratory systems

6917

14008

2.63

307.65

2.5

1.9

7.04

8.00

ug/l

2.16

6019

12080

Episodal and paroxysmal disorders

6722

19749

1.82

307.65

2.5

2.1

5.97

7.96

ug/l

10.90

5824

17041

Aortic valve malfunction, age under 60 years

928

2450

4.73

307.65

2.5

2.3

15.65

8.87

ug/l

9.72

890

2224

Pain in limb

4756

18324

1.98

307.65

2.7

2.2

6.06

7.86

ug/l

6.66

4154

15867

Calcific aortic valvular stenosis, operated

3151

11192

3.33

307.65

2.8

2.4

9.94

6.64

ug/l

16.10

2882

9316

STROKE

4455

9698

3.55

307.65

2.7

1.8

7.10

6.05

ug/l

2.35

3962

8231

Spondylopathies

5328

16882

2.03

307.65

2.6

2.2

5.98

8.19

ug/l

9.21

4602

14650

Hypertension, essential

4961

12707

2.37

307.65

2.5

2.0

7.89

7.40

ug/l

0.66

4389

11084

Sciatica+with lumbago

3294

14276

2.35

307.65

2.7

2.2

5.09

8.27

ug/l

18.30

2979

12476

Other bacterial diseases

6623

22837

2.14

307.65

2.6

2.2

7.35

7.41

ug/l

0.06

5684

19927

GASTRO-related operations

4630

12212

1.98

307.65

2.4

2.1

7.48

7.40

ug/l

0.07

3951

10740

Pneumonias (Asthma/COPD co-morbidities)

6388

23448

1.99

307.65

2.7

2.2

7.71

7.27

ug/l

0.72

5499

20552

Cardiac arrhythmias

4912

6884

5.26

307.65

2.6

1.6

10.08

4.85

ug/l

23.60

4407

5849

Condition for Implicit Sepsis (Organ dysfunction codes)

6688

20459

2.59

307.65

2.8

2.1

9.44

6.93

ug/l

7.24

5760

17859

Coronary revascularization (ANGIO or CABG)

4852

10045

4.02

307.65

2.9

2.0

10.94

5.92

ug/l

34.36

4434

8403

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5862

18349

2.12

307.65

2.6

2.1

7.77

7.27

ug/l

0.77

5046

16059

Parasetamol

5125

10698

2.58

307.65

2.5

2.0

6.98

8.66

ug/l

4.34

4469

9434

Coronary angioplasty

3006

8926

2.91

307.65

3.1

2.0

7.85

5.78

ug/l

4.68

2635

7437

Hypertensive diseases (excluding secondary)

3145

4309

4.58

307.65

2.5

1.5

8.72

3.36

ug/l

22.79

2831

3669

Diseases of arteries, arterioles and capillaries

5185

19011

2.22

307.65

2.7

2.3

8.88

7.11

ug/l

5.80

4536

16329

Complications of procedures, not elsewhere classified

5171

23693

2.00

307.65

2.8

2.2

7.01

7.24

ug/l

0.32

4544

20503

Heart failure,strict

5073

12793

3.33

307.65

3.2

2.1

10.44

6.98

ug/l

10.07

4474

11089

Complications of surgical and medical care, not elsewhere classified

6571

24526

2.04

307.65

2.7

2.2

7.22

7.26

ug/l

0.05

5733

21215

Coronary artery bypass grafting

3508

6504

5.30

307.65

2.9

2.0

12.66

5.86

ug/l

51.39

3280

5365

Cerebrovascular diseases (FINNGEN)

2483

3105

6.49

307.65

2.5

1.5

7.84

3.53

ug/l

17.83

2209

2622

Oral corticosteroids

6771

23100

1.86

307.65

2.6

2.2

7.96

7.15

ug/l

1.45

5903

20008

Myocardial infarction, strict

4651

10576

3.77

307.65

3.0

2.0

11.94

5.97

ug/l

23.69

4145

8875

Other CVD (FINNGEN)

975

1093

8.46

307.65

3.4

1.5

6.33

3.79

ug/l

3.16

800

884

AV-block

1476

3978

3.90

307.65

3.2

1.9

10.31

6.34

ug/l

4.24

1290

3238

Malaise and fatigue

3718

12399

2.74

307.65

3.0

2.1

5.75

7.77

ug/l

6.38

3102

10698

Persons encountering health services for examination and investigation

4083

9807

2.19

307.65

2.4

2.0

7.68

8.47

ug/l

0.92

3544

8589

Depression medications

1233

1330

4.87

307.65

2.4

1.3

6.66

3.30

ug/l

3.94

1081

1156

Pneumonia, organism unspecified

5971

22081

2.08

307.65

2.7

2.1

7.42

7.30

ug/l

0.14

5119

19358

Asthma, unspecified (mode), excluding more controls

3082

10825

2.37

307.65

2.7

1.9

5.77

7.29

ug/l

5.27

2656

9512

Hypothyroidism and >3 levothyroxin purchases

1078

1246

5.22

307.65

2.3

1.3

7.67

3.38

ug/l

5.73

961

1085

Renal tubulo-interstitial diseases

5808

22676

2.09

307.65

2.6

2.2

8.26

6.99

ug/l

2.71

4964

19716

All-cause Heart Failure

5329

15243

2.88

307.65

3.1

2.2

9.35

6.95

ug/l

6.32

4664

13117

Codeine or tramadol medication

7066

22996

1.78

307.65

2.5

2.2

6.50

7.60

ug/l

3.40

6123

19980

Heart failure and antihypertensive medication

2732

2702

8.19

307.65

3.3

1.7

13.42

5.73

ug/l

13.99

2466

2263

Metabolic disorders

6673

20181

2.19

307.65

2.6

2.1

7.61

7.33

ug/l

0.45

5770

17608

Other soft tissue disorders, not elsewhere classified

5457

18808

1.87

307.65

2.6

2.2

6.01

7.88

ug/l

8.15

4750

16279

Persons encountering health services for specific procedures and health care

6691

23221

1.87

307.65

2.6

2.2

8.21

7.10

ug/l

2.11

5846

20124

Conduction disorders

2236

6041

3.46

307.65

3.0

1.9

9.35

6.07

ug/l

5.03

1917

5017

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7122

20441

2.56

307.65

2.7

2.1

11.36

6.01

ug/l

36.72

6342

17642

Diseases of oesophagus, stomach and duodenum

6590

23178

1.81

307.65

2.6

2.2

6.36

7.61

ug/l

4.57

5674

20194

Valvular heart disease excluding rheumatic fever

5239

8807

5.26

307.65

2.7

1.9

12.85

5.91

ug/l

58.20

4800

7453

Intracranial trauma

3448

10958

2.49

307.65

2.6

2.0

5.71

8.50

ug/l

13.32

2967

9644

Cardiomyopathy

1387

4085

3.91

307.65

3.1

1.9

17.22

6.49

ug/l

10.82

1270

3451

Hypertensive diseases

4854

12872

2.26

307.65

2.4

2.0

8.51

7.38

ug/l

2.03

4320

11226

Opioids

6036

16970

1.95

307.65

2.5

2.1

6.89

7.83

ug/l

2.09

5194

14853

Major coronary heart disease event

7265

15995

3.54

307.65

3.0

2.1

11.27

5.84

ug/l

36.62

6552

13589

Cerebrovascular diseases

5384

20024

2.08

307.65

2.6

2.3

7.02

7.49

ug/l

0.86

4669

17349

General examination and investigation of persons without complaint and reported diagnosis

4864

9743

2.86

307.65

2.8

2.0

6.07

8.50

ug/l

8.14

4297

8544

Low back pain

4628

17493

2.16

307.65

2.6

2.2

5.08

8.20

ug/l

27.36

3973

15215

Stroke, including SAH

4491

17666

2.03

307.65

2.6

2.3

6.68

7.56

ug/l

2.06

3895

15162

Tramadol

5564

16288

2.35

307.65

2.6

2.1

6.81

7.94

ug/l

2.88

4795

14281

Medical observation and evaluation for suspected diseases and conditions

4922

9797

2.75

307.65

2.5

2.0

7.04

8.48

ug/l

3.27

4116

8584

Syncope and collapse

3262

12386

2.54

307.65

2.9

2.1

6.76

7.97

ug/l

1.96

2776

10711

Pure hypercholesterolaemia

4961

17831

1.99

307.65

2.5

2.2

7.84

7.34

ug/l

0.83

4222

15571

Antihypertensive medication - note that there are other indications

3081

5046

3.52

307.65

2.4

1.6

7.82

4.92

ug/l

6.49

2757

4270

5862

18349

2.12

307.65

2.6

2.1

7.77

7.27

ug/l

0.77

5046

16059

Other special examinations and investigations of persons without complaint or reported diagnosis

4373

9806

2.38

307.65

2.5

2.0

6.92

8.47

ug/l

3.57

3837

8589

Presence of cardiac and vascular implants and grafts

5300

12474

3.91

307.65

3.0

2.3

13.12

6.55

ug/l

37.64

4778

10647

Bleeding

5810

22039

2.05

307.65

2.7

2.2

7.39

ug/l

0.01

5048

19085

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2160

4031

3.60

307.65

2.3

1.4

7.51

3.36

ug/l

9.33

1913

3419

Non-ischemic cardiomyopathy

2144

6332

3.12

307.65

2.6

1.9

9.25

5.19

ug/l

6.47

1824

5224

Dorsalgia

6542

18000

2.07

307.65

2.5

2.2

5.57

8.16

ug/l

19.49

5704

15614

Symptoms and signs involving cognition, perception, emotional state and behaviour

6739

23030

2.19

307.65

2.7

2.2

6.26

7.70

ug/l

5.34

5735

20152

Renal failure

3359

15385

2.19

307.65

2.8

2.4

9.89

7.04

ug/l

5.19

2891

13109

Diverticular disease of intestine

4877

17473

1.97

307.65

2.6

2.2

5.84

7.96

ug/l

10.47

4216

15240

Asthma (only as main-diagnosis), excluding more controls

3935

11610

2.12

307.65

2.6

1.9

5.64

7.28

ug/l

6.96

3435

10230

General symptoms and signs

7410

17475

2.25

307.65

2.5

2.0

6.87

7.96

ug/l

3.01

6459

15294

Other neurological diseases

4992

21490

2.00

307.65

2.7

2.3

6.36

7.38

ug/l

2.82

4376

18450

Hypertensive heart and/or renal disease

2108

6288

2.92

307.65

2.8

2.2

6.42

7.58

ug/l

2.35

1800

5339

Dialysis, with operation codes

1215

3814

3.87

307.65

2.8

2.3

20.48

7.47

ug/l

11.20

1123

3371

Ischemic heart diseases

7448

14636

3.66

307.65

2.9

1.9

10.62

5.85

ug/l

30.41

6719

12451

Hard cardiovascular diseases

7552

15306

3.64

307.65

2.8

2.0

10.46

5.96

ug/l

28.23

6797

13088

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6170

24479

1.90

307.65

2.6

2.2

8.27

7.03

ug/l

2.77

5268

21310

Left ventricular outflow tract obstruction (LVOTO), broad definition

981

2598

4.67

307.65

2.5

2.3

15.70

8.60

ug/l

11.26

937

2357

Cardiac arrest

582

723

8.36

307.65

3.4

1.5

19.27

4.40

ug/l

7.37

532

578

Heart failure, strict

5489

15489

2.93

307.65

3.2

2.2

10.01

7.01

ug/l

8.87

4813

13338

Influenza and pneumonia

6795

22979

2.05

307.65

2.7

2.1

7.67

7.29

ug/l

0.59

5859

20142

First line medication for Crohn's disease

6661

21543

1.75

307.65

2.5

2.2

7.86

7.31

ug/l

0.81

5753

18755

Other diseases of intestines

6297

20762

1.84

307.65

2.5

2.1

6.46

7.91

ug/l

4.63

5427

18134

Cardiovascular diseases (excluding rheumatic etc)

3863

5059

4.74

307.65

2.4

1.4

9.98

3.25

ug/l

29.34

3487

4303

Unstable angina pectoris

3440

10768

3.04

307.65

3.5

2.1

6.96

5.59

ug/l

3.07

3056

8991

Examination and observation for other reasons

4860

9601

3.37

307.65

2.8

2.0

6.62

8.54

ug/l

5.55

4272

8443

Heart failure and bmi 25plus

2906

8097

2.81

307.65

3.0

2.2

10.31

7.35

ug/l

4.35

2498

6827

Paroxysmal tachycardia

1667

2423

6.60

307.65

2.9

1.5

12.38

3.49

ug/l

11.94

1501

2016

Other dorsopathies, not elsewhere classified

6308

18040

1.93

307.65

2.5

2.2

5.68

8.16

ug/l

18.28

5464

15650

Other heart diseases

4526

4308

8.00

307.65

2.7

1.5

12.76

3.40

ug/l

55.31

4167

3658

Atrial fibrillation and flutter

3026

2987

7.74

307.65

2.8

1.5

11.23

3.53

ug/l

31.75

2780

2527

All pneumoniae

6433

23454

2.00

307.65

2.7

2.2

7.73

7.28

ug/l

0.73

5537

20559

Lower back pain or/and sciatica

6634

24905

1.95

307.65

2.6

2.2

5.20

7.81

ug/l

25.45

5777

21606

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6257

23515

1.97

307.65

2.7

2.2

7.57

7.34

ug/l

0.32

5386

20611

Any reimbursement code in KELA

2693

5955

2.35

295.97

2.4

1.7

8.06

6.75

ug/l

1.43

2402

5148

Viral Sepsis

1514

5705

3.01

291.48

3.5

2.3

10.29

6.80

ug/l

2.89

1305

4896

Implicit viral Sepsis

1512

5694

3.01

291.46

3.5

2.3

10.30

6.81

ug/l

2.90

1303

4886

Nephropathy related operations

1134

3705

3.69

288.93

2.8

2.4

19.59

7.59

ug/l

9.91

1053

3293

Cardiomyopathies, Primary/intrinsic

961

2802

3.97

287.07

3.4

1.9

19.04

6.65

ug/l

9.03

890

2379

Neurological diseases

4879

13746

1.85

286.43

2.4

2.1

6.56

8.25

ug/l

5.24

4212

12087

Complications of medical and surgical care

4448

24160

1.84

281.81

2.7

2.3

7.56

7.08

ug/l

0.65

3857

20886

Oxycodone

2475

11317

2.30

281.41

3.0

2.2

5.10

7.92

ug/l

10.87

2046

9857

Type 2 diabetes, wide definition

5044

19164

1.81

280.06

2.6

2.2

7.11

7.57

ug/l

0.71

4362

16592

Asthma (only as main-diagnosis)

4091

13419

1.92

276.69

2.6

2.0

5.64

7.69

ug/l

10.58

3561

11829

Transient ischemic attack

3652

16384

1.99

276.66

2.8

2.3

6.26

7.32

ug/l

2.37

3227

13965

Injuries to the head

6319

25514

1.67

274.34

2.6

2.2

6.52

7.46

ug/l

2.90

5380

22235

Other postsurgical states

633

1432

5.61

274.17

2.8

2.1

5.24

6.19

ug/l

0.63

581

1250

Dorsopathies

5901

18089

1.72

272.82

2.4

2.2

5.94

8.16

ug/l

11.89

5105

15694

Other disorders of skin and subcutaneous tissue

4262

22365

1.85

268.48

2.5

2.3

6.74

7.05

ug/l

0.34

3645

19301

COPD/asthma related infections

6034

18356

1.71

266.70

2.6

2.1

6.83

7.27

ug/l

0.68

5220

16066

COPD/asthma/ILD related infections

6034

18356

1.71

266.70

2.6

2.1

6.83

7.27

ug/l

0.68

5220

16066

Pain (limb, back, neck, head abdominally)

4374

12131

1.88

266.12

2.4

2.1

6.09

9.03

ug/l

13.89

3795

10477

Asthma

4462

13419

1.86

265.77

2.6

2.0

6.05

7.69

ug/l

6.82

3898

11829

Neurological diseases, wide definition

1518

2653

3.00

264.69

2.5

1.8

7.01

10.87

ug/l

5.19

1334

2346

Cardiomyopathy (excluding other)

977

3037

3.70

263.92

3.4

1.9

18.95

6.49

ug/l

9.43

906

2581

Other disorders of fluid, electrolyte and acid-base balance

2138

9550

2.37

257.49

3.2

2.2

6.10

7.01

ug/l

1.24

1768

8177

Ischaemic Stroke, excluding all haemorrhages

3875

16489

1.90

254.20

2.7

2.3

6.73

7.42

ug/l

1.27

3342

14091

Endocrine, nutritional and metabolic diseases

4317

12281

1.85

254.19

2.4

2.0

7.37

7.73

ug/l

0.41

3799

10766

Other symptoms and signs involving cognitive functions and awareness

2941

14517

2.04

246.70

2.6

2.3

5.54

7.50

ug/l

6.54

2389

12547

Asthma (mode)

4311

13508

1.82

243.65

2.5

2.0

5.75

7.70

ug/l

9.51

3755

11910

Factors influencing health status and contact with health services

1949

4092

2.51

242.74

2.5

1.9

8.45

8.17

ug/l

0.14

1715

3608

Peripheral artery disease

3225

14105

1.99

242.02

2.9

2.4

6.88

6.91

ug/l

0.03

2775

11991

Diabetes mellitus

5803

21590

1.66

241.78

2.5

2.2

7.42

7.41

ug/l

0.01

5079

18704

6613

22352

1.62

240.32

2.7

2.2

6.61

7.30

ug/l

1.36

5676

19379

Diabetes, varying definitions

5784

21564

1.66

240.31

2.5

2.2

7.44

7.42

ug/l

0.02

5063

18681

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5571

21097

1.68

239.15

2.5

2.2

6.91

7.43

ug/l

0.93

4874

18276

Certain infectious and parasitic diseases

5669

17451

1.68

238.86

2.4

2.1

7.55

7.43

ug/l

0.12

4896

15263

Vocal cord dysfunction

674

1571

4.29

237.26

2.5

1.5

7.94

5.32

ug/l

1.62

571

1362

Other antidepressants

6138

20234

1.64

235.11

2.5

2.2

6.77

7.80

ug/l

2.22

5185

17845

Type 2 diabetes

5672

21043

1.66

234.65

2.5

2.2

7.30

7.42

ug/l

0.14

4970

18232

Lumbar disc prolapse

3600

16052

1.87

234.62

2.5

2.2

6.11

8.35

ug/l

9.41

3181

14097

Atherosclerosis, excluding cerebral and coronary sclerosis

3066

13317

2.00

230.18

2.9

2.4

6.85

6.88

ug/l

0.03

2628

11290

Shoulder lesions

4706

17319

1.74

229.35

2.5

2.2

6.05

7.99

ug/l

6.62

4170

15073

Psychiatric diseases

6285

20073

1.62

228.69

2.6

2.2

6.81

7.65

ug/l

1.80

5354

17800

Left ventricular outflow tract obstruction, narrow definition

501

1094

5.91

227.44

2.4

2.2

17.71

7.76

ug/l

10.89

484

984

Other pulmonary diagnosis

4590

13539

1.76

226.99

2.5

2.0

7.63

7.71

ug/l

0.07

3996

11936

Diabetes, insulin treatment (Kela reimbursement)

5871

22891

1.63

225.21

2.5

2.2

6.80

7.54

ug/l

1.67

5139

19796

Erysipelas

3506

18245

1.86

224.61

2.7

2.3

6.62

7.67

ug/l

2.28

3027

15866

Acute renal failure

1625

7194

2.55

223.91

3.0

2.4

13.48

6.99

ug/l

7.29

1406

6154

Other headache syndromes

2263

11218

2.13

223.10

2.7

2.1

4.57

7.86

ug/l

17.67

1959

9713

Transplanted organ and tissue status

757

2237

3.96

222.98

2.7

2.1

30.41

6.71

ug/l

16.68

709

1992

Polyarthropathies

3921

15112

1.80

222.37

2.5

2.2

7.12

8.22

ug/l

1.65

3390

13207

Cervicobrachial syndrome

1389

5672

2.66

222.21

2.8

2.1

4.77

8.47

ug/l

8.81

1269

4969

Excluding asthma or asthma-COPD overlap

4564

13539

1.75

221.11

2.5

2.0

7.63

7.71

ug/l

0.07

3980

11936

Congenital malformations of aortic and mitral valves

455

944

6.43

221.01

2.4

2.3

18.31

7.26

ug/l

11.87

442

845

Nerve, nerve root and plexus disorders

6103

24876

1.60

217.81

2.4

2.3

6.29

7.55

ug/l

3.69

5338

21530

Hyperlipidaemia, other/unspecified

2630

13224

2.03

216.19

2.7

2.3

7.46

7.35

ug/l

0.09

2291

11477

Symptoms and signs involving the nervous and musculoskeletal systems

3390

19482

1.83

213.24

2.7

2.3

5.81

7.30

ug/l

4.17

3017

16816

Acute tubulo-interstitial nephritis

3594

18513

1.81

213.16

2.7

2.3

6.23

6.74

ug/l

0.88

2990

15949

COPD differential diagnosis

4517

13508

1.73

212.43

2.4

2.0

7.55

7.70

ug/l

0.13

3943

11910

Soft tissue disorders

5765

19081

1.62

211.73

2.4

2.2

6.69

7.85

ug/l

2.89

5025

16490

ILD differential diagnosis

4512

13508

1.73

211.30

2.4

2.0

7.54

7.70

ug/l

0.14

3938

11910

Dentinal caries

1488

6435

2.50

207.71

2.7

2.2

11.30

7.63

ug/l

4.19

1285

5638

Dental caries

1625

7261

2.39

206.84

2.7

2.2

11.51

7.50

ug/l

5.06

1407

6362

Congenital malformations of the circulatory system

955

3253

3.18

205.91

2.3

16.21

7.65

ug/l

13.53

885

2887

Secondary hypertension

436

882

5.45

204.31

2.5

1.5

6.34

3.92

ug/l

2.13

371

724

Diabetes medication

5718

22499

1.60

203.98

2.5

2.2

6.99

7.48

ug/l

0.87

5011

19481

Myocarditis

322

499

7.43

203.58

3.2

1.5

16.85

4.29

ug/l

3.94

287

419

Any mental disorder

6363

20950

1.57

202.57

2.5

2.2

6.86

7.53

ug/l

1.26

5365

18552

Chronic kidney disease

2158

10987

2.14

202.28

2.8

2.4

9.53

6.74

ug/l

3.24

1866

9291

Congenital malformations of heart and great arteries

874

2864

3.32

201.92

2.4

2.3

16.45

7.74

ug/l

13.22

817

2542

All influenza

1632

7474

2.37

201.63

3.2

2.2

6.96

7.40

ug/l

0.29

1394

6471

Benzodiazepine use

5604

25953

1.59

201.51

2.5

2.2

6.04

7.51

ug/l

4.64

4602

22775

Migraine

2158

9144

2.09

201.44

2.5

2.0

5.24

7.90

ug/l

7.14

1915

7967

Symptoms and signs involving the skin and subcutaneous tissue

3817

22904

1.73

200.21

2.5

2.3

6.18

7.27

ug/l

2.43

3329

19882

Cough

2055

9793

2.12

199.55

2.7

1.9

5.54

7.76

ug/l

6.06

1753

8433

Visual disturbances and blindness

2966

16754

1.87

198.79

2.7

2.3

6.99

7.02

ug/l

0.02

2488

14463

Bicuspidal aortic valve syndrome

413

874

6.42

197.15

2.5

2.3

18.26

7.39

ug/l

10.37

402

791

Insulin medication

3604

18305

1.77

196.35

2.7

2.3

6.82

7.76

ug/l

1.87

3142

15774

Cardiodefibrillation

2596

14247

1.98

196.32

2.8

2.4

12.08

7.22

ug/l

11.05

2367

12303

Spondylosis

3137

15403

1.84

195.24

2.6

2.2

5.18

8.26

ug/l

19.98

2782

13432

Hernia

5315

23391

1.60

192.53

2.5

2.3

6.54

7.53

ug/l

3.04

4630

20231

Type 2 diabetes, definitions combined

5357

20672

1.60

192.05

2.5

2.2

7.21

7.42

ug/l

0.25

4678

17901

Hypothyroidism, drug reimbursement

521

836

4.67

191.33

2.0

1.3

9.78

3.54

ug/l

3.39

454

730

Type 2 diabetes, strict (exclude DM1)

5369

20784

1.60

190.19

2.5

2.2

7.19

7.45

ug/l

0.33

4689

18000

Asthma, hospital admission 2, infections

3288

19028

1.78

188.73

2.8

2.2

5.79

7.23

ug/l

5.30

2847

16296

Asthma-related infections

3288

19028

1.78

188.73

2.8

2.2

5.79

7.23

ug/l

5.30

2847

16296

Bronchitis

5854

25510

1.55

187.92

2.8

2.2

6.93

7.22

ug/l

0.36

5041

22112

Glucagon-like peptide-1 (GLP-1) analogues

3545

17567

1.76

185.10

2.7

2.3

6.74

7.70

ug/l

1.68

3032

15191

Finngen Rheumatological endpoints

5242

19314

1.60

185.10

2.3

2.2

6.82

7.92

ug/l

2.46

4540

16875

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1018

3779

2.87

185.04

2.3

14.99

7.44

ug/l

13.20

944

3350

Aplastic and other anaemias

2927

15992

1.85

184.03

2.9

2.4

7.41

6.94

ug/l

0.45

2492

13562

Familial hypercholesterolemia, with ischemic heart disease

760

2560

3.48

182.10

3.3

2.0

7.65

5.69

ug/l

2.01

641

2115

Intracranial injury

3290

18897

1.76

181.43

2.7

2.3

5.68

7.40

ug/l

7.06

2772

16353

Aortic aneurysm

1719

8281

2.25

181.38

2.7

2.3

12.48

7.53

ug/l

9.56

1553

7153

Nausea and vomiting

1585

7329

2.28

181.18

2.9

2.2

6.11

7.51

ug/l

1.88

1329

6169

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3495

21094

1.73

181.04

2.7

2.3

7.87

7.04

ug/l

1.13

3022

18248

Oedema, not elsewhere classified

1813

8945

2.15

180.56

2.8

2.1

5.96

7.72

ug/l

3.74

1507

7715

Ulcer of lower limb, not elsewhere classified

1111

4592

2.78

179.82

2.8

2.4

6.62

7.32

ug/l

0.60

956

3949

Endocarditis

348

679

6.58

179.24

2.8

1.9

15.95

6.42

ug/l

6.57

324

572

Other CVD

1470

6858

2.40

178.40

3.4

2.4

7.20

6.56

ug/l

0.51

1195

5783

Iron deficiency anaemia

2544

14071

1.91

177.96

2.8

2.3

7.95

6.64

ug/l

1.55

2104

11984

Cardiomyopathy, other and unspecified

577

1649

4.05

177.91

3.6

1.8

20.87

6.29

ug/l

6.07

525

1408

Type 2 diabetes, definitions combined, including avohilmo

5292

20539

1.58

177.88

2.5

2.2

7.28

7.48

ug/l

0.24

4629

17794

Other/unspecified dorsalgia

2089

10911

2.01

175.28

2.7

2.2

5.13

7.96

ug/l

11.72

1808

9393

Mood disorders, excluding more controls

5058

20079

1.58

173.99

2.5

2.2

6.59

7.55

ug/l

1.85

4269

17808

Disorders of gallbladder, biliary tract and pancreas

5550

23927

1.55

173.09

2.5

2.3

5.62

7.69

ug/l

13.47

4797

20764

Benign neoplasm of colon, rectum, anus and anal canal

3419

14719

1.75

172.62

2.5

2.3

6.07

8.16

ug/l

8.06

2943

12880

Thoracic aortic aneurysm

1085

4554

2.74

170.33

2.5

2.3

14.32

7.73

ug/l

10.09

997

4027

Visual disturbances

2663

15248

1.84

170.30

2.7

2.3

7.00

7.08

ug/l

0.05

2282

13217

Rotator cuff syndrome

3603

16393

1.71

170.18

2.5

2.2

6.26

8.06

ug/l

3.99

3210

14322

Pain in joint

2918

11055

1.81

169.90

2.3

2.1

5.83

9.23

ug/l

12.60

2474

9660

Depression or dysthymia

4005

13872

1.67

169.44

2.5

2.2

6.74

8.34

ug/l

3.46

3350

12432

Insulin, intermediate and long-acting

3326

19878

1.73

169.08

2.7

2.3

6.36

7.75

ug/l

4.29

2904

17217

Asthma (diagnoses ohter than nonallergic)

4634

25902

1.58

168.34

2.6

2.2

5.68

7.43

ug/l

10.76

4009

22384

Chronic lower respiratory diseases

6493

24185

1.49

167.86

2.5

2.2

6.34

7.65

ug/l

5.11

5640

21019

Peripheral arterial reconstruction

1365

6359

2.43

167.66

3.1

2.4

7.98

6.64

ug/l

1.08

1181

5413

Migraine with aura

1070

4379

2.58

167.17

2.7

2.0

5.02

7.29

ug/l

4.16

958

3816

Gastrointestinal diseases

2958

8378

1.82

166.87

2.4

2.0

7.11

8.12

ug/l

1.20

2581

7313

Diarrhoea and gastroenteritis of presumed infectious origin

3769

21441

1.66

166.68

2.7

2.2

6.73

7.30

ug/l

0.65

3236

18544

L04AD Calcineurin inhibitors

751

2624

3.26

166.67

2.7

2.2

29.75

7.75

ug/l

14.64

705

2362

Disorders of thyroid, IBD co-morbidities

820

2071

3.04

163.53

2.4

1.9

9.89

11.44

ug/l

0.51

703

1836

Other (not insulin) diabetes medications

5362

21672

1.54

163.15

2.5

2.2

6.66

7.52

ug/l

2.10

4677

18766

Substance abuse, excluding more controls

3029

15774

1.75

163.06

2.8

2.2

6.59

8.26

ug/l

3.98

2657

14104

Pain in thoracic spine

908

3533

2.80

160.89

3.1

2.1

4.05

8.32

ug/l

13.41

813

3081

Other anaemias

2684

15138

1.82

160.89

2.9

2.4

7.29

6.93

ug/l

0.31

2283

12821

Operations for atrial fibrillation

261

462

10.75

160.31

2.8

2.5

27.26

7.57

ug/l

15.08

256

408

Amiodarone users

867

3404

3.02

158.60

3.4

2.4

16.44

7.58

ug/l

5.76

805

2967

Other and unspecified anaemias

2653

15033

1.82

157.97

2.9

2.4

7.30

6.93

ug/l

0.31

2258

12733

Benign neoplasm: Colon

3041

14024

1.76

157.02

2.6

2.3

6.25

8.06

ug/l

5.46

2631

12253

2326

12966

1.86

156.80

2.9

2.2

5.54

7.40

ug/l

5.91

2019

11155

Other symptoms and signs involving the nervous and musculoskeletal systems

2306

12975

1.87

156.09

2.7

2.3

5.37

7.31

ug/l

4.72

2096

11234

ILD medications: immunosuppressive drugs

3153

18452

1.70

155.92

2.4

2.2

12.40

7.12

ug/l

10.22

2779

16243

Hypotension

1264

5871

2.42

155.64

3.4

2.4

6.01

6.44

ug/l

0.32

1005

4932

Biguanides

5307

22126

1.53

155.37

2.5

2.3

6.26

7.60

ug/l

5.40

4616

19177

Diseases of the skin and subcutaneous tissue

5676

19319

1.51

155.11

2.5

2.2

7.07

7.67

ug/l

1.03

4878

16829

Nutritional anaemias

2889

16892

1.75

154.85

2.7

2.4

7.69

6.59

ug/l

1.37

2391

14398

Osteopathies and chondropathies

3091

17915

1.72

153.85

2.7

2.3

7.33

7.00

ug/l

0.25

2525

15544

Intestinal infectious diseases

4951

25941

1.53

153.79

2.6

2.2

6.75

7.31

ug/l

0.84

4249

22481

Other functional intestinal disorders

2485

13635

1.82

153.33

2.9

2.2

4.96

7.18

ug/l

9.07

2069

11731

Hernia of abdominal wall, postoperative

1089

4753

2.48

150.69

2.8

2.2

5.40

8.06

ug/l

6.28

958

4234

Benign neoplasm of colon, rectum, anus and anal canal

3703

21483

1.63

149.80

2.5

2.3

6.13

7.40

ug/l

3.91

3186

18604

Persons encountering health services in other circumstances, wide

6603

24165

1.46

149.20

2.5

2.2

7.51

7.24

ug/l

0.36

5805

20871

Other diseases of pericardium

362

847

5.18

148.79

3.0

1.9

9.57

6.09

ug/l

3.51

314

719

Fall on same level

6043

23497

1.47

148.55

2.4

2.2

7.12

7.51

ug/l

0.58

5096

20762

Sleep disorders (combined)

5251

23508

1.51

147.76

2.6

2.2

6.12

7.69

ug/l

6.97

4512

20629

Care involving dialysis

638

2195

3.41

147.68

3.0

2.3

12.97

7.75

ug/l

2.01

582

1954

Insulin, combination of fast acting with intermediate-acting or long-acting

3614

21346

1.63

147.27

2.7

2.3

6.81

7.63

ug/l

1.57

3152

18395

Diseases of pulp and periapical tissues

1966

10738

1.93

146.70

2.6

2.2

11.04

7.51

ug/l

4.32

1712

9459

Oxicams

1647

4634

2.15

146.52

2.6

2.3

5.79

9.71

ug/l

8.16

1432

4023

Asthma/COPD (KELA code 203)

5029

24108

1.51

145.80

2.5

2.2

5.42

7.65

ug/l

19.19

4379

20952

Sequelae of cerebrovascular disease

2311

11664

1.86

145.40

2.8

2.4

6.90

7.11

ug/l

0.21

1882

9902

Asthma, hospital admissions , main diagnosis only

4274

25466

1.55

143.66

2.6

2.2

5.56

7.36

ug/l

10.29

3715

22010

Other and unspecified iron deficiency

1935

10644

1.94

142.65

2.7

2.3

8.10

6.50

ug/l

1.68

1586

9068

Disorders of choroid and retina

4607

22663

1.54

141.29

2.5

2.3

6.50

7.47

ug/l

2.64

3899

19697

Follow-up examination after treatment for conditions other than malignant neoplasms

2061

7359

1.90

140.09

2.4

2.0

6.76

8.03

ug/l

1.47

1747

6419

Symptoms and signs involving the urinary system

4337

22482

1.55

138.98

2.5

2.3

6.37

7.38

ug/l

3.11

3607

19600

Convulsions, not elsewhere classified

1223

5674

2.25

138.97

2.5

2.0

6.66

8.40

ug/l

2.38

1055

4982

Other specific joint derangements/joint disorders

3568

15238

1.62

138.51

2.3

2.2

6.04

8.28

ug/l

5.98

3045

13404

Disorders of lens

3875

15911

1.60

137.90

2.6

2.2

7.13

8.13

ug/l

2.10

3363

14124

Hypo-osmolality and hyponatraemia

1165

5446

2.35

137.89

3.2

2.3

5.78

6.78

ug/l

1.28

961

4618

Dysphagia

1461

7416

2.11

137.65

2.5

2.2

6.68

8.05

ug/l

1.37

1201

6393

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3166

20046

1.65

137.04

2.7

2.3

7.78

6.99

ug/l

0.99

2723

17369

Gonarthrosis [arthrosis of knee](FG)

4398

17277

1.55

136.75

2.4

2.2

6.08

8.04

ug/l

5.58

3830

15108

Asthma, including avohilmo

6182

25571

1.44

135.55

2.6

2.2

5.76

7.66

ug/l

13.47

5381

22147

Personality disorders, excluding more controls

1139

5261

2.27

134.42

2.6

2.0

5.27

8.41

ug/l

5.59

979

4722

Diseases of the respiratory system

3489

11018

1.63

132.94

2.4

2.0

7.13

7.61

ug/l

0.50

3047

9663

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3655

22297

1.58

132.41

2.5

2.3

6.71

7.22

ug/l

0.81

3131

19301

Other or ill-defined heart diseases

369

947

4.46

131.97

3.0

1.8

11.30

6.16

ug/l

1.99

317

807

Asthma-related pneumonia

2128

12324

1.82

130.92

3.0

2.3

5.99

6.91

ug/l

1.75

1821

10413

Asthma-related pneumonia or sepsis

2129

12345

1.82

130.37

3.0

2.3

5.99

6.91

ug/l

1.76

1822

10431

Asthma, hospital admissions 3, pneumonia

2129

12345

1.82

130.37

3.0

2.3

5.99

6.91

ug/l

1.76

1822

10431

Gonarthrosis

3796

14234

1.59

129.31

2.4

2.2

6.17

8.27

ug/l

5.09

3299

12452

Diseases of the musculoskeletal system and connective tissue

2642

7819

1.74

128.81

2.3

2.1

6.56

9.33

ug/l

7.05

2307

6877

Gastro-oesophageal reflux disease

3607

21019

1.58

128.69

2.6

2.2

5.79

7.65

ug/l

8.43

3031

18378

Mood disorders

5242

24186

1.46

126.76

2.5

2.2

6.60

7.43

ug/l

1.50

4432

21176

Mood [affective] disorders

5224

24146

1.46

126.09

2.5

2.2

6.55

7.44

ug/l

1.72

4418

21151

Benign neoplasm: Colon

3117

19709

1.63

125.74

2.6

2.4

6.22

7.34

ug/l

2.76

2693

17050

Other disorders of ear

4990

23226

1.48

125.71

2.5

2.3

6.22

7.63

ug/l

5.10

4222

20278

Chronic ulcer of skin, not elsewhere classified

565

1995

3.35

125.63

3.3

2.4

5.50

7.50

ug/l

1.16

486

1729

Depression

4757

22672

1.48

125.40

2.5

2.2

6.54

7.55

ug/l

1.88

4035

19926

Other retinal disorders

3659

19540

1.57

124.11

2.6

2.3

6.14

7.30

ug/l

3.52

3071

16860

Dermatitis

3186

20666

1.60

123.57

2.5

2.3

5.87

7.40

ug/l

5.33

2780

17918

Anxiety disorders, excluding more controls

4003

17778

1.53

123.50

2.6

2.1

6.94

7.56

ug/l

0.68

3387

15812

Disturbances of skin sensation

1345

6861

2.07

123.16

2.6

2.2

5.51

7.35

ug/l

3.27

1170

6021

Gout

1793

9180

1.91

123.04

3.0

2.4

7.56

8.68

ug/l

0.82

1544

7954

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

610

1572

3.09

122.01

2.6

2.0

11.84

11.74

ug/l

0.02

535

1399

Other disorders of urethra and urinary system

3553

17547

1.57

121.77

2.5

2.2

5.54

7.05

ug/l

4.82

2983

15221

Volume depletion

678

2656

2.89

121.39

3.6

2.3

5.58

7.21

ug/l

2.09

564

2240

Lung transplantation

137

160

17.65

120.33

2.8

2.5

35.78

9.21

ug/l

12.69

137

140

Autoimmune diseases excluding thyroid diseases

5450

21510

1.44

119.04

2.4

2.2

6.88

7.61

ug/l

1.43

4754

18729

Mental and behavioural disorders due to psychoactive substance use

3130

19201

1.59

118.93

2.8

2.2

6.66

8.13

ug/l

3.19

2752

16932

Insulin, fast-acting

2023

11861

1.79

118.87

2.8

2.3

6.51

7.63

ug/l

1.81

1773

10281

Lung transplant status

136

160

17.45

118.76

2.8

2.5

35.95

9.21

ug/l

12.74

136

140

3251

19086

1.58

118.28

2.7

2.3

6.69

8.19

ug/l

3.01

2872

16792

Constipation

4692

23534

1.47

118.27

2.7

2.3

5.64

7.48

ug/l

9.53

3818

20618

Autoimmune diseases excluding thyroid diseases, strict definition

5310

20999

1.44

117.34

2.4

2.2

6.74

7.59

ug/l

1.88

4615

18298

Disorders of eyelid, lacrimal system and orbit

4467

24418

1.48

117.27

2.6

2.3

5.72

7.37

ug/l

7.30

3756

21209

Temporomandibular joint disorders

731

2960

2.61

117.22

2.4

2.0

6.24

9.28

ug/l

1.50

641

2595

Injuries to the thorax

2550

15949

1.68

117.08

2.6

2.3

7.00

7.56

ug/l

0.64

2138

13839

Persons encountering health services in other circumstances

1936

11226

1.80

117.02

3.4

2.2

5.77

7.10

ug/l

2.03

1762

9709

Other acute lower respiratory infections

2866

17554

1.62

115.76

2.8

2.3

6.65

7.22

ug/l

0.63

2431

15023

Chronic periapical parodontitis

1217

6160

2.12

115.62

2.8

2.2

13.78

7.79

ug/l

5.22

1066

5416

Anxiety (asthma-related co-morbidities)

2545

12383

1.67

115.53

2.6

2.1

6.07

7.75

ug/l

2.44

2140

10948

Sleep apnoea

4790

22897

1.46

115.39

2.5

2.2

6.29

7.78

ug/l

5.65

4140

20144

Subjective visual disturbances

1337

6990

2.04

115.38

2.7

2.3

6.85

6.91

ug/l

0.03

1144

6076

Other joint disorders

4393

16041

1.49

115.28

2.3

2.2

6.41

8.21

ug/l

4.66

3777

14018

Infections of the skin and subcutaneous tissue

2847

18195

1.61

115.16

2.7

2.2

7.17

7.86

ug/l

0.78

2445

15967

Arthrosis

3979

14761

1.53

115.09

2.4

2.2

6.19

8.28

ug/l

7.34

3451

12925

Obesity related asthma

1769

10100

1.85

114.54

2.8

2.2

5.64

7.72

ug/l

5.69

1517

8891

Diseases of the digestive system

2633

16657

1.65

114.17

2.8

2.4

6.42

7.29

ug/l

1.32

2275

14239

Conductive and sensorineural hearing loss

4441

21468

1.48

113.97

2.6

2.3

6.05

7.63

ug/l

6.22

3730

18719

3109

18708

1.58

113.79

2.7

2.3

6.40

8.22

ug/l

5.45

2745

16469

COPD (mode)

1871

8556

1.84

113.71

2.8

2.2

6.96

8.03

ug/l

1.38

1584

7514

Alcohol use disorder, Swedish definition

2990

18056

1.60

113.56

2.7

2.3

6.70

8.28

ug/l

3.02

2640

15931

Substance abuse

3029

18905

1.59

113.00

2.8

2.2

6.59

8.15

ug/l

3.56

2657

16680

Special screening examination for other diseases and disorders

472

1560

3.29

112.77

2.5

2.0

4.85

7.42

ug/l

3.72

438

1365

Other disorders of teeth and supporting structures

1246

6416

2.08

112.63

2.9

2.2

9.52

7.36

ug/l

1.68

1072

5587

Senile cataract

3561

14748

1.56

112.62

2.6

2.2

6.96

8.03

ug/l

2.25

3056

13072

Extracorporeal dialysis

484

1669

3.44

112.43

3.0

2.4

14.93

7.60

ug/l

2.32

443

1494

Other and unspecified dermatitis

2624

16654

1.64

112.22

2.5

2.3

5.65

7.34

ug/l

5.94

2285

14436

Sensorineural hearing loss

4280

20866

1.49

111.62

2.6

2.3

5.96

7.65

ug/l

7.09

3589

18189

Diaphragmatic hernia

2095

12654

1.75

111.52

2.6

2.3

5.84

7.29

ug/l

3.72

1786

10863

Benign neoplasms

5074

20143

1.44

110.93

2.4

2.2

6.92

7.71

ug/l

1.52

4362

17626

Osteoporosis

1573

8386

1.92

110.87

2.8

2.4

5.97

6.26

ug/l

0.20

1232

7029

Myocardial infarction, with ST-elevation

1280

6748

2.08

110.73

3.1

2.4

14.85

7.27

ug/l

8.71

1147

5756

Other mental disorders due to brain damage and dysfunction and to physical disease

820

3669

2.52

110.62

3.3

2.4

4.80

7.20

ug/l

5.49

662

3174

Other nutritional deficiencies

2971

18990

1.58

109.73

2.5

2.2

5.97

7.68

ug/l

5.24

2503

16756

Injuries to the abdomen, lower back, lumbar spine and pelvis

2166

13150

1.72

108.86

2.6

2.4

6.07

7.07

ug/l

1.35

1773

11245

Provisional assignment of new diseases of uncertain etiology

2157

13148

1.71

108.34

2.8

2.3

7.19

7.12

ug/l

0.05

1827

11436

L04AA Selective immunosuppressants

1157

5883

2.10

108.13

2.5

2.3

19.19

7.15

ug/l

11.80

1052

5179

Codes for special purposes

2158

13170

1.70

107.88

2.8

2.3

7.19

7.12

ug/l

0.05

1828

11454

Non-invasive ventilation

719

2791

2.52

107.76

2.3

1.5

7.92

5.39

ug/l

2.16

578

2388

Autoimmune diseases

5799

21587

1.40

107.60

2.4

2.2

7.13

7.61

ug/l

0.76

5041

18795

GI-bleeding

1984

11953

1.76

107.02

3.0

2.4

6.49

7.34

ug/l

0.96

1735

10169

Carpal tunnel syndrome

3125

18770

1.56

106.27

2.4

2.3

6.08

7.41

ug/l

2.39

2759

16242

Epilepsy

1610

9091

1.85

106.27

2.6

2.2

6.13

8.11

ug/l

4.01

1368

7827

Obesity and other hyperalimentation

2845

18404

1.58

105.66

2.4

2.2

5.95

7.69

ug/l

5.43

2398

16225

Heartburn

619

2464

2.75

105.40

2.8

2.2

4.80

8.43

ug/l

5.32

519

2180

Peripheral artery operations in Hilmo

916

4356

2.32

105.16

3.0

2.4

6.66

7.02

ug/l

0.28

810

3691

Cholelithiasis, broad definition with cholecystitis

4585

22372

1.44

104.52

2.6

2.3

5.65

7.57

ug/l

9.35

3938

19325

Obesity

2826

18317

1.58

104.37

2.4

2.2

5.92

7.71

ug/l

5.68

2384

16148

Any operation in hilmo

195

122

8.49

104.18

2.2

1.3

10.14

2.75

ug/l

3.30

177

108

Gonarthrosis,primary

4996

22695

1.43

104.04

2.4

2.3

5.89

7.74

ug/l

6.43

4314

19737

Cervical disc disorders

1911

11443

1.75

103.59

2.5

2.2

5.98

8.60

ug/l

6.72

1645

10059

Use of hypnotics and sedatives

5539

23433

1.40

103.58

2.5

2.2

6.76

7.66

ug/l

1.91

4766

20559

Familial hypercholesterolemia

1063

5372

2.16

103.41

3.0

2.3

6.75

7.21

ug/l

0.34

901

4627

Other anxiety disorders

1834

9533

1.76

103.38

2.7

2.1

6.31

7.64

ug/l

1.13

1529

8391

Artrosis, including avohilmo

4493

17382

1.46

103.24

2.4

2.2

6.24

8.32

ug/l

8.09

3894

15230

All influenza (not pneumonia)

857

3962

2.32

103.15

3.4

2.2

7.57

7.63

ug/l

0.02

751

3461

Acute bronchitis

2258

13829

1.67

103.13

2.8

2.3

6.36

6.92

ug/l

0.65

1886

11739

Sleep apnoea, including avohilmo

4951

23194

1.42

102.91

2.4

2.2

6.20

7.72

ug/l

6.12

4285

20360

Poisoning by drugs, medicaments and biological substances

1098

5549

2.08

102.81

2.7

2.2

5.50

7.71

ug/l

2.71

938

4904

Other cataract

2443

11970

1.65

102.75

2.6

2.2

6.48

7.83

ug/l

3.51

2133

10524

Acute upper respiratory infections of multiple and unspecified sites

3583

18345

1.50

102.45

2.8

2.2

7.55

7.43

ug/l

0.10

3111

15950

Other diseases of the digestive system

1956

11889

1.74

102.03

3.0

2.4

6.56

7.29

ug/l

0.76

1694

10132

Diseases of the eye and adnexa

3887

13304

1.50

101.93

2.4

2.1

7.65

8.29

ug/l

0.74

3422

11851

Mental and behavioural disorders due to alcohol

2708

17209

1.59

101.73

2.7

2.2

6.45

8.29

ug/l

4.72

2396

15185

Used for control exclusion in common control thyroid runs

5490

20295

1.40

101.43

2.4

2.2

7.28

7.66

ug/l

0.52

4758

17699

Insulin, fast-acting or short human

2030

12427

1.71

101.28

2.8

2.3

6.49

7.56

ug/l

1.70

1780

10760

Adjustment and management of implanted device

1268

6865

2.01

100.84

3.0

2.4

14.52

6.99

ug/l

7.07

1155

5814

All anxiety disorders

2563

13203

1.61

100.40

2.6

2.1

6.05

7.66

ug/l

2.30

2155

11670

Congenital malformations, deformations and chromosomal abnormalities

2560

15809

1.60

100.09

2.3

2.2

10.11

7.18

ug/l

6.89

2279

13833

Other diseases of urinary system

5206

21311

1.41

99.98

2.6

2.2

6.09

7.59

ug/l

6.08

4390

18676

Pericarditis

265

659

4.72

99.96

3.1

1.9

9.34

5.71

ug/l

1.46

222

562

Other diseases of pleura

2698

15685

1.60

99.96

2.8

2.4

7.56

7.29

ug/l

0.26

2320

13460

Abnormal findings on diagnostic imaging of lung

2763

17786

1.58

99.82

2.6

2.4

6.83

7.35

ug/l

0.63

2362

15388

Diseases of oral cavity, salivary glands and jaws

4995

18473

1.42

99.59

2.5

2.2

7.43

6.94

ug/l

0.73

4327

15932

Other gastritis (incl. Duodenitis)

1362

7530

1.93

99.42

2.9

2.3

5.81

7.52

ug/l

3.02

1173

6509

Dental operations

3837

13554

1.50

99.31

2.4

2.2

6.86

7.38

ug/l

0.84

3301

11542

Amputation

738

3313

2.51

98.78

3.0

2.4

7.05

7.33

ug/l

0.16

644

2810

Cervicalgia

1091

5606

2.07

98.52

2.6

2.2

6.11

8.00

ug/l

1.55

938

4839

Care involving use of rehabilitation procedures

3212

20755

1.52

97.99

2.8

2.2

8.36

7.14

ug/l

1.32

2911

17970

Acute sinusitis

2355

13952

1.62

97.86

2.6

2.1

7.00

7.61

ug/l

0.56

2030

12221

Poisoning by medicine

989

4915

2.12

97.14

2.7

2.2

5.54

7.88

ug/l

2.54

851

4359

Other reaction to severe stress, and adjustment disorders

1493

8469

1.83

96.64

2.6

2.1

8.87

7.60

ug/l

0.74

1299

7474

Aneurysms, operations, SAH

994

5015

2.14

96.25

2.7

2.3

5.60

7.29

ug/l

1.67

877

4310

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2385

15343

1.62

96.10

2.8

2.3

6.36

8.48

ug/l

5.52

2107

13582

Mycoses

1410

7988

1.87

94.29

2.8

2.3

6.56

7.35

ug/l

0.67

1212

6944

Injury, poisoning and certain other consequences of external causes

2733

8832

1.59

94.27

2.4

2.1

6.59

7.81

ug/l

2.41

2386

7745

Covid-19 confirmed case

1506

8695

1.83

93.96

2.6

2.3

8.25

6.98

ug/l

1.20

1265

7512

Cholelithiasis

4366

22051

1.43

93.52

2.6

2.3

5.65

7.53

ug/l

8.57

3747

19037

Migraine without aura

697

3048

2.38

93.45

2.1

1.9

5.06

7.31

ug/l

1.84

609

2674

Other degenerative diseases of the nervous system

1418

6012

1.88

93.43

2.5

2.1

5.81

7.84

ug/l

3.96

1071

5230

Arthropathies

4428

16063

1.43

93.29

2.3

2.2

6.49

8.21

ug/l

4.60

3829

14034

Unknown and unspecified causes of morbidity

459

1673

3.02

93.12

2.7

2.1

4.18

7.89

ug/l

8.95

437

1461

Early onset COPD, excluding more controls

1136

6035

2.00

93.02

2.8

2.1

8.07

8.63

ug/l

0.31

993

5393

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1102

5752

1.99

92.95

2.5

2.0

6.06

8.11

ug/l

2.33

938

5119

Recurrent or chronic depression

1753

7491

1.74

92.34

2.3

2.1

6.53

8.56

ug/l

2.72

1486

6777

Organic, including symptomatic, mental disorders

2927

14277

1.55

91.47

2.7

2.4

5.12

7.03

ug/l

10.06

2249

12378

Fracture of rib(s), sternum and thoracic spine

1724

10449

1.75

90.93

2.6

2.4

6.87

7.58

ug/l

0.73

1414

9047

Coxarthrosis

2844

12916

1.55

90.20

2.5

2.3

6.42

8.30

ug/l

5.60

2451

11273

Personality disorders

1139

6092

1.95

89.80

2.6

2.2

5.27

7.97

ug/l

4.41

979

5425

Parodontitis or operation codes

4606

24857

1.40

89.63

2.3

7.99

7.27

ug/l

1.11

4033

21727

Gastroduodenal ulcer

1616

9649

1.77

89.37

2.9

2.3

6.75

7.51

ug/l

0.60

1410

8252

Pulmonary heart disease, diseases of pulmonary circulation

1864

11576

1.70

89.22

2.7

2.4

8.73

6.78

ug/l

1.59

1581

9857

Neurotic, stress-related and somatoform disorders

4070

20732

1.43

89.02

2.6

2.2

7.01

7.49

ug/l

0.46

3453

18237

Parodontitis

4598

24855

1.40

89.01

2.3

8.00

7.27

ug/l

1.13

4026

21724

Venous thromboembolism

2997

19983

1.51

88.97

2.5

2.4

6.92

7.08

ug/l

0.12

2534

17164

Chronic periodontitis, including avohilmo

4579

24842

1.40

88.78

2.3

8.02

7.27

ug/l

1.17

4006

21725

Anxiety disorders

4128

21023

1.42

88.78

2.5

2.2

6.99

7.49

ug/l

0.50

3503

18479

Viral pneumonia

731

3380

2.34

88.75

2.9

2.2

9.01

7.78

ug/l

0.52

626

2945

Other disorders of skin and subcutaneous tissue, not elsewhere classified

870

4311

2.19

88.74

3.0

2.3

5.45

7.25

ug/l

1.60

706

3727

Traumatic subdural haemorrhage

792

3723

2.27

88.31

2.6

2.2

6.35

8.25

ug/l

2.23

670

3229

Falls/tendency to fall

5528

20670

1.37

87.55

2.4

2.2

7.26

7.56

ug/l

0.40

4675

18322

Coxarthrosis [arthrosis of hip](FG)

3062

15181

1.51

87.53

2.5

2.3

6.30

7.98

ug/l

5.20

2635

13218

Benign neoplasms

3655

14475

1.46

87.22

2.3

2.2

6.91

8.30

ug/l

3.02

3161

12793

Selective serotonin reuptake inhibitors

5195

20291

1.38

86.91

2.3

2.2

6.50

7.81

ug/l

3.88

4372

17888

Presence of other functional implants

2976

14386

1.52

86.41

2.6

2.2

5.73

6.15

ug/l

0.74

2437

12271

Diabetic nephropathy, excluding more controls

906

3810

2.17

86.32

3.0

2.3

6.27

7.80

ug/l

1.71

814

3290

Specific personality disorders

992

5144

2.02

85.99

2.6

2.2

5.46

7.95

ug/l

3.11

846

4581

Disorders of adult personality and behaviour

1170

6396

1.90

85.99

2.5

2.2

5.48

7.99

ug/l

3.92

999

5698

Alcohol use disorder, ICD-based

2171

14045

1.61

85.84

2.8

2.3

6.23

8.46

ug/l

5.52

1916

12439

Cystitis

4141

18252

1.42

85.38

2.6

2.2

5.73

7.12

ug/l

4.51

3468

15858

Disorder of lipoprotein metabolism, unspecified

875

4418

2.16

85.34

2.8

2.3

8.79

7.39

ug/l

0.99

746

3823

Chronic periodontitis

897

4559

2.13

85.20

2.7

2.2

11.64

7.86

ug/l

2.84

792

4013

Acute upper respiratory infections

5258

24713

1.36

84.65

2.7

2.2

6.83

7.19

ug/l

0.44

4520

21399

DVT of lower extremities and pulmonary embolism

2352

15542

1.58

84.05

2.6

2.4

6.78

7.15

ug/l

0.27

1982

13285

Paralytic ileus and intestinal obstruction

1433

8431

1.79

83.83

2.7

2.3

5.17

7.61

ug/l

8.45

1222

7252

Allergic asthma (mode), excluding more controls

918

4570

2.04

83.67

2.5

1.9

5.71

6.68

ug/l

1.03

826

4008

Cardiac murmurs and other cardiac sounds

422

1523

2.92

83.61

2.3

1.8

7.34

7.29

ug/l

0.02

371

1303

Diseases of the ear and mastoid process

5805

22259

1.34

83.48

2.4

2.2

6.78

7.68

ug/l

1.85

4976

19522

Kidney transplant status

362

1245

3.35

83.47

2.3

9.80

7.98

ug/l

0.46

339

1127

Dental caries 1 and operation codes

4764

18035

1.39

82.71

2.4

2.3

6.75

7.21

ug/l

0.87

4140

15495

Deposits [accretions] on teeth

428

1547

2.96

82.32

3.1

2.2

13.29

8.11

ug/l

2.04

371

1376

Genitourinary diseases

3086

10552

1.50

82.32

2.4

2.1

8.64

8.48

ug/l

0.10

2733

9491

Dental caries 3 and operation codes

4913

18706

1.38

82.22

2.4

2.3

6.92

7.20

ug/l

0.40

4269

16097

Dental caries, including avohilmo

4390

16370

1.41

82.01

2.4

2.3

6.79

7.16

ug/l

0.60

3777

14028

Dental caries 1

4393

16383

1.40

81.92

2.4

2.3

6.78

7.16

ug/l

0.60

3778

14043

Open wound of head

2681

18015

1.52

81.76

2.7

2.3

7.00

7.86

ug/l

1.18

2238

15681

Misadventures to patients during surgical and medical care

808

4013

2.18

81.69

3.1

2.3

6.44

6.91

ug/l

0.32

718

3483

Injuries to the shoulder and upper arm

4219

26022

1.39

81.50

2.4

2.3

7.13

7.37

ug/l

0.24

3636

22627

Gout, FINNGEN

1793

11313

1.68

81.29

3.0

2.4

7.56

7.67

ug/l

0.05

1544

9763

Vascular disorders of the intestines

492

2018

2.77

80.84

3.4

2.4

7.11

7.67

ug/l

0.25

445

1740

Missing teeth due to accident, extraction or parodontitis

707

3364

2.29

80.55

3.0

2.3

8.75

7.50

ug/l

0.54

629

2943

Parodontitis and operation codes

4284

24575

1.39

80.45

2.3

8.02

7.31

ug/l

1.02

3763

21522

Symptoms and signs concerning food and fluid intake

575

2502

2.49

80.36

2.8

2.1

5.95

7.90

ug/l

1.05

488

2165

Oter anti-inflammatory and antirheumatic agents, non-steroids

1407

4474

1.83

80.27

2.5

2.3

6.00

9.56

ug/l

8.67

1184

3880

Dental caries 3

4558

17160

1.39

80.08

2.4

2.3

6.79

7.17

ug/l

0.61

3929

14743

Localized swelling, mass and lump of skin and subcutaneous tissue

1598

9797

1.71

79.60

2.6

2.3

6.08

7.56

ug/l

1.81

1408

8512

Dental pulpitis 2

3979

14711

1.42

79.05

2.4

2.3

6.96

7.11

ug/l

0.18

3438

12535

Other disorders of lacrimal gland

1666

10351

1.68

78.56

2.6

2.3

4.98

7.00

ug/l

5.14

1388

8948

Obesity due to excess calories

2026

13141

1.59

78.39

2.4

2.2

5.83

7.71

ug/l

5.35

1706

11636

Amputation of toe

529

2292

2.64

77.84

3.0

2.4

6.81

7.36

ug/l

0.33

467

1981

Pulmonary embolism

1672

10466

1.68

77.52

2.6

2.4

7.49

6.96

ug/l

0.29

1415

8926

Glomerular disorders in diseases classified elsewhere

725

3548

2.24

77.17

2.8

2.3

6.47

8.13

ug/l

1.68

643

3122

Pulmonary heart disease

1672

10497

1.68

76.59

2.6

2.4

7.49

7.01

ug/l

0.25

1415

8950

Gastric ulcer

1108

6242

1.90

76.58

3.0

2.3

7.05

7.42

ug/l

0.16

971

5321

Disorders of lacrimal system

2042

13382

1.59

76.25

2.6

2.3

5.14

6.82

ug/l

4.29

1702

11566

External causes of morbidity and mortality

3378

11915

1.45

76.20

2.4

2.1

6.75

7.41

ug/l

0.89

2920

10538

Paracetamol of NSAID medication

847

2061

2.13

75.64

2.4

2.0

6.83

10.47

ug/l

3.93

737

1792

Other arthrosis

2738

13497

1.50

75.63

2.5

2.2

6.63

8.32

ug/l

2.38

2351

11865

Dental pulpitis 2, only avohilmo

4035

15084

1.40

74.80

2.4

2.3

6.79

7.23

ug/l

0.69

3476

12862

Type 1 diabetes, wide definition, subgroup 1

982

5318

1.93

74.79

2.6

2.1

7.51

7.90

ug/l

0.24

863

4635

Other diseases of anus and rectum

1560

9654

1.69

74.58

2.7

2.2

6.52

7.46

ug/l

0.81

1304

8326

Fitting and adjustment of other devices

2037

12490

1.59

74.40

2.4

4.98

6.87

ug/l

7.31

1621

10590

Accidents

4256

15682

1.39

74.34

2.4

2.2

7.13

7.48

ug/l

0.37

3613

13909

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4888

24136

1.35

74.04

2.4

2.3

7.06

7.46

ug/l

0.45

4196

21048

Dental operations, only avohilmo

3959

14803

1.41

73.91

2.4

2.3

6.79

7.59

ug/l

1.60

3417

12661

Hyperkalaemia

394

1517

2.97

73.86

3.5

2.3

4.96

7.34

ug/l

2.16

339

1295

Other external causes of accidental injury

4250

15682

1.38

73.58

2.4

2.2

7.13

7.48

ug/l

0.40

3598

13909

Obesity, other/unspecified

1455

8857

1.70

73.57

2.4

2.2

5.30

7.48

ug/l

4.59

1232

7812

Fungal Sepsis

284

920

3.65

73.35

3.7

2.2

11.02

7.52

ug/l

0.79

241

814

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5445

23842

1.33

73.06

2.3

2.2

7.48

7.25

ug/l

0.28

4743

20653

Hernia of abdominal wall

2364

16130

1.52

73.00

2.7

2.3

5.50

7.96

ug/l

13.24

2082

14070

Non-allergic asthma (mode), excluding more controls

913

4829

1.96

72.75

2.8

2.0

5.84

6.93

ug/l

1.55

822

4183

Implicit fungal Sepsis

265

828

3.81

72.74

3.7

2.2

11.68

7.33

ug/l

0.98

224

736

Preparatory care for dialysis

330

1177

3.32

72.51

2.6

2.4

6.83

7.61

ug/l

0.31

297

1058

Endovascular or surgical operations to intracerebral aneurysms

423

1699

2.80

72.19

2.7

2.3

5.26

6.77

ug/l

0.91

386

1501

Other systemic involvement of connective tissue (FG)

1312

7783

1.75

72.18

2.5

2.3

6.69

6.87

ug/l

0.08

1091

6656

Nontraumatic intracranial haemmorrhage

1182

6920

1.82

71.26

2.6

2.4

5.79

6.89

ug/l

1.63

1017

5838

Gout, idiopatic and unspecified

1488

9285

1.71

71.13

3.0

2.4

8.06

7.57

ug/l

0.23

1279

8071

Chronic gastritis

1577

9941

1.67

70.89

2.6

2.3

6.10

7.08

ug/l

1.22

1296

8496

Glomerular diseases

1012

5675

1.90

70.82

2.7

2.4

6.50

7.85

ug/l

1.45

900

4959

Unspecified kidney failure

664

3264

2.25

70.49

3.0

2.4

7.22

6.80

ug/l

0.24

563

2755

Systemic connective tissue disorders

1782

11552

1.61

70.26

2.5

2.3

6.57

6.62

ug/l

0.02

1482

9852

Myalgia

1012

5657

1.87

69.78

2.5

2.2

6.29

7.62

ug/l

1.11

849

4909

Cerebral aneurysm, nonruptured

510

2265

2.47

69.03

2.7

2.3

6.52

6.75

ug/l

0.07

450

2000

Unspecified haematuria

2328

13678

1.52

68.90

2.5

2.4

6.87

7.74

ug/l

1.51

1981

11956

Diabetic retinopathy, excluding more controls

1401

4750

1.76

68.85

2.8

2.3

7.24

7.39

ug/l

0.08

1217

4111

Cardiomyopathy, Hypertrophic obstructive

154

339

5.57

68.70

5.5

1.9

30.29

5.27

ug/l

5.01

144

291

Focal epilepsy

1094

6318

1.83

68.40

2.7

2.3

5.90

7.26

ug/l

2.18

944

5475

Nonischemic cardiomyopathy

324

1162

3.10

68.30

2.7

1.9

18.98

6.38

ug/l

2.90

299

1009

Alcohol abuse, main dg, excluding more controls

736

3748

2.08

68.29

3.2

2.2

5.66

8.87

ug/l

6.10

658

3385

Migraine with aura and triptan purchases

548

2480

2.31

68.26

2.2

4.73

6.60

ug/l

2.17

483

2176

Allergic asthma (mode)

918

4895

1.90

68.23

2.5

1.9

5.71

7.46

ug/l

2.43

826

4310

Behavioural syndromes associated with physiological disturbances and physical factors

1259

7522

1.73

67.84

3.0

2.1

5.74

7.43

ug/l

1.51

1072

6572

Focal epilepsy, mode (most common among epilepsy diagnosis)

987

5553

1.88

67.78

2.7

2.3

5.93

7.34

ug/l

2.03

853

4821

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

692

3447

2.11

67.63

2.7

2.2

5.86

7.86

ug/l

1.52

594

3084

Deforming dorsopathies

1258

7550

1.73

67.38

2.4

2.2

8.28

7.94

ug/l

0.11

1090

6551

Undetermined asthma, excluding more controls

597

2822

2.24

67.36

2.7

2.0

5.67

6.64

ug/l

0.86

520

2463

Soft tissue disorders related to use, overuse and pressure

1329

8121

1.71

67.07

2.4

2.2

7.30

8.04

ug/l

0.38

1134

7048

Presence of other devices

1253

7561

1.75

66.88

2.5

2.3

4.58

6.02

ug/l

3.78

1130

6326

Type 1 diabetes

1191

7049

1.76

66.85

2.6

2.2

7.15

7.86

ug/l

0.62

1047

6128

Iron deficiency anaemia secondary to blood loss (chronic)

936

5226

1.92

66.72

2.9

2.4

7.96

6.54

ug/l

0.76

795

4438

Focal epilepsy, strict definition

1033

5919

1.84

66.63

2.7

2.3

6.01

7.37

ug/l

2.01

891

5131

Cervicocranial syndrome

549

2537

2.32

66.31

2.9

2.1

6.01

7.72

ug/l

0.88

500

2212

Alzheimer’s disease (Atypical or mixed), excluding more controls

503

1937

2.47

65.87

2.8

2.3

5.26

6.64

ug/l

1.16

364

1633

Cutaneous abscess, furuncle and carbuncle

1192

7108

1.75

65.82

2.9

2.3

7.05

7.64

ug/l

0.44

1019

6261

Retention of urine

1959

11083

1.56

65.78

2.8

2.4

6.59

7.52

ug/l

1.49

1619

9657

Dental caries 1, only avohilmo

4386

16936

1.35

65.61

2.4

2.3

6.62

7.42

ug/l

1.88

3777

14531

Dental caries 3, only avohilmo

4559

17700

1.35

65.58

2.4

2.3

6.66

7.37

ug/l

1.54

3935

15217

Ventral hernia

1285

7853

1.72

65.52

2.7

2.3

5.08

7.21

ug/l

6.86

1119

6778

Left bundle-branch block

378

1495

2.76

65.41

2.3

1.9

9.90

5.76

ug/l

1.50

311

1253

Fracture of lumbar spine and pelvis

1233

7468

1.75

65.29

2.6

2.4

6.01

6.77

ug/l

0.68

970

6287

Injuries to the hip and thigh

2477

15911

1.47

64.99

2.5

2.4

6.57

7.10

ug/l

0.50

2044

13589

Dialysis

288

1007

3.31

64.85

3.0

2.4

8.30

7.40

ug/l

0.26

272

909

Other or unspecified ileus, impaction or obstruction

1027

5929

1.83

64.74

2.7

2.3

4.90

7.63

ug/l

8.07

881

5101

COPD

2512

14589

1.47

64.37

2.8

2.3

6.85

7.97

ug/l

1.94

2120

12648

Superficial injury of head

1119

6612

1.77

64.13

2.7

2.3

6.04

7.08

ug/l

0.84

936

5654

Gingivitis and periodontal diseases

4627

18231

1.34

63.97

2.4

2.2

7.32

6.95

ug/l

0.53

4027

15779

Coxibs

1480

4844

1.68

63.84

2.3

6.12

9.56

ug/l

8.58

1231

4205

Other chronic obstructive pulmonary disease

2432

14184

1.48

63.78

2.8

2.3

6.83

7.93

ug/l

1.85

2041

12291

Other diseases of upper respiratory tract

5689

23281

1.30

63.73

2.4

2.3

6.90

7.43

ug/l

0.76

4905

20166

Alzheimer disease, excluding more controls

990

3719

1.88

63.43

2.5

2.2

5.47

7.75

ug/l

3.56

731

3231

Direct fill therapy

667

3375

2.11

63.41

2.5

2.3

12.43

7.96

ug/l

2.56

579

3021

Hypertrophic cardiomyopathy

309

1144

3.17

63.30

4.1

2.5

21.91

7.64

ug/l

4.93

289

1017

Exposure to other specified factors

3300

22854

1.38

62.85

2.4

2.2

7.81

7.45

ug/l

0.26

2802

20094

Sequelae of external causes of morbidity and mortality

1313

8154

1.69

62.80

2.7

2.3

6.81

7.19

ug/l

0.26

1180

7017

Cellulitis

1090

6448

1.78

62.57

2.6

2.3

7.74

ug/l

0.00

945

5652

Autoimmune diseases related-to ILD

4010

26803

1.34

62.43

2.5

2.3

6.19

7.37

ug/l

3.10

3461

23276

Nonorganic sleeping disorders, excluding more controls

737

3866

1.99

61.97

3.1

2.1

4.93

7.56

ug/l

5.61

613

3433

Other diseases of intestine

693

3601

2.07

61.85

2.8

2.3

6.28

7.99

ug/l

1.70

630

3144

Problems related to lifestyle

508

2340

2.31

61.67

2.9

2.2

5.76

8.27

ug/l

0.94

449

2095

Benign neoplasm: Sigmoid colon

1055

6254

1.80

61.50

2.7

2.4

6.69

7.33

ug/l

0.47

924

5400

Delirium, not induced by alcohol and other psychoactive substances

702

3684

2.07

61.30

3.0

2.4

4.75

7.06

ug/l

8.05

571

3158

Gout, unspecified

1217

7504

1.73

61.29

3.0

2.4

8.83

7.65

ug/l

0.55

1049

6522

Intestinal stricture

1652

10892

1.59

60.97

2.7

2.4

5.48

7.01

ug/l

3.94

1423

9332

Benign neoplasm: Stomach

593

2946

2.21

60.94

2.9

2.4

5.26

6.81

ug/l

1.50

519

2554

Artificial joint operation, meniscal resection

4714

24349

1.32

60.83

2.4

2.3

5.93

7.68

ug/l

7.93

4069

21184

Gonarthrosis, primary, with knee surgery

3031

18165

1.41

60.81

2.4

5.20

7.47

ug/l

12.29

2590

15713

Other symptoms and signs involving the digestive system and abdomen

757

4054

1.96

60.31

2.5

2.1

5.92

7.41

ug/l

1.04

615

3495

Schizophrenia or delusion, excluding more controls

1267

7768

1.67

60.05

2.5

2.1

5.78

7.97

ug/l

3.41

1066

6892

Heart failure and hypertrophic cardiomyopathy

175

483

4.75

59.84

5.2

2.6

28.51

7.93

ug/l

4.04

162

425

Type 1 diabetes, wide definition

1014

5926

1.78

59.74

2.6

2.2

7.42

7.73

ug/l

0.18

890

5153

Benign neoplasm: Sigmoid colon

1055

6305

1.79

59.71

2.7

2.4

6.69

7.76

ug/l

0.96

924

5468

Hypokalaemia

634

3234

2.11

59.57

3.4

2.3

5.43

6.78

ug/l

1.24

520

2770

Disorders of synovium and tendon

2337

14797

1.46

59.51

2.3

2.2

5.85

7.98

ug/l

8.30

2032

12920

Other and unspecified myopathies

540

2621

2.27

59.23

2.8

2.4

15.45

7.31

ug/l

4.37

421

2280

Dermatitis and eczema

5176

26710

1.29

58.95

2.5

2.3

6.10

7.50

ug/l

5.95

4504

23180

Diseases of the myoneural junction and muscle

696

3688

2.04

58.92

2.8

2.4

13.30

7.55

ug/l

3.65

550

3224

COPD related to multimorbidity

2253

13341

1.48

58.89

2.9

2.4

6.81

7.43

ug/l

0.75

1884

11512

Anosmia

153

6.83

58.87

2.5

1.5

4.79

4.05

ug/l

0.36

132

Injuries to the knee and lower leg

5683

25838

1.28

58.61

2.3

6.88

7.36

ug/l

0.67

4870

22488

Gout, strict definition

1082

6570

1.77

58.14

3.1

2.4

7.98

7.47

ug/l

0.20

929

5710

Polycystic ovarian syndrome, consortium definition

2722

11762

1.42

57.98

2.2

5.79

5.56

ug/l

0.21

2220

10049

Congenital malformations of cardiac septa

332

1258

2.77

57.95

2.2

2.3

16.06

6.97

ug/l

6.14

297

1102

Other complications of surgical and medical care, not elsewhere classified

507

2402

2.27

57.95

3.6

2.2

5.59

6.70

ug/l

0.72

462

2099

Benign neoplasm: Stomach

593

3011

2.15

57.42

2.9

2.4

5.26

7.26

ug/l

2.26

519

2590

Other bacterial intestinal infections

965

5670

1.80

57.21

2.6

2.3

6.96

7.18

ug/l

0.11

806

4834

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1102

6654

1.71

57.19

2.5

2.2

6.06

7.56

ug/l

1.46

938

5895

Dentofacial anomalies [including malocclusion]

1077

6400

1.72

56.91

2.3

2.1

6.78

7.13

ug/l

0.14

949

5641

Impingement syndrome of shoulder

1209

7534

1.68

56.51

2.3

2.2

6.18

8.72

ug/l

3.79

1048

6677

ILD medications: azathioprine

677

3572

1.99

56.43

2.4

2.1

13.08

7.34

ug/l

2.36

608

3165

Hypothyroidism, strict autoimmune

3502

17440

1.36

56.16

2.4

2.2

6.51

7.21

ug/l

1.00

2996

15112

Substance use, excluding alcohol

835

4736

1.84

54.98

2.9

2.2

6.95

8.25

ug/l

0.73

705

4203

Non-selective monoamine reuptake inhibitors

1900

12713

1.50

54.88

2.5

2.3

5.37

7.25

ug/l

3.77

1553

11183

Dissection of aorta

258

938

3.24

54.83

2.6

2.5

17.75

6.61

ug/l

3.02

242

816

Maze procedure for atrial fibrillation

134

11.95

54.65

2.6

2.9

29.07

9.11

ug/l

3.70

116

Undetermined asthma

597

3053

2.06

54.57

2.7

2.1

5.67

7.39

ug/l

1.91

520

2674

Other chronic obstructive pulmonary disease, including avohilmo

2889

17814

1.39

54.45

2.8

2.4

6.88

7.70

ug/l

1.32

2424

15479

Candidiasis

647

3420

2.01

54.28

3.2

2.3

7.47

6.58

ug/l

0.35

540

2977

Dental pulpitis 4

5372

22175

1.28

54.24

2.4

2.3

7.34

7.07

ug/l

0.34

4696

19146

Degeneration of macula and posterior pole

2573

15470

1.42

54.13

2.6

2.4

5.57

6.97

ug/l

5.21

2115

13181

Dental pulpitis 1

5370

22182

1.28

54.00

2.4

2.3

7.33

7.07

ug/l

0.34

4695

19151

Radiculopathy

858

4953

1.83

53.98

2.9

2.2

5.05

7.94

ug/l

7.58

757

4245

Cholecystectomy

3411

22903

1.35

53.98

2.5

2.3

5.37

7.14

ug/l

6.45

2944

19690

Atrial septal defect

219

715

3.40

53.87

2.2

2.3

15.96

6.82

ug/l

3.83

196

626

Polyarthrosis

1042

6079

1.73

53.72

2.7

2.3

4.77

6.98

ug/l

3.48

839

5186

Non-allergic asthma (mode)

913

5298

1.78

53.65

2.8

2.1

5.84

7.27

ug/l

2.32

822

4617

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

448

2098

2.35

53.61

2.7

2.4

5.28

6.78

ug/l

1.06

386

1785

Acute pancreatitis

1048

6408

1.72

53.52

2.6

2.3

5.04

8.10

ug/l

11.40

910

5592

Diseases of pulp and periapical tissues, including avohilmo

5359

22155

1.28

53.46

2.4

2.3

7.33

7.07

ug/l

0.33

4683

19122

Other and unspecified polyneuropathies, also in other diseases

1072

6620

1.72

53.31

2.9

2.4

7.04

7.53

ug/l

0.26

906

5762

Benign neoplasm of other and ill-defined parts of digestive system

951

5689

1.77

53.25

2.7

2.3

5.52

7.04

ug/l

2.17

834

4904

Benign neoplasm of other and ill-defined parts of digestive system

951

5706

1.77

52.67

2.7

2.4

5.52

7.44

ug/l

3.20

834

4925

Azathioprine

677

3655

1.94

52.64

2.4

2.1

13.08

7.38

ug/l

2.33

608

3228

Sequelae with surgical and medical care as external cause

1050

6464

1.72

52.45

2.7

2.4

6.71

7.18

ug/l

0.30

941

5570

Abnormal involuntary movements

678

3695

1.95

52.05

2.9

2.3

6.32

7.76

ug/l

0.97

565

3225

Other medical care

2043

14111

1.46

51.92

2.7

2.3

5.98

6.84

ug/l

0.99

1783

12055

Alcohol dependence

1380

9049

1.59

51.88

3.0

2.3

6.12

8.55

ug/l

4.35

1208

8036

Temporomandibular joint disorders, including avohilmo

1479

9784

1.55

51.52

2.3

2.1

5.23

6.92

ug/l

1.74

1273

8575

Enterocolitis due to Clostridium difficile

628

3364

2.01

51.50

2.7

2.4

7.62

6.74

ug/l

0.38

519

2851

Visual impairment including blindness (binocular or monocular)

413

1907

2.38

51.25

2.6

2.5

6.43

6.49

ug/l

0.02

289

1613

Suicide or other Intentional self-harm

999

6076

1.70

50.82

2.6

2.2

6.43

7.89

ug/l

1.20

846

5394

Polyneuropathies and other disorders of the peripheral nervous system

1181

7553

1.65

50.54

2.9

2.4

7.39

7.35

ug/l

0.02

1005

6568

Myocardial infarction, unclassifiable

1419

8417

1.58

50.15

3.2

2.5

9.45

6.44

ug/l

4.12

1208

7015

Subarachnoid haemorrhage

594

3152

2.03

50.02

2.7

2.3

4.67

6.93

ug/l

4.82

524

2685

Bacterial intestinal infections, IBD co-morbidities

964

5878

1.73

49.82

2.6

2.4

7.15

6.99

ug/l

0.08

805

5011

Vascular syndromes of brain in cerebrovascular disorders

327

1400

2.66

49.53

3.1

2.5

5.03

6.87

ug/l

1.07

292

1234

Emotionally unstable personality disorder

426

1991

2.23

49.14

2.4

2.1

3.65

7.13

ug/l

6.57

358

1767

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1129

7172

1.64

48.87

2.5

2.2

5.79

8.69

ug/l

5.37

1016

6428

Explicit bacterial Sepsis

543

2811

2.06

48.80

2.8

2.3

8.76

7.19

ug/l

0.64

471

2452

Alzheimer’s disease (Late onset), excluding more controls

818

3141

1.84

48.67

2.5

2.2

5.52

7.10

ug/l

1.95

596

2703

Other systemic involvement of connective tissue

1329

8771

1.58

48.50

2.5

2.3

6.64

6.43

ug/l

0.10

1105

7456

Panic disorder

516

2604

2.06

48.39

2.6

2.0

4.92

6.73

ug/l

1.62

431

2300

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

457

2236

2.20

48.18

3.3

2.3

6.03

6.52

ug/l

0.22

411

1959

Spondylolisthesis/Spondylolysis

837

4948

1.77

48.08

2.4

2.2

5.41

8.23

ug/l

6.11

745

4311

Chronic sinusitis

1862

13112

1.46

47.81

2.4

2.2

7.54

7.59

ug/l

0.02

1641

11492

Persons encountering health services for specific procedures, not carried out

374

1694

2.37

47.73

2.4

2.3

5.95

7.16

ug/l

0.85

331

1514

Hypothyroidism, strict autoimmune, 3 medication purchases required

3881

20676

1.30

47.54

2.4

2.3

6.34

6.92

ug/l

0.86

3315

17859

Bipolar affective disorders

710

4007

1.84

47.27

2.3

2.2

4.73

7.80

ug/l

7.50

610

3582

Dementia in Alzheimer disease

1059

5712

1.68

47.21

2.6

2.5

4.81

5.96

ug/l

1.50

686

4736

Somatoform disorder

702

3964

1.85

47.20

2.6

2.2

5.95

7.14

ug/l

0.60

584

3486

Other symptoms and signs involving the circulatory and respiratory systems

310

1306

2.55

46.67

2.8

1.9

8.22

8.03

ug/l

0.03

245

1134

Excessive, frequent and irregular menstruation

1482

5464

1.54

46.63

2.2

4.55

6.15

ug/l

3.47

1209

4662

Rheumatoid arthritis

1534

9511

1.51

46.60

2.4

2.2

6.25

7.62

ug/l

1.35

1310

8235

Sleep disorders

882

5320

1.72

46.57

3.1

2.2

4.85

7.35

ug/l

6.38

738

4673

Other dialysis

214

767

3.25

46.48

2.7

2.4

6.97

7.60

ug/l

0.21

202

691

Alcohol abuse, main dg

736

4244

1.82

46.41

3.2

2.2

5.66

8.56

ug/l

5.28

658

3821

Other and unspecified effects of external causes

1075

6807

1.63

46.40

2.6

2.3

5.17

7.46

ug/l

5.10

935

5939

Other skin changes

872

5295

1.74

46.05

2.6

2.3

6.80

7.23

ug/l

0.20

751

4548

Noninfective enteritis and colitis

2048

14764

1.42

45.82

2.7

2.3

5.77

7.46

ug/l

4.58

1770

12808

Streptococcal septicaemia

477

2424

2.13

45.75

2.7

2.3

8.82

7.78

ug/l

0.35

418

2125

Diabetic nephropathy

910

5553

1.73

45.72

3.0

2.6

6.27

7.37

ug/l

1.19

816

4787

Superficial injury of lower leg

1064

6757

1.63

45.67

2.5

2.3

6.39

7.20

ug/l

0.45

890

5826

Meniscus derangement

2725

13973

1.36

45.55

2.3

2.2

6.78

8.39

ug/l

2.35

2379

12308

Disorders of the thyroid gland

4463

23277

1.27

45.50

2.4

2.3

6.96

7.25

ug/l

0.34

3836

20189

Dermatophytosis

687

3929

1.86

45.34

2.6

2.3

5.53

7.93

ug/l

3.37

600

3461

Functional dyspepsia

1182

7708

1.59

45.26

2.5

2.2

5.68

7.47

ug/l

2.73

1028

6667

Other congenital malformations of upper alimentary tract

190

7.00

45.25

3.7

2.3

2.90

7.16

ug/l

2.36

170

Neoplasms

3348

13745

1.33

45.11

2.2

7.32

8.28

ug/l

1.23

2915

12180

Acute pancreatitis (for exclusion)

1048

6686

1.65

45.09

2.6

2.4

5.04

7.84

ug/l

10.17

910

5826

Bacterial pneumoniae

1982

12614

1.43

45.07

2.7

2.2

7.18

7.35

ug/l

0.14

1705

10898

Other epidermal thickening

266

1074

2.76

45.00

2.9

2.4

6.11

7.16

ug/l

0.37

237

951

Inguinal hernia

3025

15549

1.34

44.90

2.4

2.3

7.60

8.35

ug/l

1.04

2684

13570

Coxarthrosis, primary

3113

20849

1.33

44.64

2.5

2.4

6.10

7.25

ug/l

3.20

2661

17951

Alzheimer’s disease, wide definition, excluding more controls

836

3378

1.77

44.49

2.6

2.2

5.55

7.64

ug/l

2.78

604

2920

Insomnia

655

3694

1.85

44.21

3.3

2.2

4.67

7.34

ug/l

5.25

549

3261

1662

10362

1.48

43.99

2.6

2.5

5.17

6.33

ug/l

3.02

1318

8674

Xerosis cutis

135

384

4.43

43.80

2.9

2.4

6.47

7.44

ug/l

0.16

120

336

Later onset COPD, excluding more controls

1171

5991

1.60

43.14

2.9

2.2

5.78

7.52

ug/l

3.97

961

5138

Injuries to the neck

942

5900

1.65

42.86

2.3

6.89

7.44

ug/l

0.23

820

5177

COPD, hospital admissions

2434

15452

1.38

42.81

2.8

2.4

6.83

7.41

ug/l

0.73

2040

13365

Acetic acid derivatives and related substances

1392

4828

1.54

42.60

2.3

6.63

9.56

ug/l

4.67

1157

4192

Other and unspecified drugs and medicaments

433

2180

2.14

42.46

3.3

2.4

6.05

6.74

ug/l

0.31

391

1912

COPD, early/later onset

2451

15562

1.37

42.33

2.8

2.4

6.80

7.41

ug/l

0.80

2053

13469

Disorders of vitreous body and globe

2398

17567

1.37

42.21

2.5

2.3

6.00

7.14

ug/l

1.61

2115

15239

Conotruncal defects

177

5.73

42.06

1.7

2.4

23.89

8.67

ug/l

3.04

158

Dronedarone medication

177

600

3.36

41.95

3.3

1.9

9.90

6.26

ug/l

0.72

160

510

Viral hepatitis, IBD co-morbidity

188

645

3.06

41.79

2.3

1.9

10.87

13.23

ug/l

0.32

166

576

Hypothyreosis and Thyroxine purchase for inclusion criteria

4232

22406

1.27

41.33

2.4

2.3

6.62

7.12

ug/l

0.67

3615

19393

Bacterial pneumonia, not elsewhere classified

1875

11996

1.42

41.32

2.7

2.2

7.23

7.32

ug/l

0.06

1614

10344

Viral infections characterized by skin and mucous membrane lesions

1821

13117

1.42

41.30

2.4

2.3

7.35

7.57

ug/l

0.14

1567

11405

Hypothyroidism, other/unspecified

4095

21620

1.27

41.06

2.4

2.3

6.66

7.11

ug/l

0.56

3500

18716

Seborrhoeic keratosis

1127

7477

1.58

40.75

2.5

2.4

7.23

6.99

ug/l

0.10

1000

6436

COPD, hospital admission 2, with asthma infections

1761

10804

1.44

40.70

3.0

2.4

6.93

7.26

ug/l

0.26

1459

9279

Migraine without aura and triptan purchases

481

2514

1.97

40.68

2.1

4.27

6.33

ug/l

2.30

422

2220

Acute alcohol intoxication

1224

8238

1.54

40.62

3.1

2.3

5.88

8.42

ug/l

5.36

1086

7266

Viral and other specified intestinal infections

736

4269

1.73

40.52

2.7

2.1

6.79

7.07

ug/l

0.11

649

3654

Cholecystitis

761

4616

1.74

40.44

2.8

2.3

5.08

7.25

ug/l

3.60

649

3929

Psychotic depression

286

1238

2.46

40.43

2.6

2.2

4.72

8.59

ug/l

3.94

245

1126

Congenital malformations of great arteries

114

289

4.35

40.42

2.3

2.2

17.19

8.13

ug/l

2.99

108

249

Mouth breathing

1840

13341

1.42

40.32

2.4

2.3

5.97

8.39

ug/l

5.45

1665

11877

Haemorrhoids and perianal venous thrombosis

1416

9829

1.49

39.99

2.3

5.33

7.54

ug/l

5.54

1196

8491

Internal derangement of knee

1668

11871

1.44

39.97

2.2

6.61

8.42

ug/l

2.44

1441

10476

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

895

5545

1.64

39.95

2.5

2.2

5.43

6.91

ug/l

2.01

771

4860

Irritable bowel syndrome

1087

7151

1.56

39.67

2.3

2.2

5.58

7.30

ug/l

2.56

891

6238

Disorders of vitreous body

2312

17068

1.36

39.64

2.5

2.3

6.00

7.12

ug/l

1.51

2047

14808

Benign neoplasm: Transverse colon

577

3285

1.90

39.44

2.9

2.4

6.63

7.32

ug/l

0.37

513

2875

Disorders of muscles

487

2620

1.97

38.85

2.7

2.2

11.31

8.62

ug/l

1.13

437

2301

Nonorganic sleeping disorders

737

4451

1.72

38.78

3.1

2.2

4.93

7.29

ug/l

4.92

613

3924

Disorders of vestibular function (Vertigo)

2209

16493

1.37

38.74

2.5

2.3

6.08

6.86

ug/l

0.82

1850

14242

Early onset COPD

1136

7638

1.55

38.44

2.8

2.3

8.07

8.04

ug/l

0.01

993

6750

Unspecified fall

2236

16709

1.36

38.30

2.6

2.3

6.38

7.26

ug/l

1.34

1809

14394

Exposure to unspecified factor

4344

27412

1.25

38.29

2.4

2.3

8.48

7.10

ug/l

2.33

3649

23938

Kela-code for severe mental illness

1541

10937

1.44

38.12

2.5

2.3

5.64

7.79

ug/l

4.35

1323

9573

Trochanteric bursitis

620

3607

1.80

38.04

2.5

2.3

5.95

6.95

ug/l

0.47

527

3091

Acute alcohol intoxication, ICD10

887

5648

1.63

38.01

3.1

2.3

5.84

8.56

ug/l

4.37

790

5058

1197

7726

1.54

38.01

2.7

2.5

4.68

6.20

ug/l

4.83

940

6381

Unspecified misadventure during surgical and medical care

307

1423

2.37

37.99

3.1

2.4

5.61

7.11

ug/l

1.32

277

1267

Benign neoplasm: Ascending colon

712

4334

1.75

37.93

2.6

2.4

6.07

6.89

ug/l

0.68

632

3756

Haemorrhage, not elsewhere classified

232

955

2.72

37.88

2.8

2.1

9.18

7.31

ug/l

0.63

205

816

Parodontitis or/and operation codes

2917

13428

1.32

37.87

2.3

2.4

7.67

6.97

ug/l

0.74

2570

11829

Fracture of femur

1439

9250

1.48

37.86

2.5

6.15

6.45

ug/l

0.23

1156

7672

Pleural effusion

857

5455

1.66

37.80

2.9

2.4

7.58

6.98

ug/l

0.27

746

4693

Symptoms and signs involving speech and voice

1502

10663

1.45

37.69

2.5

2.3

6.41

6.93

ug/l

0.39

1252

9193

L04AX Other immunosuppressants

2349

17846

1.34

37.67

2.3

8.88

7.14

ug/l

1.49

2049

15613

Other aneurysm

331

1589

2.29

37.57

3.3

2.4

8.60

7.12

ug/l

0.59

296

1370

Disorders of skin appendages

1866

13696

1.39

37.44

2.3

2.2

6.96

7.46

ug/l

0.35

1625

11991

Benign neoplasm: Ascending colon

712

4350

1.75

37.41

2.6

2.4

6.07

7.39

ug/l

1.33

632

3767

Hydrocephalus

444

2366

2.03

37.39

2.5

2.4

4.96

7.03

ug/l

2.16

372

2002

Benign neoplasm: Transverse colon

577

3342

1.86

37.22

2.9

2.4

6.63

7.69

ug/l

0.65

513

2908

Propionic acid derivatives

1437

4969

1.49

37.13

2.4

2.3

6.08

9.58

ug/l

10.76

1227

4308

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

500

2765

1.93

37.11

2.9

2.4

7.60

7.20

ug/l

0.14

447

2426

Unspecified mental disorder

1662

11997

1.42

37.11

2.5

2.3

5.90

7.72

ug/l

3.22

1427

10501

Complications of cardiac and vascular prosthetic devices, implants and grafts

163

574

3.38

37.09

3.2

2.4

13.63

6.12

ug/l

1.72

146

501

Diplopia

635

3762

1.78

36.81

2.9

2.3

7.73

7.40

ug/l

0.11

554

3293

severe traumatic brain injury, does not include concussion

1159

7899

1.53

36.77

2.5

2.4

6.68

7.21

ug/l

0.48

975

6748

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2250

16690

1.35

36.71

2.4

2.3

8.39

7.94

ug/l

0.25

1940

14749

Fracture of lower leg, including ankle

2461

18822

1.33

36.62

2.4

2.3

6.01

7.32

ug/l

2.46

2112

16414

Other shoulder lesions

415

2157

2.03

36.61

2.4

2.2

6.68

8.81

ug/l

1.08

356

1917

Second line medication for Crohn's disease

2387

18265

1.33

36.34

2.3

8.88

7.14

ug/l

1.51

2080

15982

Other pleural conditions

594

3486

1.82

36.30

2.9

2.4

6.16

7.15

ug/l

1.01

509

2983

Corns and callosities

370

1870

2.14

36.14

3.1

2.4

6.40

7.44

ug/l

0.47

316

1651

Irregular menses

1435

8172

1.45

36.06

2.0

2.1

5.36

5.85

ug/l

0.37

1220

7085

Vascular diseases of the intestine

252

1105

2.56

36.04

3.3

2.5

6.93

6.34

ug/l

0.17

224

931

Mixed hyperlipidaemia

249

1083

2.55

35.95

2.9

2.2

7.51

7.41

ug/l

0.02

220

959

529

2982

1.85

35.83

2.3

2.1

17.99

7.00

ug/l

4.90

468

2605

Diabetic retinopathy

1750

8068

1.42

35.67

2.8

2.5

6.81

7.08

ug/l

0.20

1498

7028

Acute gastritis

420

2226

2.02

35.61

2.8

2.3

4.84

7.54

ug/l

4.17

357

1938

Post-traumatic stress disorder

249

1066

2.43

35.52

2.2

1.9

5.32

6.43

ug/l

0.61

215

942

Complications of internal orthopaedic prosthetic devices, implants and grafts

1132

7747

1.52

35.19

2.6

2.4

6.02

6.76

ug/l

0.60

954

6591

Diagnoses used for exclusion with ILD

1267

8852

1.48

35.02

2.7

2.4

9.65

7.28

ug/l

1.50

1091

7605

Other enthesopathies

1235

8559

1.48

34.95

2.3

2.1

6.38

8.03

ug/l

1.28

1080

7486

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

404

2129

2.04

34.92

3.2

2.4

6.82

6.56

ug/l

0.09

354

1860

Decubitus ulcer and pressure area

343

1720

2.18

34.66

2.8

2.4

9.54

6.99

ug/l

1.41

264

1457

Other diseases of hard tissues of teeth

2733

15889

1.30

34.53

2.4

2.2

7.43

7.15

ug/l

0.24

2383

13992

Other and unspecified visual disturbances

453

2485

1.94

34.31

2.6

2.4

6.38

6.91

ug/l

0.33

393

2194

Schizophrenia, schizotypal and delusional disorders

1278

8943

1.47

34.27

2.5

2.3

5.77

7.94

ug/l

3.36

1071

7842

Lesion of ulnar nerve

656

3991

1.72

34.22

2.6

2.3

7.64

8.43

ug/l

0.29

581

3554

Other respiratory disorders and diseases

1076

7337

1.53

34.19

2.9

2.4

8.10

7.00

ug/l

0.90

912

6225

Other diseases of the respiratory system

1076

7337

1.53

34.19

2.9

2.4

8.10

7.00

ug/l

0.90

912

6225

Other extrapyramidal and movement disorders in other diseases

1065

7242

1.53

34.08

2.6

2.4

5.16

7.01

ug/l

4.31

882

6262

Gangrene, not elsewhere classified

166

5.91

34.07

3.1

2.0

3.61

8.83

ug/l

2.05

141

Septal defects

270

1201

2.34

34.04

2.2

2.3

14.58

7.05

ug/l

4.28

238

1059

Intestinal adhesions without obstruction

436

2375

1.96

33.98

2.6

2.3

4.96

7.40

ug/l

4.33

366

2076

Other noninfective gastroenteritis and colitis

1066

7229

1.52

33.90

2.7

2.3

5.29

7.14

ug/l

4.03

904

6181

Schizophrenia or delusion

1267

8873

1.46

33.83

2.5

2.3

5.78

7.91

ug/l

3.22

1066

7788

Asthma and allergy, excluding more controls

376

1899

2.01

33.78

2.2

1.8

5.88

5.99

ug/l

0.04

334

1666

Intracerebral haemorrhage

672

4148

1.71

33.51

2.4

2.3

6.46

6.65

ug/l

0.10

571

3463

Menorrhagia

1346

5186

1.47

33.37

2.2

4.84

6.26

ug/l

2.65

1092

4422

Idiopathic gout

532

3112

1.84

33.28

3.0

2.4

5.48

7.51

ug/l

2.00

455

2723

Dental pulpitis 4, only avohilmo

5268

22981

1.21

33.20

2.4

2.3

7.10

7.25

ug/l

0.18

4617

19853

Ovarian cyst

1305

5239

1.47

33.12

2.2

4.38

6.11

ug/l

3.50

1085

4500

Other viral diseases

1054

7136

1.51

32.97

2.6

2.2

9.24

7.53

ug/l

0.95

929

6276

Fentanyl

539

3148

1.81

32.95

2.8

2.3

5.82

6.78

ug/l

0.41

431

2683

Hypertensive Renal Disease

217

923

2.60

32.87

2.6

2.2

6.94

7.77

ug/l

0.22

180

777

Right bundle-branch block

185

728

2.78

32.73

2.5

1.9

8.28

6.27

ug/l

0.45

147

615

Ulcer of oesophagus

414

2255

1.98

32.70

3.1

2.3

5.62

7.83

ug/l

1.07

375

1974

Superficial injury of abdomen, lower back and pelvis

645

3944

1.70

32.70

2.6

2.3

4.61

7.40

ug/l

7.19

556

3437

Acute posthaemorrhagic anaemia

228

998

2.55

32.66

3.4

2.4

8.74

6.70

ug/l

0.38

189

842

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

262

1194

2.31

32.64

2.4

2.2

5.72

8.25

ug/l

1.47

233

1073

Dementia, including avohilmo

2369

12650

1.33

32.62

2.5

5.33

6.58

ug/l

3.68

1737

10890

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1292

9155

1.45

32.60

2.5

2.3

6.80

7.46

ug/l

0.56

1041

7964

Benign paroxysmal vertigo

1328

9485

1.45

32.49

2.6

2.3

6.25

6.81

ug/l

0.31

1102

8162

Hyperkinetic disorders, excluding more controls

223

917

2.43

32.30

1.8

1.7

4.30

6.80

ug/l

2.11

191

795

Insulin, fast-acting (human)

605

3647

1.72

32.25

2.6

2.2

7.37

7.68

ug/l

0.15

532

3169

Unspecified acute lower respiratory infection

685

4273

1.67

32.24

3.0

2.3

8.30

7.92

ug/l

0.10

609

3742

Other diseases of arteries and capillaries

462

2603

1.89

32.20

2.8

2.3

6.80

6.88

ug/l

0.04

399

2247

Charcot foot

256

4.21

32.11

2.6

1.8

4.53

7.45

ug/l

1.83

222

Other diseases of lip and oral mucosa

736

4677

1.64

32.09

2.4

2.3

7.57

7.18

ug/l

0.11

644

4048

Disorders of other endocrine glands

1832

13535

1.36

31.98

2.8

2.3

6.60

6.82

ug/l

0.15

1530

11572

KRA_PSY_EATING, excluding more controls

205

838

2.51

31.96

2.1

1.8

5.28

5.84

ug/l

0.15

173

730

Disorders of oesophagus in diseases classified elsewhere

145

519

3.25

31.78

3.2

2.4

4.86

7.22

ug/l

1.48

131

451

Umbilical hernia

1223

8640

1.46

31.69

2.6

2.3

5.69

8.62

ug/l

8.79

1096

7648

Generalized anxiety disorder

471

2652

1.83

31.63

2.1

7.09

7.10

ug/l

0.00

374

2350

Panniculitis affecting regions of neck and back

200

830

2.62

31.60

2.6

2.2

6.00

7.39

ug/l

0.53

181

739

Disorders of sclera, cornea, iris and ciliary body

2332

18139

1.31

31.59

2.5

2.3

6.35

7.48

ug/l

1.44

2043

15792

Inflammatory diseases of female pelvic organs

2102

12068

1.33

31.56

2.2

4.62

5.77

ug/l

2.67

1739

10320

Enlarged lymph nodes

627

3840

1.69

31.39

2.3

2.1

6.76

8.25

ug/l

0.79

541

3358

Abnormal findings on examination of blood, without diagnosis

2279

16576

1.32

31.29

2.7

2.4

7.38

7.89

ug/l

0.53

2043

14406

Extrapyramidal and movement disorders

1762

13249

1.37

31.19

2.6

2.4

5.34

7.03

ug/l

5.81

1431

11426

Dementia

2210

11779

1.33

31.08

2.5

5.24

6.59

ug/l

3.91

1611

10120

Urticaria and erythema

1381

9964

1.42

31.08

2.6

2.3

5.53

7.09

ug/l

2.94

1164

8652

Artificial opening status

276

1326

2.26

31.07

2.5

2.2

5.13

6.54

ug/l

0.93

242

1161

Brachial plexus disorders

353

1833

2.01

31.07

2.2

2.1

4.80

7.48

ug/l

1.54

315

1648

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

184

739

2.69

31.01

2.6

2.1

9.82

8.18

ug/l

0.42

166

682

Dental pulpitis 1, only avohilmo

5254

23068

1.20

30.93

2.4

2.3

7.02

7.29

ug/l

0.38

4602

19931

Sub-endpoint used in defining T1D endpoints

1331

9402

1.43

30.92

2.7

2.3

6.89

7.26

ug/l

0.32

1171

8020

Other viral diseases, not elsewhere classified

722

4580

1.62

30.91

2.7

2.2

9.32

7.44

ug/l

0.81

637

4023

Amputation of thigh

207

896

2.63

30.85

3.0

2.7

6.28

6.23

ug/l

0.01

173

752

Diseases of external ear

1480

10845

1.40

30.76

2.3

6.07

7.44

ug/l

2.14

1124

9487

Other arthritis (FG)

1296

9283

1.43

30.67

2.4

2.3

7.90

7.75

ug/l

0.06

1130

8120

Arterial embolism and thrombosis

340

1771

2.08

30.65

3.5

2.5

10.11

6.65

ug/l

1.49

296

1494

Persistent mood disorders

813

5332

1.58

30.48

2.8

2.2

6.12

7.36

ug/l

0.67

663

4632

Other problems related to primary support group, including family circumstances

364

1867

1.97

30.34

2.4

2.2

4.42

6.36

ug/l

2.53

316

1639

Dissociative [conversion] disorders

155

576

2.87

30.23

2.9

2.2

3.84

5.98

ug/l

0.85

131

510

Other benign neoplasms of skin

1705

12561

1.37

30.16

2.5

2.4

6.71

7.60

ug/l

0.64

1428

10848

Pain and other conditions associated with female genital organs and menstrual cycle

556

3178

1.72

30.13

1.7

2.1

4.84

6.54

ug/l

0.90

453

2778

Other symptoms and signs involving general sensations and perceptions

209

908

2.52

30.06

2.8

2.3

5.61

6.87

ug/l

0.36

173

771

Reimbursement for rheumatic diseases

2516

19836

1.29

30.01

2.3

6.61

6.93

ug/l

0.23

2175

17159

Adhesive capsulitis of shoulder

766

4987

1.60

30.00

2.4

2.2

5.09

8.07

ug/l

7.20

681

4335

Other local infections of skin and subcutaneous tissue

471

2720

1.83

30.00

2.8

2.3

5.68

7.47

ug/l

1.81

408

2399

Correction of physiology of bite - demanding therapy visit

282

1375

2.17

29.85

2.5

2.2

3.59

6.74

ug/l

7.61

252

1233

Chronic pancreatitis

614

3816

1.70

29.85

2.9

2.3

4.35

8.87

ug/l

15.44

532

3394

Diseases of inner ear

2508

19443

1.29

29.66

2.5

2.3

6.27

6.98

ug/l

0.80

2098

16838

Asthma and allergy

376

1986

1.92

29.64

2.2

1.9

5.88

6.93

ug/l

0.50

334

1748

Any dementia, excluding more controls

1845

9717

1.36

29.48

2.6

2.4

5.37

6.61

ug/l

2.93

1326

8376

Postmenopausal bleeding

1198

4609

1.47

29.45

2.6

2.2

4.95

6.35

ug/l

2.03

977

3938

Zoster [herpes zoster]

856

5744

1.55

29.43

2.7

2.4

6.92

6.83

ug/l

0.05

716

4877

COPD, hospital admissions 3, with asthma pneumonia sepsis

1467

9196

1.41

29.40

3.1

2.4

6.72

7.15

ug/l

0.39

1200

7861

Abdominal aortic aneurysm (AAA)

593

3640

1.71

29.39

3.0

2.4

7.58

6.57

ug/l

0.66

513

3047

Fibromyalgia

308

1554

2.07

29.39

2.1

2.0

3.28

6.15

ug/l

4.74

256

1345

Other specified and unspecified personality disorders

355

1883

1.97

29.39

2.5

2.2

4.91

8.08

ug/l

4.06

296

1707

Injuries to the elbow and forearm

2922

21253

1.26

29.20

2.4

2.3

6.99

6.96

ug/l

0.02

2454

18409

Toxic effects of substances chiefly nonmedicinal as to source

478

2786

1.79

29.17

2.8

2.3

5.78

7.96

ug/l

2.54

429

2488

Trigger finger

604

3757

1.67

28.71

2.5

2.2

6.26

8.23

ug/l

2.10

531

3288

Dislocation, sprain and strain of joints and ligaments at neck level

538

3243

1.71

28.62

2.3

5.20

6.96

ug/l

1.93

474

2883

Use of other anti-dementia drugs

1380

8830

1.41

28.54

2.4

2.6

4.83

5.97

ug/l

2.43

956

7308

Use of memantine

1380

8830

1.41

28.54

2.4

2.6

4.83

5.97

ug/l

2.43

956

7308

Abnormalities of gait and mobility

595

3717

1.69

28.47

2.5

2.3

6.15

7.09

ug/l

0.91

522

3189

Superficial injury of hip and thigh

699

4517

1.61

28.47

2.6

2.4

6.14

6.95

ug/l

0.47

575

3825

Phobic anxiety disorders

390

2143

1.87

28.38

2.4

2.0

5.16

7.34

ug/l

1.44

340

1899

Osteomyelitis

342

1833

2.01

28.34

2.8

2.3

8.18

7.59

ug/l

0.19

292

1625

Viral pneumonia (unknown virus, not influenza)

305

1565

2.07

28.29

2.8

2.3

11.99

7.14

ug/l

1.51

262

1392

Other infectious diseases

413

2344

1.88

28.29

3.0

2.4

7.16

7.02

ug/l

0.05

374

2031

Mental and behavioural disorders due to sedatives or hypnotics

290

1459

2.10

28.28

2.5

2.2

6.01

8.14

ug/l

1.30

236

1313

Benign neoplasm: Rectum

892

6102

1.53

28.16

2.4

5.34

7.43

ug/l

3.30

760

5285

Benign neoplasm: Caecum

534

3268

1.74

28.05

2.8

2.4

5.80

7.12

ug/l

1.40

471

2841

Urticaria

1080

7605

1.45

28.03

2.6

2.2

5.22

7.09

ug/l

3.16

913

6633

Benign neoplasm: Rectum

892

6112

1.53

27.93

2.4

5.34

7.89

ug/l

4.55

760

5328

TMD related operations

618

3889

1.64

27.80

2.4

2.2

4.47

7.63

ug/l

7.58

557

3488

Other and unspecified local infections of skin and subcutaneous tissue

437

2529

1.82

27.68

2.9

2.3

5.80

7.32

ug/l

1.36

386

2227

Primary gonarthrosis, bilateral

2457

17112

1.28

27.63

2.4

5.85

7.43

ug/l

2.80

2041

14795

Other benign neoplasms of skin

1705

12977

1.35

27.62

2.5

2.3

6.71

6.92

ug/l

0.11

1428

11153

Speech and linguistic disorders, excluding more controls

230

994

2.25

27.61

2.1

6.97

6.94

ug/l

0.01

197

864

Chronic periodontitis, complicated

476

2835

1.78

27.52

2.7

2.3

10.81

8.37

ug/l

1.24

423

2534

Alzheimer’s disease (Atypical or mixed)

528

3233

1.74

27.51

2.8

2.6

5.20

5.45

ug/l

0.14

381

2616

Status epilepticus

189

818

2.51

27.37

2.9

2.3

8.27

7.68

ug/l

0.08

160

720

Anti-inflammatory and antirheumatic products, non-steroids

1370

4969

1.41

27.37

2.4

2.3

6.00

9.58

ug/l

12.18

1186

4308

Parkinson's disease, excluding more controls

610

3753

1.65

27.32

2.4

2.2

6.30

8.60

ug/l

2.75

458

3280

Other other unspecified disorders of the circulatory system

215

991

2.39

27.24

3.2

2.4

13.12

7.20

ug/l

2.28

197

860

Varicose veins

3011

18491

1.25

27.24

2.5

2.3

5.49

7.01

ug/l

4.64

2555

15970

Acute peritonitis

340

1842

1.98

27.23

3.2

2.5

7.72

7.10

ug/l

0.16

308

1618

Rheumatism, unspecified

563

3490

1.67

27.09

2.3

2.2

4.44

7.04

ug/l

3.66

469

3001

Benign neoplasm: Rectum, anus and anal canal

993

6979

1.48

27.08

2.4

5.56

7.27

ug/l

2.55

847

6035

Conjunctivitis (acute, non atopic)

1056

7434

1.45

27.06

2.5

2.3

4.98

7.26

ug/l

5.13

913

6514

Parkinson's disease, strict definition, excluding more controls

575

3520

1.67

27.06

2.4

2.2

6.33

8.43

ug/l

2.26

426

3074

Other diseases of pancreas

389

2203

1.89

26.99

2.4

2.3

5.27

7.88

ug/l

3.89

347

1942

Diseases of peritoneum

500

3030

1.74

26.87

2.9

2.4

6.94

7.00

ug/l

0.02

438

2629

Enthesopathies of lower limb, excluding foot

835

5651

1.52

26.85

2.3

2.1

6.63

8.66

ug/l

1.60

707

4976

Fracture of skull and facial bones

876

6004

1.50

26.59

2.8

2.3

7.80

8.10

ug/l

0.13

737

5293

Retinal vascular occlusion

640

4140

1.63

26.58

2.7

2.4

6.69

6.98

ug/l

0.11

546

3513

Use of pramipexole

1032

7325

1.46

26.46

2.6

2.4

5.37

7.05

ug/l

2.57

857

6283

Retinal vascular disorders

649

4214

1.62

26.46

2.7

2.4

6.67

6.96

ug/l

0.11

555

3574

Benign neoplasm: Rectum, anus and anal canal

993

7011

1.47

26.42

2.4

5.56

7.68

ug/l

3.64

847

6081

Type of accident

1172

8476

1.42

26.39

2.4

6.93

7.31

ug/l

0.25

938

7354

Acidosis

128

474

3.09

26.25

3.2

2.3

7.80

7.33

ug/l

0.12

110

424

Injuries to the ankle and foot

2609

19108

1.26

26.21

2.5

2.2

7.15

7.68

ug/l

0.54

2251

16818

Secondary parkinsonism, excluding more controls

142

550

2.85

26.21

3.2

2.2

4.87

7.21

ug/l

1.35

114

492

Other disorders of eyelid

2100

15978

1.30

26.19

2.5

2.3

5.41

6.94

ug/l

4.07

1758

13730

Gastrojejunal ulcer

295

3.76

25.89

3.0

2.5

4.79

9.08

ug/l

1.42

259

Failure and rejection of transplanted organs and tissues

269

3.86

25.85

2.4

2.3

30.43

6.84

ug/l

2.38

244

Chondrocostal junction syndrome [Tietze]

193

866

2.43

25.83

3.2

2.4

5.46

7.11

ug/l

0.66

169

769

Lung diseases due to external agents

712

4733

1.57

25.80

2.8

2.4

8.96

7.01

ug/l

0.77

590

4029

ILD, hospital admission 2, with pulmonary infections

475

2876

1.75

25.75

2.8

2.3

10.41

7.45

ug/l

2.19

412

2475

Other and unspecified tonsillitis

1063

6400

1.43

25.51

2.1

2.0

7.73

8.64

ug/l

0.42

935

5768

Mental and behavioural disorders due to opioids

145

570

2.70

25.38

5.2

2.2

12.28

9.36

ug/l

0.33

130

518

Amputation of foot

171

745

2.62

25.33

2.8

2.6

5.76

7.25

ug/l

0.81

152

663

Bacterial pneumonia (organism specified)

2115

15220

1.29

25.30

2.7

2.3

7.08

7.18

ug/l

0.08

1818

12977

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

435

2310

1.75

25.25

2.0

2.1

4.60

7.10

ug/l

3.36

379

2024

Chronic rhinitis, nasopharyngitis and pharyngitis

1216

8901

1.40

25.24

2.2

5.88

7.57

ug/l

2.98

1036

7816

2077

15459

1.30

25.21

2.5

2.4

5.67

6.69

ug/l

2.11

1762

13087

Unspecific neurodegenerative disorder

2136

11638

1.30

25.19

2.4

2.5

5.25

6.42

ug/l

2.98

1563

9891

Embolic stroke with flimmer

158

659

2.66

25.17

2.7

2.2

6.42

5.68

ug/l

0.22

133

537

Noninfectious colitis NAS

575

3654

1.64

25.13

2.7

2.3

4.95

7.20

ug/l

4.27

484

3184

Other pulmonary heart/vessel disease

272

1413

2.10

25.12

2.7

2.6

18.99

6.68

ug/l

3.12

236

1204

Keratitis

1451

10934

1.36

25.04

2.5

2.3

6.96

7.54

ug/l

0.32

1259

9523

Normal-pressure hydrocephalus

310

1692

2.01

24.98

2.6

2.5

4.61

6.22

ug/l

1.59

261

1426

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

490

2983

1.69

24.96

2.1

2.2

4.12

5.44

ug/l

1.25

418

2552

Adverse effects, not elsewhere classified

704

4675

1.55

24.90

2.6

2.3

4.72

7.23

ug/l

5.45

606

4076

Voice disturbances

1111

8053

1.42

24.87

2.4

2.3

5.90

7.00

ug/l

1.01

946

6975

Benign neoplasm: Caecum

534

3374

1.68

24.74

2.8

2.4

5.80

7.35

ug/l

1.83

471

2921

Elevated blood glucose level

390

2261

1.82

24.71

2.7

2.3

8.58

6.94

ug/l

0.50

338

1987

Injuries to the wrist and hand

4214

25823

1.20

24.64

2.3

7.44

7.40

ug/l

0.03

3660

22591

Appendectomy

2541

19779

1.25

24.63

2.3

2.2

5.86

7.62

ug/l

3.34

2254

17326

Early lumbar disc prolapse, operated

295

1560

1.95

24.39

1.9

5.83

10.81

ug/l

2.95

272

1423

Diseases of salivary glands

801

5492

1.50

24.37

2.5

2.2

6.10

7.14

ug/l

0.77

684

4767

Contact with and exposure to communicable diseases

368

6279

0.57

24.28

1.9

2.1

12.93

7.17

ug/l

1.54

311

5562

Transient global amnesia

470

2895

1.72

24.08

2.4

5.97

7.01

ug/l

0.76

413

2541

Covid-19 suspected case

705

4717

1.53

23.93

3.3

2.2

5.02

6.94

ug/l

3.26

606

4161

Transport accidents

1806

12462

1.30

23.85

2.4

2.2

7.09

7.68

ug/l

0.40

1556

11111

Other and unspecified injuries of head

293

1577

1.98

23.80

2.5

2.3

6.47

7.54

ug/l

0.35

245

1380

Lateral epicondylitis

522

3285

1.64

23.62

2.2

2.1

7.31

8.59

ug/l

0.33

461

2936

Open wound of lower leg

637

4204

1.57

23.62

2.7

2.3

6.97

7.52

ug/l

0.28

536

3659

Certain disorders involving the immune mechanism

809

5603

1.49

23.54

2.5

2.3

9.13

7.48

ug/l

0.69

721

4926

Superficial injury of thorax

653

4338

1.56

23.47

2.6

2.3

7.09

7.53

ug/l

0.17

562

3772

Basal cell carcinoma, including avohilmo

2881

18684

1.24

23.47

2.5

2.4

5.96

6.97

ug/l

2.61

2413

15955

Focal brain injury

291

1564

1.96

23.42

2.6

2.2

7.06

8.85

ug/l

0.96

246

1398

Cerebral cysts

233

1163

2.12

23.35

2.8

2.3

13.65

6.80

ug/l

1.60

209

1027

Skin changes due to chronic exposure to nonionizing radiation

1965

14755

1.29

23.35

2.6

2.4

5.55

6.61

ug/l

2.21

1670

12461

Other specified/unspecified arthritis

1075

7821

1.41

23.32

2.4

2.3

8.58

8.02

ug/l

0.21

929

6859

Tobacco use

237

1196

2.12

23.26

2.5

2.3

7.13

7.56

ug/l

0.05

210

1080

Vitreous haemorrhage

482

3010

1.69

23.14

2.7

2.4

6.44

7.59

ug/l

1.04

431

2629

Actinic keratosis

1926

14500

1.30

23.12

2.6

2.5

5.62

6.61

ug/l

1.93

1636

12232

Pneumonitis due to solids and liquids

424

2568

1.75

23.09

2.9

2.4

8.94

7.11

ug/l

0.37

334

2188

Disorders resulting from impaired renal tubular function

200

961

2.29

22.93

2.1

2.4

5.83

7.26

ug/l

0.95

179

854

Shock, not elsewhere classified

216

4.09

22.90

2.8

2.3

18.14

8.05

ug/l

1.37

187

COPD, hospital admissions 1, only main diagnosis

1784

11921

1.31

22.89

2.9

2.4

7.18

7.34

ug/l

0.11

1495

10242

Malignant neoplasm of skin

3106

19431

1.23

22.88

2.5

2.4

6.11

7.02

ug/l

2.15

2581

16684

Coagulation defects, purpura and other haemorrhagic conditions

797

5534

1.49

22.86

2.6

2.3

8.14

7.27

ug/l

0.57

695

4784

Hallux rigidus

643

4287

1.56

22.83

2.5

2.3

5.38

7.79

ug/l

4.47

530

3724

Diseases of liver

1472

11278

1.34

22.82

2.5

2.3

7.81

7.73

ug/l

0.04

1275

9887

Other disorders of glucose regulation and pancreatic internal secretion

381

2243

1.78

22.75

2.6

2.4

5.58

7.00

ug/l

1.10

335

1946

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

267

1408

1.99

22.75

2.7

2.2

4.36

7.20

ug/l

3.54

229

1254

Viral pneumonia (known virus, not influenza)

140

582

2.69

22.68

3.3

2.5

5.55

7.35

ug/l

0.83

128

518

Seborrhoeic dermatitis

448

2758

1.71

22.67

2.6

2.3

6.14

7.97

ug/l

1.34

395

2445

Eating disorders

302

1648

1.88

22.59

2.4

2.3

7.38

5.96

ug/l

0.22

263

1434

Moderate visual impairment, binocular

185

869

2.35

22.51

2.5

2.6

7.07

5.77

ug/l

0.16

102

716

Secondary right heart disease

243

1263

2.10

22.49

2.8

2.6

19.62

6.59

ug/l

3.05

212

1072

Other necrotizing vasculopathies (FG)

300

1660

1.93

22.48

2.9

2.4

4.95

7.60

ug/l

3.49

247

1446

Visual field defects

410

2477

1.75

22.46

2.5

2.4

5.51

6.87

ug/l

1.33

350

2163

COPD-related respiratory insufficiency

615

4094

1.58

22.45

2.6

2.4

10.24

7.20

ug/l

1.59

493

3512

Other condition

557

3608

1.60

22.42

2.5

2.3

7.51

7.62

ug/l

0.03

485

3191

Polymyalgia rheumatica

687

4688

1.54

22.24

2.6

2.4

5.96

6.57

ug/l

0.43

559

3921

Other/unspecified cytomegaloviral diseases

110

413

3.00

21.90

2.6

2.3

16.96

7.13

ug/l

1.29

100

370

Disorders of calcium metabolism

281

1533

1.95

21.90

2.7

2.2

4.93

7.06

ug/l

2.37

234

1350

Basal cell carcinoma

2805

18490

1.23

21.90

2.5

2.4

5.98

6.95

ug/l

2.39

2345

15778

Amputation of ankle bones

144

620

2.63

21.81

3.2

2.6

5.34

7.04

ug/l

0.97

130

541

Other bursopathies

585

3862

1.57

21.75

2.6

2.2

7.84

8.12

ug/l

0.06

496

3342

Seropositive rheumatoid arthritis

1101

8123

1.39

21.73

2.3

6.40

7.08

ug/l

0.37

944

7004

Disorders of ocular muscles, binocular movement, accommodation and refraction

1712

13325

1.29

21.58

2.3

7.08

7.28

ug/l

0.12

1476

11633

Coxarthrosis, primary, with hip surgery

2284

17621

1.26

21.54

2.5

2.4

6.40

6.98

ug/l

0.80

1964

15097

Sulfasalazine

1150

8567

1.37

21.46

2.3

2.2

6.85

7.16

ug/l

0.15

1027

7485

Disorders of mineral metabolism

351

2055

1.80

21.44

2.6

2.1

5.02

7.53

ug/l

3.01

289

1799

Cerebral palsy and other paralytic syndromes

486

3089

1.64

21.37

2.7

2.4

6.60

7.36

ug/l

0.45

405

2693

Other embolism and thrombosis

602

4022

1.56

21.28

2.6

2.3

10.29

7.57

ug/l

0.71

516

3485

Amenorrhoea

175

804

2.24

21.26

2.0

2.5

5.06

5.67

ug/l

0.25

151

696

Somnolence, stupor and coma

216

1091

2.12

21.24

2.9

2.4

9.52

7.54

ug/l

0.31

195

951

Congenital malformations of pulmonary and tricuspid valves

5.52

21.19

2.0

2.6

32.21

7.28

ug/l

2.10

Disorders of parathyroid gland

983

7105

1.41

21.05

2.7

2.4

6.01

6.18

ug/l

0.10

798

5947

Cardiomyopathy in other diseases

5.91

21.03

3.3

2.1

4.80

5.00

ug/l

0.07

Other and unspecified disorders of vitreous body

1783

14087

1.29

20.95

2.5

2.3

6.09

7.15

ug/l

0.98

1578

12264

Assault

440

2736

1.66

20.83

2.5

2.2

6.85

8.89

ug/l

0.75

378

2472

Acute suppurative otitis media

732

4722

1.47

20.74

2.2

2.1

7.91

7.43

ug/l

0.13

631

4176

Fissure and fistula of anal and rectal regions

990

7252

1.40

20.72

2.3

2.2

6.99

8.10

ug/l

0.60

820

6415

Peritonsillar abscess

734

5098

1.47

20.67

2.2

5.48

8.13

ug/l

6.50

652

4559

Wet age-related macular degeneration

918

6565

1.43

20.65

2.5

5.42

6.06

ug/l

0.72

724

5410

Anaemia in chronic diseases classified elsewhere

150

673

2.50

20.63

2.5

2.4

9.83

7.28

ug/l

0.43

135

588

Hypoglycaemia, other or unspecified

305

1737

1.85

20.57

2.6

2.4

5.22

6.92

ug/l

2.03

269

1514

Any dementia

1965

11110

1.28

20.53

2.6

2.5

5.35

6.28

ug/l

2.06

1403

9441

Fracture of shoulder and upper arm

1523

11884

1.31

20.41

2.4

2.3

8.91

7.22

ug/l

1.04

1239

10162

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1298

8630

1.33

20.40

2.1

4.95

6.11

ug/l

1.74

1155

7469

Other congenital malformations of the digestive system

183

874

2.21

20.37

2.8

2.4

6.47

7.37

ug/l

0.25

164

770

Ascites

327

1910

1.81

20.29

2.7

2.3

7.40

8.23

ug/l

0.32

297

1683

Erythema intertrigo

139

607

2.55

20.25

3.1

2.6

5.47

6.62

ug/l

0.32

119

534

DVT of lower extremities

890

6452

1.42

20.25

2.5

2.4

6.74

7.37

ug/l

0.22

748

5551

Arterial embolism and thrombosis of lower extremity artery

205

1043

2.14

20.12

3.2

2.5

11.21

6.39

ug/l

1.48

176

883

Central retinal artery occlusion

145

651

2.51

20.04

2.5

2.6

4.34

6.73

ug/l

1.77

127

562

Other disorders of bone

755

5312

1.46

20.04

2.5

2.2

8.75

7.51

ug/l

0.43

631

4699

Unspecified privation

467

2990

1.63

20.02

2.4

9.57

7.40

ug/l

1.02

419

2620

Diabetic retinopathy, strict definition

847

5361

1.44

19.99

2.8

2.5

6.30

7.52

ug/l

1.55

722

4683

Cytomegalovirus infection, IBD co-morbidity

121

498

2.69

19.95

2.6

2.4

16.48

7.06

ug/l

1.36

110

447

Osteoporosis with pathological fracture (FG)

341

2032

1.79

19.94

3.0

2.5

5.98

5.86

ug/l

0.04

260

1674

Inflammatory bowel disease

1212

9206

1.34

19.82

2.6

2.3

6.17

7.95

ug/l

2.76

1067

8069

Use of disulfiram, acamprosate or naltrexone

375

2284

1.72

19.75

2.8

2.3

10.67

9.31

ug/l

0.20

332

2087

Other disorders of eye and adnexa

527

3469

1.57

19.73

2.5

2.3

5.74

6.74

ug/l

0.45

437

3030

Other diseases of oesophagus

462

2966

1.63

19.71

2.6

2.3

7.98

7.72

ug/l

0.06

379

2563

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2731

17983

1.22

19.60

2.5

2.4

5.92

6.93

ug/l

2.53

2264

15352

127

536

2.57

19.57

2.5

2.2

5.29

7.60

ug/l

0.70

121

491

Eating disorder

205

1031

2.04

19.56

2.1

2.2

5.28

5.29

ug/l

0.00

173

897

Other abnormal uterine and vaginal bleeding

885

4547

1.42

19.51

2.3

2.2

6.21

6.15

ug/l

0.02

629

3873

Sequelae of other external causes

249

1359

1.95

19.47

2.6

2.4

6.97

7.10

ug/l

0.03

233

1201

Combinations of oral blood glucose lowering drugs

1300

10036

1.33

19.36

2.6

2.3

6.02

8.54

ug/l

6.17

1155

8843

Strabismus

982

7254

1.38

19.21

2.4

2.3

6.79

7.28

ug/l

0.23

835

6318

Foreign body in alimentary tract

255

1409

1.92

19.20

3.1

2.4

4.44

7.34

ug/l

5.18

219

1259

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2677

15221

1.22

19.13

2.4

6.28

7.82

ug/l

4.21

2283

13236

Disorders of psychological development

301

1595

1.79

19.11

2.2

2.3

6.63

6.69

ug/l

0.02

255

1381

Open wound of wrist and hand

1693

13349

1.28

19.08

2.3

7.94

8.26

ug/l

0.18

1483

11865

Preterm labour and delivery

733

5163

1.45

19.06

2.4

2.0

4.67

6.15

ug/l

1.62

658

4486

Monoamine oxidase A inhibitors

502

3299

1.58

19.05

2.5

2.2

5.57

8.15

ug/l

3.58

423

2959

Examination and encounter for administrative purposes

181

890

2.16

19.05

2.4

2.1

9.29

8.01

ug/l

0.17

161

792

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1163

8812

1.34

18.89

2.6

2.1

7.53

7.72

ug/l

0.08

990

7763

Hypotension due to drugs

101

397

2.96

18.86

3.4

2.7

8.70

7.38

ug/l

0.20

348

Other diseases of jaws

288

1653

1.82

18.83

2.5

2.2

5.41

6.96

ug/l

0.82

250

1461

Embolic stroke

264

1490

1.90

18.73

2.5

6.89

6.44

ug/l

0.17

226

1267

Rheumatoid arthritis, including avohilmo

1653

13188

1.28

18.64

2.4

2.3

6.23

6.88

ug/l

0.52

1415

11326

Sulfonylureas

1903

12295

1.26

18.60

2.8

2.4

5.63

7.31

ug/l

4.95

1603

10402

TMD related pain

132

578

2.43

18.50

2.5

2.2

3.58

5.54

ug/l

1.61

118

522

Benign neoplasm: Skin of eyelid, including canthus

689

4861

1.47

18.49

2.6

2.4

7.11

6.89

ug/l

0.06

584

4183

Glucosamine medication

2443

16193

1.23

18.46

2.4

5.77

6.66

ug/l

1.83

2009

13872

Hallux valgus (acquired)

1401

7889

1.31

18.44

2.4

2.2

5.47

7.26

ug/l

4.00

1172

6814

Benign neoplasm: Descending colon

342

2089

1.74

18.36

2.8

2.5

6.71

7.40

ug/l

0.18

298

1837

Injury of muscle and tendon at shoulder and upper arm level

1603

12785

1.28

18.30

2.5

2.3

6.61

8.19

ug/l

1.84

1450

11306

Other hammer toe(s) (acquired)

784

5300

1.43

18.29

2.3

5.86

6.83

ug/l

0.75

611

4519

Tubulo-interstitial nephritis, not specified as acute or chronic

322

1926

1.75

18.28

2.8

2.4

6.32

6.48

ug/l

0.06

270

1633

Polyuria

1023

7705

1.37

18.25

2.6

2.4

6.20

7.38

ug/l

1.23

844

6756

Other specified/unspecified dorsopathies

164

792

2.21

18.23

2.5

2.2

4.33

7.71

ug/l

4.27

142

688

Benign neoplasm: Skin of eyelid, including canthus

689

4874

1.47

18.22

2.6

2.4

7.11

7.49

ug/l

0.10

584

4200

Unspecified visual impairment (binocular)

330

3.04

18.22

2.3

5.47

6.53

ug/l

0.26

287

Glaucoma

2667

19639

1.21

18.19

2.5

2.4

6.09

6.97

ug/l

1.24

2258

16816

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

394

2491

1.67

18.18

3.0

2.4

5.67

6.40

ug/l

0.51

340

2111

Benign neoplasm: Descending colon

342

2096

1.74

18.13

2.8

2.4

6.71

7.70

ug/l

0.28

298

1824

Superficial injury of wrist and hand

663

4637

1.46

18.12

2.4

2.3

5.86

7.35

ug/l

1.57

561

4084

Benign neoplasm: Colon, unspecified

1159

8857

1.34

18.11

2.5

6.45

7.90

ug/l

2.16

975

7670

Pregnancy hypertension

1115

7611

1.34

18.10

2.1

2.0

5.08

5.91

ug/l

0.90

992

6608

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1175

9013

1.33

18.08

2.3

7.51

8.04

ug/l

0.23

1032

7912

Cytomegaloviral disease

122

528

2.54

18.02

2.6

2.4

16.35

7.36

ug/l

1.29

111

472

Abnormal results of function studies

357

2200

1.70

18.01

2.7

2.4

9.06

6.88

ug/l

0.70

308

1955

Schizoaffective disorder

288

1672

1.79

18.01

2.9

2.2

4.90

7.63

ug/l

2.24

245

1510

Specific development disorders of scholastic skills

112

452

2.54

17.96

1.9

1.8

8.31

7.13

ug/l

0.20

393

Calcific tendinitis of shoulder

244

1354

1.89

17.94

2.5

2.2

5.46

8.03

ug/l

1.77

226

1207

Malignant neoplasm, wide definition for exclusion

3923

19976

1.17

17.92

2.2

2.3

6.35

7.94

ug/l

4.80

3378

17514

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3922

19972

1.17

17.91

2.2

2.3

6.35

7.94

ug/l

4.80

3376

17510

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3922

19974

1.17

17.87

2.2

2.3

6.35

7.94

ug/l

4.82

3377

17512

Mixed connective tissue disease

268

1535

1.84

17.79

2.5

2.3

10.49

6.68

ug/l

0.60

224

1345

Open wound of ankle and foot

411

2626

1.63

17.76

2.5

2.3

6.72

8.30

ug/l

0.94

369

2330

Otitis externa

849

6229

1.40

17.74

2.3

5.78

7.17

ug/l

1.47

705

5485

Outcome of delivery

1381

0.39

17.71

1.3

1.8

7.00

5.91

ug/l

0.29

1194

Alcohol-induced chronic pancreatitis

320

1935

1.75

17.70

3.2

2.3

4.69

9.57

ug/l

8.51

289

1764

Recurring oral aphthae, including avohilmo

531

3588

1.53

17.68

2.6

2.3

4.90

6.85

ug/l

3.12

452

3115

Hyperparathyroidism

862

6295

1.40

17.52

2.8

2.4

5.85

6.19

ug/l

0.18

703

5236

Lesion of lateral popliteal nerve

236

1313

1.91

17.48

2.7

2.4

7.87

7.71

ug/l

0.03

216

1176

Other specified/unspecified systemic involvement of connective tissue

247

1391

1.87

17.39

2.5

2.3

11.01

6.51

ug/l

0.68

210

1215

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2457

14050

1.22

17.38

2.4

6.08

7.65

ug/l

4.23

2076

12157

Alcohol withdrawal state with delirium

344

2131

1.71

17.32

3.1

2.4

6.73

9.25

ug/l

1.59

297

1938

Other disorders of kidney and ureter

581

4026

1.50

17.31

2.4

6.27

7.71

ug/l

1.47

516

3518

Other eating disorders

122

527

2.39

17.28

2.3

1.9

6.80

5.84

ug/l

0.17

100

462

Parodontitis, under 40 years and operation codes

176

878

2.05

17.23

1.7

2.1

8.48

6.09

ug/l

0.52

151

765

ILD, hospital admissions 3, with pneumonia sepsis

400

2573

1.64

17.19

2.9

2.3

10.66

7.33

ug/l

2.16

342

2198

Otitis externa, unspecified

411

2644

1.61

17.19

2.5

2.3

6.18

7.34

ug/l

0.52

362

2354

Parodontitis, operation under 40 years and operation codes

176

879

2.05

17.18

1.7

2.1

8.48

6.09

ug/l

0.53

151

766

Postprocedural disorders of nervous system

225

1228

1.90

17.17

2.3

2.0

3.65

6.75

ug/l

3.75

195

1098

Olecranon bursitis

302

1813

1.76

17.14

2.3

2.2

8.50

10.15

ug/l

0.24

257

1618

Hyperkinetic disorders

225

1206

1.88

17.12

1.8

2.1

4.31

7.37

ug/l

3.11

193

1045

Endometriosis

1149

5199

1.33

17.11

2.1

2.2

5.29

6.15

ug/l

0.67

958

4463

Benign neoplasm: Colon, unspecified

1159

8974

1.33

17.09

2.5

2.4

6.45

7.11

ug/l

0.68

975

7767

Exclusions for E4_PCOS_CONSORTIUM

2611

13688

1.21

17.05

2.4

2.2

5.78

6.50

ug/l

1.16

2165

11809

Inflammatory disease of uterus

393

2496

1.61

17.04

2.2

2.1

3.82

5.27

ug/l

1.68

332

2159

Obsessive-compulsive disorder

176

885

2.05

17.04

1.8

2.0

4.81

7.21

ug/l

1.91

149

785

Preparation and fitting of bite rail to mouth

471

3124

1.55

17.01

2.4

2.2

4.30

7.58

ug/l

6.79

429

2805

Cramp and spasm

204

1092

1.98

17.00

2.9

2.5

5.06

6.64

ug/l

0.71

168

980

Mixed and other personality disorders

271

1571

1.79

16.96

2.5

2.1

4.33

7.92

ug/l

4.32

228

1419

Paralytic ileus

194

1026

2.03

16.94

3.1

2.3

5.17

7.34

ug/l

2.09

169

903

Haemorrhage in early pregnancy

736

5165

1.41

16.93

2.1

5.25

6.09

ug/l

0.48

652

4465

Childhood asthma (age<16), excluding more controls

245

1073

1.84

16.88

1.8

1.6

8.46

5.21

ug/l

1.28

209

938

Superficial injury of forearm

353

2200

1.66

16.84

2.8

2.3

8.58

7.09

ug/l

0.26

298

1952

Pneumonia due to other infectious organisms, not elsewhere classified

157

773

2.19

16.78

2.3

2.2

7.32

7.41

ug/l

0.02

138

682

Other necrotizing vasculopathies

345

2157

1.69

16.76

2.8

2.4

4.92

6.64

ug/l

2.29

288

1878

Hypertrophic disorders of skin

204

1092

1.95

16.70

2.5

2.2

11.92

7.31

ug/l

0.57

181

972

Traumatic subarachnoid haemorrhage

167

842

2.12

16.64

2.3

8.16

7.41

ug/l

0.15

142

750

Disorders of continuity of bone

355

2225

1.66

16.62

2.4

2.3

9.26

7.26

ug/l

0.30

297

1979

Speech and linguistic disorders

232

1234

1.85

16.60

2.2

2.5

7.15

6.85

ug/l

0.08

199

1062

Restless leg syndrome

505

3432

1.53

16.54

2.7

2.3

5.18

6.87

ug/l

2.14

427

2993

Invasive ventilation

333

2069

1.69

16.49

2.2

2.4

12.09

7.40

ug/l

1.23

294

1813

Methotrexate

581

4048

1.48

16.47

2.3

2.2

5.27

7.02

ug/l

2.49

509

3519

Degenerative macular diseases

597

4207

1.48

16.38

2.6

2.4

5.39

6.84

ug/l

2.12

501

3550

Pain associated with micturition

478

3216

1.54

16.37

2.6

2.3

4.00

6.76

ug/l

7.18

373

2807

Duodenal ulcer

536

3697

1.51

16.36

2.7

2.3

6.47

7.46

ug/l

0.94

455

3175

Other metabolic disorders

436

2873

1.56

16.23

2.3

2.1

8.15

6.46

ug/l

0.68

374

2504

Speech disturbances, not elsewhere classified

409

2677

1.60

16.23

2.9

2.4

7.77

7.11

ug/l

0.18

319

2295

Oesophagitis

260

1523

1.81

16.17

3.2

2.3

6.23

7.76

ug/l

0.56

230

1351

Exclusion endpoint for clefts

272

2.99

16.17

2.2

2.4

13.61

7.93

ug/l

1.22

244

Corneal ulcer

694

5007

1.42

16.13

2.7

2.3

5.76

7.84

ug/l

2.05

612

4408

Car occupant injured in other and unspecified transport accidents

650

4635

1.43

16.04

2.6

2.2

5.64

7.35

ug/l

1.98

564

4077

Parodontitis, under 40 years

182

943

1.97

16.02

1.8

2.1

8.23

5.96

ug/l

0.52

157

820

Acquired absence of limb

203

3.54

16.01

2.9

2.4

5.25

6.73

ug/l

0.47

170

Acute appendicitis, no complications

2072

17127

1.22

16.00

2.3

2.2

6.38

7.92

ug/l

2.02

1872

15127

Other and unspecified nonorganic psychotic disorders

603

4243

1.45

15.94

2.5

2.2

5.99

7.88

ug/l

1.18

496

3766

Disturbance of activity and attention

204

1085

1.89

15.94

1.8

2.1

3.88

7.54

ug/l

4.13

176

941

Discitis, unspecified

409

2.69

15.92

3.0

2.2

9.32

7.63

ug/l

0.36

359

Need for immunization against other single viral diseases

111

489

2.50

15.87

2.7

2.4

10.44

7.73

ug/l

0.31

444

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2365

13678

1.21

15.87

2.4

6.18

7.59

ug/l

3.42

1989

11822

Otalgia

287

1727

1.73

15.84

2.4

2.3

3.93

6.80

ug/l

5.63

246

1520

Other follicular disorders

260

1523

1.78

15.83

2.4

2.3

6.77

7.22

ug/l

0.15

223

1374

Ocular pain

303

1851

1.70

15.80

2.8

2.3

3.40

6.79

ug/l

9.73

250

1634

Parodontitis, under 40 years, or operation codes

182

948

1.96

15.78

1.8

2.1

8.23

5.95

ug/l

0.52

157

824

Spinal instabilities

130

609

2.28

15.71

2.3

2.1

3.63

7.85

ug/l

6.60

115

541

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2391

13820

1.21

15.67

2.4

6.21

7.57

ug/l

3.29

2013

11952

Other sleep disorders

430

2854

1.56

15.65

2.7

2.2

5.93

8.34

ug/l

2.53

357

2530

Myositis

137

661

2.25

15.57

3.0

2.2

16.20

7.87

ug/l

2.67

126

585

Other and unspecified epidermal thickening

131

620

2.28

15.57

3.0

2.5

5.14

7.60

ug/l

1.54

120

548

Acute appendicitis

2753

22118

1.19

15.56

2.2

6.54

7.74

ug/l

1.91

2473

19424

129

2586

0.48

15.54

3.0

2.4

10.08

8.18

ug/l

0.36

110

2269

Pre-eclampsia or eclampsia

586

4119

1.45

15.54

2.2

2.1

4.86

5.90

ug/l

0.91

516

3564

Other disorders of patella

585

4116

1.45

15.54

2.4

2.2

7.08

8.64

ug/l

0.69

495

3676

Noninflammatory disorders of female genital tract

1393

5514

1.29

15.54

2.2

4.89

6.13

ug/l

2.17

1157

4703

Retinal detachments and breaks

1588

12894

1.26

15.53

2.5

2.4

7.10

7.40

ug/l

0.22

1366

11168

Small fibre neuropathy

147

733

2.20

15.47

2.6

2.5

11.33

7.28

ug/l

0.45

118

654

Tinnitus

950

7247

1.34

15.44

2.4

2.3

5.60

7.59

ug/l

4.12

801

6376

Purpura and other haemorrhagic conditions

549

3840

1.48

15.43

2.7

2.3

7.50

7.39

ug/l

0.05

485

3340

Appendicitis, broad definition

2956

23158

1.18

15.41

2.3

2.2

6.68

7.73

ug/l

1.55

2653

20296

Exclusions for E4_PCOS_BROAD

612

4354

1.44

15.38

3.2

2.3

6.02

7.30

ug/l

0.94

519

3825

Complications of other internal prosthetic devices, implants and grafts

189

1024

1.97

15.38

2.7

2.4

5.02

6.50

ug/l

0.91

161

869

Other disorders starting during childhood or adolecense, excluding more controls

377

2.52

15.35

2.5

1.8

3.53

6.99

ug/l

2.23

318

Diseases of appendix

2983

23319

1.18

15.30

2.3

2.2

6.72

7.70

ug/l

1.40

2675

20431

Thyroiditis, ILD-related definition

403

2648

1.57

15.29

2.5

2.2

5.72

6.10

ug/l

0.14

357

2309

Atrophic disorders of skin

535

3726

1.48

15.29

2.1

2.3

5.16

6.54

ug/l

1.13

468

3205

Respiratory insufficiency

367

2368

1.61

15.28

2.8

2.2

9.61

7.20

ug/l

1.46

300

2030

Attention to artificial openings

191

1042

1.96

15.23

2.9

2.4

5.60

6.62

ug/l

0.44

157

922

Other/unspecified rheumatoid arthritis

570

4032

1.47

15.20

2.6

2.4

5.99

6.51

ug/l

0.32

471

3413

Collagenous colitis

363

2343

1.61

15.20

2.7

2.3

4.61

6.88

ug/l

3.94

312

2061

Ganglion

717

5245

1.39

15.16

2.1

5.39

7.84

ug/l

3.93

624

4594

Burns and corrosions

512

3540

1.49

15.16

2.4

2.3

5.56

7.99

ug/l

3.59

455

3175

N06DA Anticholinesterases

1634

10789

1.26

15.14

2.4

2.5

5.58

6.16

ug/l

0.69

1175

9016

Use of anticholinesterases

1634

10789

1.26

15.14

2.4

2.5

5.58

6.16

ug/l

0.69

1175

9016

Pre-eclampsia

532

3694

1.47

15.08

2.1

4.53

5.93

ug/l

1.68

468

3191

Other obstructive and reflux uropathy

179

953

1.97

15.07

2.7

2.3

4.66

6.82

ug/l

2.57

150

817

Childhood asthma (age<16)

245

1115

1.77

14.94

1.8

1.6

8.46

6.01

ug/l

0.83

209

981

Injuries to unspecified part of trunk, limb or body region

401

2654

1.57

14.94

2.9

2.4

9.90

7.24

ug/l

0.54

343

2334

Other specified disorders of muscle

141

699

2.16

14.81

2.9

2.3

11.91

8.42

ug/l

0.48

122

613

conjunctival haemorrhage

348

2247

1.63

14.80

3.0

2.4

9.09

7.24

ug/l

0.51

297

1974

Other diseases of biliary tract

386

2551

1.58

14.65

2.3

4.64

7.16

ug/l

3.73

328

2195

Squamous cell neoplasms and carcinomas of the skin

621

4499

1.44

14.64

2.6

2.4

5.26

6.61

ug/l

2.37

508

3747

Scoliosis

269

1621

1.71

14.61

2.2

2.1

12.88

7.11

ug/l

0.84

221

1399

Agoraphobia

374

2.54

14.58

2.4

2.0

6.18

7.45

ug/l

0.16

337

Pruritus

417

2799

1.54

14.45

2.8

2.3

5.17

6.61

ug/l

0.74

351

2417

Labour and delivery complicated by umbilical cord complications

147

739

2.07

14.44

2.0

1.8

3.95

5.48

ug/l

1.16

135

649

Mixed disorders of conduct and emotions, excluding more controls

139

3.57

14.29

1.9

1.5

3.86

7.77

ug/l

1.40

114

Injury of unspecified body region

315

2001

1.64

14.20

3.0

2.4

10.25

7.04

ug/l

0.52

268

1754

Hypertrophic scar

183

999

1.91

14.17

2.5

2.2

12.07

7.44

ug/l

0.50

163

887

Degenerative diseases of the nervous system

1690

10474

1.24

14.16

2.5

5.41

6.17

ug/l

1.26

1218

8805

Other and unspecified urticaria

656

4792

1.40

14.10

2.7

2.2

5.28

7.27

ug/l

1.98

549

4200

Other (seronegative) rheumatoid arthritis, wide

810

6133

1.36

14.02

2.5

2.4

5.95

6.80

ug/l

0.75

673

5259

Crohn disease

453

3106

1.50

13.99

2.4

2.2

6.62

7.98

ug/l

0.71

398

2781

Special screening examination for neoplasms

178

971

1.92

13.93

2.1

2.2

6.31

7.58

ug/l

0.64

142

857

Vasomotor and allergic rhinitis

1223

9593

1.27

13.85

2.2

6.21

7.70

ug/l

1.93

1061

8438

Nail disorders

319

2042

1.62

13.82

2.7

2.3

6.28

6.96

ug/l

0.28

280

1807

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1232

9843

1.27

13.79

2.4

2.3

8.50

6.85

ug/l

1.13

1040

8512

Diseases of male genital organs

2519

10815

1.19

13.74

2.4

2.3

8.39

9.31

ug/l

0.84

2220

9743

Maltreatment syndromes

156

815

1.98

13.73

2.4

2.1

6.54

7.92

ug/l

0.34

138

734

Budesonide

476

3309

1.48

13.69

2.4

2.2

5.67

7.24

ug/l

1.18

404

2914

Pre-eclampsia or poor fetal growth

728

5402

1.36

13.66

2.1

2.0

4.78

5.65

ug/l

0.85

648

4696

Cluster headache, strict

131

649

2.12

13.57

2.5

2.2

5.19

8.22

ug/l

0.89

111

593

Infarction of spleen

146

3.94

13.55

2.6

7.49

8.04

ug/l

0.08

132

Other respiratory diseases principally affecting the interstitium

832

6368

1.35

13.54

2.7

2.4

10.04

6.97

ug/l

3.36

729

5435

Bruxism

294

2.74

13.52

2.0

2.2

3.36

6.43

ug/l

2.20

267

Acute and transient psychotic disorders

421

2868

1.51

13.49

2.5

2.3

6.92

8.09

ug/l

0.35

350

2559

Achilles tendinitis

386

2587

1.54

13.48

2.4

2.1

5.96

9.44

ug/l

3.20

340

2322

Explicit fungal Sepsis

135

3.93

13.47

3.4

2.3

7.56

7.35

ug/l

0.02

118

Alzheimer disease, including avohilmo

1735

10389

1.23

13.45

2.5

5.11

6.08

ug/l

2.21

1282

8678

Ulcerative colitis, NAS

505

3567

1.45

13.35

2.8

2.2

5.57

7.83

ug/l

2.37

451

3176

Injury of intra-abdominal organs

113

536

2.26

13.33

2.6

2.3

16.97

8.29

ug/l

0.91

101

482

Diseases of tongue

271

1688

1.68

13.31

2.8

2.3

4.74

6.73

ug/l

1.76

225

1472

Cluster headache, wide

141

723

2.04

13.27

2.5

2.2

5.09

8.29

ug/l

1.05

119

654

Endometriosis of rectovaginal septum and vagina

280

1753

1.65

13.25

2.4

2.3

6.90

6.21

ug/l

0.13

238

1505

Hyperhidrosis

100

449

2.33

13.25

2.4

1.9

3.78

6.60

ug/l

1.66

396

Anorexia (incl.atypical)

177

974

1.87

13.22

2.5

2.1

7.60

6.74

ug/l

0.08

157

859

Sequelae of injuries, of poisoning and of other consequences of external causes

883

6810

1.32

13.22

2.1

2.3

8.44

7.85

ug/l

0.23

756

6036

Open wound of forearm

368

2457

1.55

13.19

2.4

5.65

7.51

ug/l

1.79

301

2162

SLE (Finngen)

144

748

2.04

13.18

2.4

2.2

6.47

5.87

ug/l

0.20

121

655

Temporal arteritis

196

1134

1.86

13.15

3.2

2.5

4.99

6.53

ug/l

1.17

161

981

Ulcerative colitis

906

7014

1.32

13.12

2.6

2.2

5.89

7.71

ug/l

2.57

801

6177

Neuralgia and neuritis, unspecified

206

1197

1.80

13.12

2.4

2.2

5.34

8.18

ug/l

1.42

173

1058

Other arterial embolism and thrombosis

150

797

2.03

13.11

3.7

2.4

8.43

6.67

ug/l

0.43

130

679

Acquired haemolytic anaemia

120

590

2.21

13.09

2.3

2.6

12.73

7.31

ug/l

0.64

110

517

Hydronephrosis

471

3308

1.47

13.07

2.5

2.3

5.78

7.02

ug/l

1.20

407

2876

Assault by bodily force

240

1448

1.71

13.07

2.4

2.2

6.05

8.42

ug/l

1.00

199

1316

Postprocedural endocrine and metabolic disorders, not elsewhere classified

389

2624

1.52

13.06

2.3

2.1

7.26

6.17

ug/l

0.36

334

2290

Thyrotoxicosis, other and/or unspecified

699

5225

1.37

13.05

2.4

2.2

10.12

6.58

ug/l

1.90

581

4499

Opening and dilatation of root channel of tooth

227

1355

1.74

13.00

2.4

2.2

7.98

7.38

ug/l

0.19

193

1220

Alzheimer disease

1501

9294

1.25

12.95

2.5

5.19

6.00

ug/l

1.34

1067

7725

Postmenopausal atrophic vaginitis

942

4381

1.32

12.91

2.2

4.19

6.39

ug/l

5.37

819

3795

Background retinopathy and retinal vascular changes

112

540

2.26

12.91

2.4

2.5

5.69

7.05

ug/l

0.62

469

Other disorders of optic [2nd] nerve and visual pathways

252

1554

1.69

12.88

2.4

4.93

7.10

ug/l

2.37

220

1383

Toxic effect of ethanol

159

859

1.94

12.86

3.0

2.3

5.82

8.32

ug/l

1.69

141

769

Fracture of neck

272

1717

1.67

12.83

2.4

8.60

6.88

ug/l

0.50

233

1499

Giant cell arteritis with polymyalgia rheumatica

196

1143

1.85

12.80

3.2

2.5

4.99

6.41

ug/l

1.04

161

987

Intestinal malabsorption

186

1059

1.85

12.78

2.4

2.3

5.66

7.41

ug/l

1.08

160

944

Herpesviral [herpes simplex] infections

423

2920

1.49

12.76

2.3

6.46

6.66

ug/l

0.04

356

2565

Other specified/unspecified soft tissue disorders

222

1330

1.75

12.74

2.9

2.3

4.61

6.79

ug/l

1.97

195

1122

D07AA Corticosteroids, weak (group I)

492

3481

1.44

12.72

2.4

2.3

5.80

6.72

ug/l

0.86

438

3028

Lesion of radial nerve

174

976

1.89

12.70

2.8

2.4

9.61

7.21

ug/l

0.55

144

862

Injury of other and unspecified intrathoracic organs

281

1789

1.64

12.68

2.5

2.3

9.27

7.36

ug/l

0.65

244

1595

Early lumbar disc prolapse operation

302

1939

1.59

12.68

1.9

2.1

5.76

8.86

ug/l

1.62

279

1753

Giant cell arteritis

214

1281

1.79

12.67

3.1

2.5

4.74

6.56

ug/l

1.71

178

1112

Extreme obesity with alveolar hypoventilation

183

1044

1.86

12.65

3.1

2.4

4.76

7.64

ug/l

2.33

146

933

Bell's palsy

463

3259

1.46

12.64

2.3

7.61

7.88

ug/l

0.07

399

2853

Injuries involving multiple body regions

155

838

1.95

12.61

2.7

2.4

6.47

7.18

ug/l

0.18

138

741

Neovascular glaucoma

197

1151

1.81

12.54

2.6

7.25

6.55

ug/l

0.10

174

987

Communicating hydrocephalus

114

560

2.22

12.52

2.8

2.5

5.37

6.45

ug/l

0.23

100

490

Other disorders of conjunctiva

607

4487

1.39

12.52

3.1

2.3

8.41

7.28

ug/l

0.41

521

3907

Bronchitis, not specified as acute or chronic

368

2485

1.53

12.51

2.6

2.3

7.79

8.11

ug/l

0.06

302

2162

Superficial injuries involving multiple body regions

115

563

2.18

12.51

2.9

2.3

6.73

7.26

ug/l

0.10

102

501

Haemolytic anaemias

153

829

1.96

12.48

2.2

2.5

11.26

6.95

ug/l

0.63

137

730

Secondary parkinsonism+Parkinsonism in other disease

145

776

2.02

12.47

3.2

2.5

4.90

6.99

ug/l

1.07

116

671

Glaucoma secondary to other eye disorders

198

1161

1.81

12.45

2.7

2.6

7.25

6.79

ug/l

0.06

174

1007

Cystic kidney disease

144

766

2.00

12.43

2.3

4.66

7.42

ug/l

2.84

131

681

Female genital prolapse

1075

4895

1.29

12.37

2.2

4.62

6.37

ug/l

3.89

913

4179

Other/unspecified enthesopathies of lower limb, excluding foot

238

1456

1.69

12.36

2.3

2.1

7.93

7.56

ug/l

0.06

196

1286

Urolithiasis

1436

11832

1.24

12.29

2.4

6.40

7.73

ug/l

2.00

1205

10376

Secondary parkinsonism

142

759

2.02

12.28

3.2

2.6

4.87

6.93

ug/l

1.03

114

655

Arthropod-borne viral fevers and viral haemorrhagic fevers

405

2804

1.50

12.23

2.6

2.3

5.71

8.30

ug/l

1.70

376

2513

Stomatitis and related lesions

298

1932

1.59

12.18

2.4

2.2

6.52

7.34

ug/l

0.33

236

1685

Blood alcohol or alcohol intoxication level

102

482

2.25

12.13

3.5

2.2

4.97

8.89

ug/l

3.48

443

Phlebitis and thrombophlebitis (not including DVT)

914

7172

1.30

12.12

2.5

2.3

7.86

7.41

ug/l

0.15

771

6220

Weight loss

395

2727

1.50

12.12

2.3

2.4

6.58

7.01

ug/l

0.10

318

2371

Behavioural disorders, excluding more controls

209

2.89

12.09

2.7

1.8

7.03

9.64

ug/l

0.62

189

Other strabismus

718

5430

1.34

12.09

2.3

6.97

7.31

ug/l

0.14

605

4749

Diseases of spleen

422

2.39

12.07

2.8

2.4

8.54

6.44

ug/l

0.46

377

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

273

1738

1.62

12.03

2.3

2.1

5.09

5.93

ug/l

0.39

247

1498

Unspecified urinary incontinence

364

2477

1.52

12.02

2.3

3.60

6.06

ug/l

5.76

232

2123

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1884

13991

1.20

11.99

2.3

2.4

5.67

7.82

ug/l

4.08

1629

12161

Sarcoidosis

539

3935

1.41

11.96

2.6

2.3

11.37

7.68

ug/l

1.30

489

3487

Malignant neoplasm

3917

20611

1.14

11.89

2.2

2.3

6.30

7.85

ug/l

4.48

3362

18056

Pure hyperglyceridaemia

107

522

2.21

11.88

2.8

2.3

4.43

7.52

ug/l

2.46

466

Other and unspecified vascular occlusions

444

3157

1.46

11.78

2.6

2.4

7.49

6.97

ug/l

0.14

377

2669

Anankastic personality disorder

128

663

2.02

11.73

2.1

6.64

7.64

ug/l

0.23

114

600

Use of galantamine

364

2504

1.53

11.71

2.5

4.29

5.94

ug/l

2.46

276

2032

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

621

4666

1.38

11.71

2.6

2.5

5.26

6.95

ug/l

3.58

508

3908

Fall involving bed

159

896

1.91

11.69

2.9

2.6

5.41

6.11

ug/l

0.27

125

752

Thyrotoxicosis

911

7174

1.29

11.65

2.5

2.3

9.67

6.66

ug/l

1.93

770

6157

Arthropathies in other diseases classified elsewhere

157

876

1.89

11.65

2.4

2.5

6.05

7.40

ug/l

0.76

133

774

Acne

225

1371

1.67

11.62

2.2

7.09

6.90

ug/l

0.05

200

1190

Other orthopaedic follow-up care

231

1432

1.68

11.60

2.2

2.3

4.55

6.62

ug/l

3.07

197

1268

Ingrowing nail

207

1247

1.73

11.58

2.8

2.3

6.42

7.72

ug/l

0.39

179

1107

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

176

1007

1.79

11.56

2.2

1.8

3.52

5.19

ug/l

1.67

150

885

Fibroblastic disorders

993

7916

1.28

11.55

2.6

2.2

6.24

8.00

ug/l

2.34

841

6847

Effects of foreign body entering through natural orifice

912

7193

1.29

11.53

2.7

2.3

6.58

8.35

ug/l

1.68

815

6416

Dependence on enabling machines and devices, not elsewhere classified

206

2.97

11.53

3.6

2.4

13.83

6.40

ug/l

1.28

176

Infective dermatitis

465

3335

1.44

11.50

2.6

2.3

6.12

7.78

ug/l

1.09

413

2937

Spondyloarthritis

702

5353

1.34

11.49

2.7

2.3

6.74

7.45

ug/l

0.23

602

4644

Vitamin D deficiency

352

2.45

11.41

2.6

2.4

5.94

7.25

ug/l

0.32

312

Fracture of forearm

2135

17134

1.18

11.41

2.4

2.3

6.90

6.64

ug/l

0.20

1781

14747

False labour

599

2765

1.37

11.40

1.7

2.0

2.92

5.96

ug/l

6.91

534

2416

Superficial injury of shoulder and upper arm

425

3004

1.46

11.37

2.5

2.3

5.27

7.73

ug/l

2.38

358

2634

Male infertility

163

923

1.83

11.30

2.2

2.1

8.00

9.77

ug/l

0.39

146

836

Hemiplegia

215

1321

1.70

11.21

2.3

2.4

6.37

6.81

ug/l

0.13

179

1154

Other and unspecified mood [affective] disorders

189

1115

1.74

11.18

2.7

2.1

6.05

7.86

ug/l

0.66

153

991

Viral warts

344

2343

1.51

11.17

2.3

6.44

7.14

ug/l

0.20

313

2088

Paralytic strabismus

309

2070

1.56

11.16

2.6

2.4

7.71

7.23

ug/l

0.09

264

1820

Any event in cancer register

3937

20799

1.13

11.16

2.2

2.3

6.45

7.80

ug/l

2.89

3374

18236

Calculus of kidney and ureter

1311

10815

1.23

11.15

2.4

6.41

7.80

ug/l

1.99

1112

9501

Alzheimer’s disease (Late onset)

1085

7520

1.27

11.15

2.5

2.6

5.42

5.73

ug/l

0.26

764

6173

Poisoning by narcotics and psychodysleptics [hallucinogens]

232

2.75

11.15

2.6

2.2

7.19

8.13

ug/l

0.21

212

Other disorders of nervous system

273

1780

1.60

11.14

2.4

2.3

8.17

7.46

ug/l

0.16

228

1581

Abnormal blood-pressure reading, without diagnosis

142

774

1.91

11.14

2.6

1.9

4.22

7.38

ug/l

3.49

122

667

Nummular dermatitis

345

2364

1.51

11.08

2.4

2.3

5.86

7.64

ug/l

1.30

310

2087

Atypical facial pain

199

1203

1.73

11.06

2.2

2.3

4.02

6.83

ug/l

4.28

165

1054

Dermatographic urticaria

216

1329

1.68

11.04

2.3

2.2

3.03

6.81

ug/l

10.55

187

1187

Sacroiliitis, not elsewhere classified

136

732

1.92

11.02

2.4

2.0

4.28

7.70

ug/l

1.98

119

649

Dermatopolymyositis (FG)

296

2.58

11.01

2.9

2.4

18.38

6.77

ug/l

2.35

258

Other congenital malformations

257

1647

1.60

10.98

2.1

2.2

9.91

6.85

ug/l

1.50

239

1463

Trigeminal neuralgia

234

1477

1.65

10.94

2.6

2.4

5.99

6.81

ug/l

0.28

191

1298

Acute laryngitis and tracheitis

298

1938

1.54

10.93

2.4

1.9

3.96

7.05

ug/l

5.14

255

1697

Glomerulonephritis

406

2873

1.46

10.92

2.6

2.4

6.04

7.65

ug/l

0.87

364

2537

Alcohol-induced acute pancreatitis

173

1017

1.81

10.89

2.7

2.4

4.85

8.68

ug/l

3.69

154

932

Fall on and from stairs and steps

976

7818

1.27

10.89

2.3

7.18

7.25

ug/l

0.02

801

6762

Systemic lupus erythematosus

144

800

1.90

10.82

2.4

2.2

6.47

6.40

ug/l

0.02

121

706

Cardiomyopathies, Secondary/extrinsic

3.95

10.81

3.3

2.1

8.35

4.70

ug/l

0.50

ILD, hospital admissions

675

5189

1.34

10.80

2.6

2.4

10.81

6.80

ug/l

4.06

590

4463

SLE, strict definition

137

751

1.92

10.76

2.2

2.3

6.61

6.26

ug/l

0.10

115

663

SLE, ICD10

137

751

1.92

10.76

2.2

2.3

6.61

6.26

ug/l

0.10

115

663

Other and unspecified follicular disorders

156

890

1.84

10.74

2.4

2.3

6.88

7.67

ug/l

0.21

133

802

Female infertility, associated with anovulation

132

706

1.90

10.72

1.4

2.3

3.10

6.25

ug/l

2.46

113

615

Blindness, monocular

224

2.89

10.69

2.5

4.70

6.97

ug/l

0.56

200

Monoarthritis, not elsewhere classified

170

994

1.79

10.68

2.8

2.4

5.22

7.42

ug/l

1.65

157

873

Disorders of conjunctiva

3106

22959

1.14

10.68

2.4

2.2

6.91

7.08

ug/l

0.13

2635

19998

Metatarsalgia

326

2218

1.51

10.66

2.5

2.2

5.07

7.72

ug/l

2.80

284

1936

Amyloidosis

103

518

2.15

10.66

2.6

2.3

4.86

7.07

ug/l

1.50

454

Pyogenic arthritis

281

1860

1.57

10.65

2.9

2.3

4.26

8.35

ug/l

6.25

241

1635

Other interstitial pulmonary diseases

682

5260

1.34

10.65

2.6

2.4

10.89

6.81

ug/l

4.18

597

4527

Acne vulgaris

170

986

1.76

10.63

2.3

2.2

7.42

7.23

ug/l

0.04

150

859

Faecal incontinence

331

2264

1.51

10.63

2.1

2.2

6.02

6.90

ug/l

0.25

258

1915

Systemic lupus erythematosus, unspecified

120

633

2.00

10.62

2.2

2.3

7.06

6.28

ug/l

0.22

103

563

Burns and corrosions of external body surface, specified by site

383

2690

1.46

10.61

2.5

2.3

5.57

8.38

ug/l

3.22

337

2413

Dislocation of lens

379

2.37

10.60

2.4

2.3

6.88

6.66

ug/l

0.06

320

Other enthesopathy of foot (+metatarsalgia)

342

2352

1.49

10.57

2.4

2.2

5.00

7.82

ug/l

3.31

299

2055

Mental and behavioural disorders due to use of other stimulants, including caffeine

380

2.28

10.55

2.2

2.0

6.80

9.60

ug/l

0.68

349

Superficial injury of ankle and foot

357

2474

1.48

10.52

2.3

2.2

5.39

7.14

ug/l

1.34

321

2191

Benign neoplasm: Duodenum

134

743

1.95

10.49

3.1

2.6

5.50

7.24

ug/l

0.90

120

654

Interstitial lung disease

682

5273

1.33

10.46

2.6

2.4

10.89

6.81

ug/l

4.17

597

4536

Interstitial lung disease endpoints

682

5273

1.33

10.46

2.6

2.4

10.89

6.81

ug/l

4.17

597

4536

Correction of physiology of bite - very demanding therapy visit

104

524

2.09

10.45

2.6

2.2

4.85

6.14

ug/l

0.48

467

Other noninfective disorders of lymphatic vessels and lymph nodes

152

870

1.84

10.42

2.8

2.3

7.28

7.34

ug/l

0.01

136

768

Lichen planus

518

3852

1.38

10.35

2.2

2.3

5.92

6.93

ug/l

0.67

436

3344

Complications following infusion, transfusion and therapeutic injection

337

2.42

10.33

2.8

2.3

4.94

6.81

ug/l

0.74

296

Papulosquamous disorders

1556

13124

1.20

10.33

2.3

5.98

7.66

ug/l

3.91

1339

11514

Crohn's disease NAS

227

1440

1.63

10.31

2.3

2.2

5.08

7.36

ug/l

1.14

194

1296

Social phobias

198

1210

1.67

10.25

2.1

1.9

5.39

7.79

ug/l

1.22

168

1063

Synovial cyst of popliteal space [Baker]

303

2057

1.53

10.21

2.5

2.3

6.52

8.09

ug/l

0.72

260

1780

Dislocation, sprain and strain of joints and ligaments of thorax

137

765

1.89

10.19

3.0

2.4

4.72

7.27

ug/l

1.57

125

681

Lichen simplex chronicus and prurigo

264

1744

1.58

10.19

2.5

2.3

6.60

7.45

ug/l

0.22

235

1539

Acute bronchiolitis

145

729

1.83

10.18

2.9

2.0

6.06

5.92

ug/l

0.03

121

624

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1071

8740

1.25

10.16

2.3

2.4

6.40

6.75

ug/l

0.16

919

7489

Disorders of breast

1564

12224

1.20

10.14

2.1

2.2

4.05

5.78

ug/l

8.67

1308

10420

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

720

5524

1.31

10.07

2.4

3.99

5.84

ug/l

5.58

613

4613

Acute pharyngitis

403

2853

1.43

10.07

2.3

2.0

8.23

8.37

ug/l

0.03

342

2556

Allergic urticaria

267

1766

1.55

10.03

2.1

2.2

7.13

6.77

ug/l

0.12

224

1562

5-aminosalicylic acid

705

5478

1.31

10.01

2.4

2.1

6.30

7.21

ug/l

0.67

623

4824

Impacted cerumen

421

3051

1.43

10.01

2.2

2.4

5.91

7.00

ug/l

0.77

221

2652

Other/unspecified seropositive rheumatoid arthritis

1089

8922

1.24

9.95

2.3

2.4

6.39

6.71

ug/l

0.15

934

7640

Amyloidosis, other/unspecified

423

2.24

9.93

2.7

2.3

5.22

6.76

ug/l

0.76

379

Dipeptidyl peptidase 4 (DPP-4) inhibitors

533

4014

1.37

9.93

2.5

2.3

7.02

7.89

ug/l

0.41

462

3504

Benign neoplasm: Duodenum

134

757

1.91

9.90

3.1

2.5

5.50

7.75

ug/l

1.33

120

657

Problems related to social environment

118

634

1.96

9.88

3.3

2.5

3.86

6.69

ug/l

2.08

101

547

Seropositive rheumatoid arthritis, wide

1101

9045

1.24

9.80

2.3

2.4

6.40

6.72

ug/l

0.15

944

7743

Spondylopathies (FG)

460

3377

1.39

9.77

2.6

2.2

6.61

8.13

ug/l

0.36

398

3016

Colonic or urogenital fistula

1061

8684

1.24

9.76

2.4

2.3

6.92

7.42

ug/l

0.23

873

7601

Hepatic failure, not elsewhere classified

166

996

1.76

9.73

2.5

9.56

7.20

ug/l

0.69

141

872

Spontaneous rupture of synovium and tendon

330

2299

1.48

9.73

2.4

2.2

6.36

8.85

ug/l

1.78

280

2010

Hypermobility syndrome

135

755

1.84

9.71

2.1

2.0

4.53

5.19

ug/l

0.15

118

680

Primary coxarthrosis, bilateral

1298

10859

1.22

9.70

2.6

2.4

5.85

6.97

ug/l

2.19

1079

9267

TMD muscular pain linked with fibromyalgia

135

3.24

9.69

2.0

2.2

4.06

4.88

ug/l

0.17

121

Bullous disorders

252

1670

1.58

9.69

2.4

2.5

6.49

6.76

ug/l

0.10

208

1441

Viral haemorrhagic fevers, not elsewhere classified/unspecified

318

2203

1.49

9.69

2.7

2.3

5.00

7.99

ug/l

2.62

294

1979

Hypothermia

475

2.14

9.67

3.3

2.7

5.93

8.17

ug/l

0.88

424

Ectropion of eyelid

204

1294

1.67

9.66

2.4

2.5

4.71

6.26

ug/l

1.61

174

1061

Other/unspecified synovitis and tenosynovitis

417

3023

1.41

9.66

2.5

2.2

6.05

8.29

ug/l

1.84

366

2632

Drug-induced osteoporosis with pathological fracture

409

2.26

9.66

2.9

2.4

8.24

5.66

ug/l

0.41

356

Pulmonary oedema

489

2.13

9.65

3.7

2.6

6.66

5.87

ug/l

0.28

409

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

454

2.10

9.63

2.2

2.3

12.37

8.14

ug/l

1.04

403

Severe visual impairment, binocular

128

3.52

9.61

2.6

5.22

7.43

ug/l

0.45

114

Endometriosis of pelvic peritoneum

397

2810

1.42

9.57

2.0

2.1

3.79

6.86

ug/l

4.68

338

2468

Pneumocystosis

431

2.22

9.56

2.2

2.6

7.56

5.76

ug/l

0.46

383

!Aliquae complicationes praecoces traumatis

173

1051

1.72

9.56

2.8

2.4

10.31

7.54

ug/l

0.64

148

935

Early complications of trauma

173

1051

1.72

9.56

2.8

2.4

10.31

7.54

ug/l

0.64

148

935

Diabetes mellitus in pregnancy

583

2848

1.34

9.55

1.9

4.56

5.60

ug/l

0.77

523

2475

Emotional disorders starting during childhood or adolecense, excluding more controls

340

2.23

9.53

1.6

1.7

5.29

7.14

ug/l

0.48

285

Gestational [pregnancy-induced] hypertension

573

4342

1.33

9.53

2.0

5.26

5.81

ug/l

0.33

525

3747

Alzheimer’s disease, wide definition

1162

8047

1.23

9.52

2.5

2.6

5.18

5.84

ug/l

0.87

819

6633

259

1722

1.55

9.52

3.2

2.4

5.13

6.28

ug/l

0.81

208

1369

Maternal care for other conditions predominantly related to pregnancy

400

2833

1.41

9.52

1.9

2.0

5.55

5.58

ug/l

0.01

361

2481

Manic episode

111

591

1.97

9.51

2.4

2.2

11.02

7.91

ug/l

0.32

521

Suppurative and necrotic conditions of lower respiratory tract

244

1614

1.58

9.49

2.8

2.4

8.10

7.33

ug/l

0.28

216

1430

Infection of intervertebral disc (pyogenic)

319

2.42

9.48

2.3

7.94

7.72

ug/l

0.03

282

Event of undetermined intent

212

1352

1.62

9.46

2.8

2.3

8.23

7.39

ug/l

0.17

184

1214

Suppurative and unspecified otitis media

1046

7571

1.24

9.44

2.2

7.64

7.36

ug/l

0.10

899

6622

Chondropathies

532

4019

1.35

9.42

2.7

2.3

8.45

7.86

ug/l

0.14

454

3581

Meralgia paraesthetica

139

800

1.83

9.39

2.6

2.4

4.50

7.72

ug/l

2.91

121

711

Other specified/unspecified spondylopathies

120

663

1.93

9.38

3.2

2.3

6.64

7.04

ug/l

0.05

574

Sequelae of injuries of head

205

1304

1.64

9.36

1.9

2.4

7.81

7.25

ug/l

0.20

173

1173

Disorders of magnesium metabolism

151

3.18

9.36

2.1

2.6

7.26

9.81

ug/l

0.51

137

Other inflammatory liver diseases

258

1728

1.55

9.33

2.6

2.4

6.93

7.38

ug/l

0.18

223

1546

Other inflammation of eyelid

479

3575

1.37

9.32

2.8

2.3

5.92

7.39

ug/l

1.26

398

3117

Rheumatic fever incl heart disease

157

939

1.77

9.31

2.4

2.5

11.73

6.44

ug/l

1.03

138

796

Effects of other external causes

511

2.03

9.29

2.1

2.3

4.03

8.91

ug/l

2.97

465

Schizophrenia

552

4200

1.34

9.28

2.5

2.3

5.94

8.35

ug/l

1.64

483

3759

Other noninflammatory disorders of uterus, except cervix

823

4470

1.28

9.27

2.5

2.2

5.64

6.17

ug/l

0.28

690

3808

Other disorders of the musculoskeletal system and connective tissue

579

4451

1.33

9.22

2.5

2.4

7.66

7.54

ug/l

0.03

502

3891

Abnormal weight loss

351

2501

1.45

9.21

2.3

2.4

7.10

7.16

ug/l

0.01

279

2177

Hypersomnia

295

2.42

9.20

2.7

2.3

3.95

7.87

ug/l

2.24

266

Status post-ami

327

1874

1.47

9.18

3.0

2.1

4.93

5.09

ug/l

0.10

276

1449

Disorder of external ear, unspecified

136

785

1.83

9.15

2.3

2.4

8.73

7.32

ug/l

0.29

123

706

Postprocedural disorders of digestive system, not elsewhere classified

145

853

1.80

9.14

2.2

2.4

6.93

7.11

ug/l

0.03

121

738

Paranoid personality disorder

380

2.21

9.12

2.2

2.4

3.51

7.92

ug/l

3.89

344

Hyperosmolality and hypernatraemia

337

2.34

9.12

3.7

2.3

8.39

6.68

ug/l

0.37

290

Polyp of the female genital tract

1053

5001

1.24

9.10

2.4

2.2

4.95

6.28

ug/l

1.75

869

4280

Dental pulpitis 3

192

851

1.64

9.08

1.8

2.0

5.86

5.60

ug/l

0.06

157

715

Dependent personality disorder

449

2.11

9.08

3.1

2.3

4.52

7.84

ug/l

2.04

403

Personal history of other diseases and conditions

256

1702

1.52

9.06

2.1

2.0

11.54

4.91

ug/l

3.62

204

1474

Other specified and unspecified retinal disorders

158

955

1.75

9.05

2.6

2.4

5.31

6.98

ug/l

0.75

141

827

Diabetic neuropathy

520

3942

1.36

9.04

2.9

2.5

5.39

7.73

ug/l

4.44

460

3422

Carcinoma in situ of other and unspecified genital organs

383

2.22

9.04

2.6

2.3

2.68

4.80

ug/l

2.86

329

Other and unspecified mononeuropathies, also in other diseases

135

781

1.83

9.02

2.5

2.4

4.72

7.25

ug/l

2.00

110

682

Cluster headache, strict, including avohilmo

160

964

1.72

9.01

2.5

2.1

4.78

7.67

ug/l

1.11

135

871

Bronchiectasis

347

2482

1.45

8.99

3.1

2.3

6.45

7.44

ug/l

0.48

281

2129

Nontoxic multinodular goitre

782

6257

1.27

8.98

2.3

2.4

5.35

5.99

ug/l

0.52

673

5286

Other diseases of blood and blood-forming organs, wide

842

6792

1.26

8.97

2.4

2.3

8.87

7.33

ug/l

0.69

707

5914

Colectomy operation

721

5728

1.29

8.92

2.4

5.73

7.26

ug/l

1.27

626

4924

Inflammatory diseases of prostate (prostatitis)

595

4620

1.32

8.90

2.8

2.3

6.96

9.28

ug/l

1.56

502

4164

ILD, hospital admissions 1, main diag only

591

4589

1.33

8.89

2.6

2.4

11.57

6.91

ug/l

4.30

521

3944

Sicca syndrome [Sjögren]

319

2247

1.46

8.88

2.1

2.3

5.53

6.18

ug/l

0.27

261

1937

Other disorders starting during childhood or adolescence

490

1.99

8.87

2.5

1.9

3.53

7.23

ug/l

3.12

422

Bulimia nervosa (incl. atypical)

301

2.29

8.87

1.6

1.9

3.18

4.85

ug/l

0.56

271

Lichen sclerosus et atrophicus

361

2599

1.43

8.86

2.1

2.3

3.93

6.51

ug/l

5.06

314

2224

Other and unspecified abdominal hernia

176

1098

1.68

8.85

2.4

2.5

6.48

7.06

ug/l

0.19

151

961

Persistent delusional disorders

301

2101

1.48

8.83

2.6

2.4

5.98

7.19

ug/l

0.45

243

1839

Burn and corrosion of trunk

124

704

1.86

8.81

2.4

5.67

8.02

ug/l

1.41

108

630

Cholangitis (primary sclerosing, PSC)

248

1670

1.54

8.80

2.5

2.4

4.84

7.43

ug/l

2.35

209

1454

Follow-up examination after treatment for malignant neoplasms

351

2514

1.43

8.78

2.3

2.1

6.33

7.58

ug/l

0.88

293

2137

Fracture of foot, except ankle

779

6234

1.27

8.77

2.5

2.2

6.64

7.71

ug/l

0.90

671

5466

Other disorders of adrenal gland

158

959

1.71

8.72

3.0

2.3

6.03

6.88

ug/l

0.29

140

852

Tongue abnormality

249

1684

1.54

8.70

2.9

2.4

4.71

6.87

ug/l

1.82

204

1478

Evidence of alcohol involvement determined by blood alcohol level

315

2.32

8.70

3.8

2.3

5.31

9.03

ug/l

1.97

289

Other ill-defined and unspecified causes of mortality

294

2059

1.49

8.70

3.2

2.5

5.97

6.89

ug/l

0.30

250

1751

Unspecified jaundice

211

1377

1.59

8.68

2.6

2.2

4.89

8.11

ug/l

2.42

183

1199

Dislocation, sprain and strain of joints and ligaments of head

127

725

1.81

8.66

2.2

4.37

7.61

ug/l

2.95

113

645

Postzoster neuralgia

420

2.17

8.65

3.3

2.5

4.99

6.27

ug/l

0.26

359

Chalazion

403

2964

1.39

8.62

3.1

2.2

5.64

7.99

ug/l

2.22

342

2629

Hyperplasia of prostate

1844

9089

1.17

8.61

2.5

2.3

7.29

9.41

ug/l

4.02

1584

8182

Inflammatory diseases of the central nervous system

305

2143

1.47

8.60

2.4

2.3

5.89

7.20

ug/l

0.91

262

1905

Other retinal artery occlusion

117

662

1.90

8.59

3.4

2.6

4.73

7.15

ug/l

1.87

100

565

Flat foot [pes planus] (acquired)

326

2317

1.44

8.57

2.4

2.3

5.13

7.60

ug/l

1.42

276

2009

Benign neoplasm: Skin of ear and external auricular canal

177

1117

1.67

8.53

2.5

5.38

6.57

ug/l

0.74

147

973

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

107

585

1.92

8.53

2.5

2.4

4.00

7.68

ug/l

3.32

531

Fenamates

574

2974

1.32

8.51

2.1

2.3

7.28

9.24

ug/l

1.22

473

2588

Disorders in reading

161

2.80

8.50

1.7

1.9

6.10

6.72

ug/l

0.07

146

Asthma and opportunity respiratory infection

206

1349

1.60

8.48

3.3

2.4

6.29

7.01

ug/l

0.29

168

1170

Crystal arthropathies, rheuma endpoint

528

2.01

8.47

3.0

2.5

4.16

6.52

ug/l

1.51

454

Vitamin deficiency

191

1226

1.62

8.46

4.3

2.5

4.97

7.30

ug/l

2.07

157

1070

Vitamin deficiency, wide

191

1226

1.62

8.46

4.3

2.5

4.97

7.30

ug/l

2.07

157

1070

Intentional self-harm by unspecified means

151

2.88

8.44

2.2

2.1

8.23

7.50

ug/l

0.07

138

Complications peculiar to reattachment and amputation

172

2.91

8.43

2.8

2.6

4.49

7.99

ug/l

1.02

150

Disorders of purine and pyrimidine metabolism

144

3.14

8.38

2.9

2.3

3.20

7.27

ug/l

1.56

130

Cluster headache, wide,, including avohilmo

170

1062

1.66

8.34

2.4

2.2

4.73

7.79

ug/l

1.31

143

957

Anorexia

281

2.35

8.33

2.2

2.4

2.70

5.08

ug/l

2.46

241

Mental and behavioural disorders due to tobacco

307

2174

1.45

8.33

2.5

2.3

6.78

8.17

ug/l

0.49

251

1962

Sequelae of injuries of neck and trunk

125

724

1.82

8.32

2.2

2.4

5.90

7.12

ug/l

0.53

111

654

Anoxic brain damage

343

2.26

8.32

3.4

2.7

25.75

7.54

ug/l

2.00

303

Abnormal spermatozoa

329

4517

0.71

8.31

2.3

2.5

6.35

8.64

ug/l

0.77

288

4017

Other disorders involving the immune mechanism, not elsewhere classified

123

709

1.82

8.31

2.3

2.4

6.71

8.03

ug/l

0.24

107

647

Other crystal arthropathies

532

1.99

8.29

3.0

2.7

4.16

6.65

ug/l

1.60

457

Other keratitis

376

2754

1.40

8.26

2.5

2.3

8.00

7.55

ug/l

0.08

342

2453

Other viral hepatitis

189

1213

1.60

8.22

2.2

11.03

8.21

ug/l

0.51

168

1100

Recurrent dislocation of patella

117

660

1.81

8.21

2.2

2.0

6.85

6.65

ug/l

0.03

583

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

504

2470

1.33

8.20

1.7

1.8

4.95

5.24

ug/l

0.12

436

2144

Benign neoplasm: Small intestine

184

1186

1.64

8.20

2.7

2.5

5.27

7.12

ug/l

1.47

164

1039

Medial epicondylitis

136

807

1.75

8.19

2.2

2.1

5.22

8.50

ug/l

2.42

123

717

Disorders of optic nerve and visual pathways

317

2262

1.44

8.17

2.4

2.3

5.28

6.88

ug/l

1.60

272

1997

Malignant neoplasm of bronchus and lung

563

6717

0.77

8.15

2.2

2.5

5.14

6.74

ug/l

1.17

480

5666

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

158

975

1.67

8.14

2.2

4.45

7.95

ug/l

3.56

145

876

Conduct disorder

262

2.34

8.14

2.7

2.0

6.95

9.05

ug/l

0.52

235

Dermatopolymyositis

338

2.23

8.14

2.9

2.3

18.38

6.57

ug/l

2.44

295

Excessive vomiting in pregnancy

184

1173

1.60

8.13

2.2

2.0

5.78

5.09

ug/l

0.20

157

1024

Pneumothorax

298

2113

1.46

8.12

2.6

2.4

7.83

7.57

ug/l

0.10

258

1854

Salpingitis and oophoritis

544

4210

1.31

8.12

2.5

2.1

5.74

6.16

ug/l

0.21

464

3663

Pyothorax

190

1235

1.62

8.12

2.7

2.5

7.75

7.67

ug/l

0.02

168

1104

Other noninflammatory disorders of vagina

237

1602

1.52

8.10

2.2

2.3

4.35

6.48

ug/l

2.35

179

1371

Carcinoma in situ of other and unspecified genital organs

400

2.12

8.10

2.6

2.3

2.68

6.32

ug/l

4.01

351

Fracture at wrist and hand level

1203

10135

1.20

8.09

2.4

2.3

7.48

7.94

ug/l

0.23

1046

8933

Mixed disorders of conduct and emotions

194

2.55

8.08

1.9

3.86

6.96

ug/l

1.11

165

Pyoderma

448

2.04

8.07

2.6

2.4

4.10

8.36

ug/l

2.52

391

Other coagulation defects

246

1680

1.51

8.07

2.2

2.3

9.56

6.87

ug/l

0.87

211

1478

Postmenopausal osteoporosis with pathological fracture

271

1899

1.49

8.05

3.0

2.4

4.96

5.36

ug/l

0.16

200

1556

Other and unspecified nail disorders

456

2.03

8.02

2.6

2.4

5.22

7.55

ug/l

0.89

403

Plantar fascial fibromatosis

325

2336

1.42

8.02

2.6

2.2

5.52

7.85

ug/l

1.61

283

2055

Smoking dependency

307

2190

1.44

8.01

2.5

2.3

6.78

8.13

ug/l

0.47

251

1974

Burns and corrosions of multiple and unspecified body regions

498

1.98

8.01

2.8

2.4

6.74

8.23

ug/l

0.49

448

Other obstetric conditions, not elsewhere classified

522

2583

1.32

8.00

1.7

1.8

5.00

5.27

ug/l

0.11

454

2251

Blepharochalasis

1200

10146

1.20

8.00

2.4

2.3

5.52

6.83

ug/l

1.67

1013

8741

Psoriatic and enteropathic arthropathies

404

3011

1.37

7.95

2.3

2.2

4.87

8.33

ug/l

6.29

353

2682

Other diseases of liver

646

5132

1.28

7.93

2.3

7.75

7.48

ug/l

0.10

563

4510

Late syphilis

316

2.27

7.91

3.4

2.4

4.49

8.45

ug/l

2.74

287

Sacrococcygeal disorders, not elsewhere classified

100

548

1.90

7.88

2.2

2.1

3.82

7.14

ug/l

3.19

487

Intentional self-harm by sharp object

345

2.14

7.87

2.7

2.1

3.08

9.23

ug/l

4.24

312

Behavioural disorders

260

2.32

7.84

2.7

2.0

7.03

8.20

ug/l

0.25

234

Retinal haemorrhage

114

659

1.84

7.79

2.8

2.6

6.18

6.43

ug/l

0.07

102

565

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

885

7276

1.23

7.77

2.4

2.2

7.96

7.69

ug/l

0.09

777

6428

Other blood glucose lowering drugs, excl. Insulins

734

5941

1.26

7.77

2.7

2.4

5.82

7.52

ug/l

2.03

641

5094

Chronic conjunctivitis

118

686

1.80

7.75

2.7

2.3

3.99

7.25

ug/l

3.37

100

611

Nontoxic goitre/thyroid nodule

1159

9793

1.20

7.74

2.3

5.34

6.19

ug/l

1.11

1005

8292

Benign neoplasm: Small intestine

184

1203

1.61

7.73

2.7

2.5

5.27

7.44

ug/l

1.93

164

1050

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

108

597

1.82

7.72

2.4

1.9

4.09

7.49

ug/l

2.92

519

Other disorders of the genitourinary system

483

3718

1.33

7.71

2.5

2.4

6.54

6.20

ug/l

0.15

403

3163

Other and unspecified paralytic syndromes

312

2.24

7.69

2.4

2.3

7.01

7.16

ug/l

0.03

282

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

113

651

1.82

7.68

2.3

2.4

4.07

8.16

ug/l

4.19

596

Persons with potential health hazards related to communicable diseases

697

8581

0.80

7.68

2.0

2.1

11.49

7.28

ug/l

1.98

593

7576

Total colectomy operation

160

1010

1.65

7.66

2.5

2.4

4.75

7.54

ug/l

1.66

141

909

Total colectomy

160

1010

1.65

7.66

2.5

2.4

4.75

7.54

ug/l

1.66

141

909

Dental caries 2 and operation codes

2598

18409

1.13

7.64

2.2

7.01

7.55

ug/l

0.60

2258

16270

Lesion of sciatic nerve

216

1463

1.54

7.62

3.0

2.5

8.53

6.80

ug/l

0.29

194

1236

Benign neoplasm: Skin of ear and external auricular canal

177

1149

1.61

7.62

2.5

5.38

7.51

ug/l

1.77

147

994

Postprocedural musculoskeletal disorders, not elsewhere classified

286

2040

1.45

7.62

2.6

2.4

4.86

7.13

ug/l

3.55

254

1789

Unspecified/other endometriosis

194

1270

1.55

7.62

1.9

2.0

2.03

6.38

ug/l

11.31

153

1094

Benign neoplasm: Skin of other and unspecified parts of face

441

3363

1.35

7.57

2.6

2.4

5.98

6.77

ug/l

0.27

353

2909

Schizoid personality disorder

395

2.07

7.57

3.3

2.2

11.70

8.93

ug/l

0.17

356

Other general symptoms and signs

143

866

1.68

7.56

2.2

2.0

4.96

7.34

ug/l

2.26

122

766

Vestibular neuronitis

344

2529

1.40

7.56

2.2

2.4

4.84

7.37

ug/l

3.03

303

2252

Algoneurodystrophy

110

630

1.82

7.54

2.0

2.2

12.66

6.31

ug/l

0.71

573

Carcinoma in situ of skin of ear and external auricular canal

393

2.12

7.54

2.3

2.8

4.65

6.85

ug/l

1.29

338

Heterophoria

245

1693

1.48

7.54

2.4

2.2

6.12

7.02

ug/l

0.27

204

1508

Lichen planus, including avohilmo

694

5598

1.26

7.53

2.2

2.3

5.79

7.40

ug/l

1.77

588

4866

Non-allergic asthma

338

2476

1.40

7.53

2.7

2.4

4.91

6.88

ug/l

2.91

306

2181

Scar conditions and fibrosis of skin

129

773

1.73

7.50

2.1

2.2

9.22

7.24

ug/l

0.34

116

690

Psoriatic arthropathies

353

2604

1.39

7.48

2.2

5.03

8.74

ug/l

5.96

305

2323

Rheumatic valve diseases

114

667

1.81

7.44

2.3

2.6

14.60

6.28

ug/l

1.22

559

Kyphosis

283

2.28

7.43

2.8

2.3

4.77

6.92

ug/l

0.98

243

Deep endometriosis

298

2140

1.42

7.42

2.3

2.2

6.56

5.46

ug/l

0.25

255

1823

Artificial joint re-operation

300

2171

1.44

7.42

2.3

2.5

5.58

6.70

ug/l

0.37

254

1882

Other juvenile arthritis

536

1.86

7.36

2.0

2.2

5.19

6.91

ug/l

0.73

466

Pemphigoid

131

801

1.74

7.36

2.3

2.5

5.28

5.94

ug/l

0.23

103

685

Other female pelvic inflammatory diseases

491

3802

1.31

7.36

2.2

4.62

6.01

ug/l

1.08

383

3261

Dissocial personality disorder

344

2.13

7.34

3.1

2.0

6.72

11.20

ug/l

1.00

321

malignant neoplasm of female genital organs

572

4531

1.29

7.32

2.4

3.96

5.56

ug/l

3.79

485

3748

Oligomenorrhoea

488

1.90

7.28

2.6

2.3

6.60

6.23

ug/l

0.08

428

Other disorders of veins

1457

12592

1.17

7.23

2.4

2.3

8.23

6.86

ug/l

0.70

1169

10941

Other noninflammatory disorders of vulva and perineum

250

1746

1.46

7.23

2.2

6.25

6.41

ug/l

0.03

206

1507

Abnormal findings on diagnostic imaging of other body structures

474

3673

1.32

7.22

2.3

6.46

6.78

ug/l

0.15

404

3187

Disturbances of smell and taste

154

978

1.64

7.21

2.5

2.3

5.83

7.40

ug/l

0.75

133

872

Other and unspecified injuries of abdomen, lower back and pelvis

306

2.20

7.20

2.9

2.3

6.87

7.66

ug/l

0.13

273

Malignant neoplasm of respiratory system and intrathoracic organs

684

7738

0.80

7.19

2.3

2.5

5.49

6.88

ug/l

1.03

588

6551

Prurigo nodularis

111

652

1.81

7.18

2.9

2.5

8.51

7.44

ug/l

0.12

103

574

Leisure time condition

635

5097

1.27

7.16

2.3

6.72

7.31

ug/l

0.36

477

4443

Volvulus

110

643

1.80

7.16

2.7

2.4

5.88

6.83

ug/l

0.23

562

Follicular cysts of skin and subcutaneous tissue

662

5340

1.26

7.15

2.3

5.32

7.47

ug/l

4.23

591

4707

Other maternal disorders predominantly related to pregnancy

1485

8041

1.17

7.15

2.1

5.69

6.10

ug/l

0.32

1327

6952

Symptoms and signs involving emotional state

522

1.87

7.14

2.0

2.2

9.99

8.06

ug/l

0.17

469

Ill-defined and unknown causes of mortality

316

2322

1.41

7.12

3.3

2.5

5.83

7.03

ug/l

0.45

270

1968

Malignant neoplasm of breast, HER-positive

869

10294

0.82

7.12

2.0

2.3

3.83

5.69

ug/l

8.19

716

8736

Polyarthritis, unspecified

143

895

1.66

7.12

2.5

2.4

4.46

6.81

ug/l

1.85

127

783

Protozoal diseases

115

683

1.78

7.12

2.2

2.4

8.35

7.12

ug/l

0.29

105

609

Congenital malformations and deformations of the musculoskeletal system

219

1488

1.49

7.10

2.0

2.1

9.11

6.85

ug/l

0.53

194

1309

Seronegative rheumatoid arthritis

439

3375

1.33

7.06

2.2

2.3

5.79

7.50

ug/l

1.15

361

2928

Immunodeficiencies

169

1101

1.59

7.06

2.6

2.3

5.18

7.11

ug/l

1.45

145

984

Dental caries 2

2655

18722

1.12

7.04

2.2

6.97

7.57

ug/l

0.71

2304

16546

Radial styloid tenosynovitis [de Quervain]

166

1074

1.59

7.04

2.3

2.2

5.83

7.15

ug/l

0.55

143

943

Infections of genitourinary tract in pregnancy

237

1648

1.46

7.01

2.1

2.3

4.54

5.42

ug/l

0.38

221

1415

Orchitis and epididymitis

394

2993

1.35

7.00

2.6

2.3

10.90

8.87

ug/l

0.42

344

2672

Glaucoma suspect

1497

13021

1.17

7.00

2.5

2.4

6.34

6.89

ug/l

0.35

1304

11125

Mixed specific developmental disorders

164

2.51

6.99

1.6

2.0

12.96

6.80

ug/l

0.59

137

Toxic effect of other and unspecified substances

198

2.46

6.97

3.5

2.2

13.87

9.11

ug/l

0.52

183

Fourth [trochlear] nerve palsy

103

598

1.83

6.97

2.8

2.4

10.35

7.15

ug/l

0.26

528

Assault by sharp object

323

2.13

6.96

2.5

2.1

6.92

9.97

ug/l

0.42

298

ILD-related respiratory insufficiency

152

979

1.64

6.92

2.7

2.5

13.75

6.38

ug/l

3.58

137

852

Entropion and trichiasis of eyelid

381

2892

1.36

6.91

2.6

2.4

5.29

7.15

ug/l

2.25

312

2454

Drug-induced cataract

569

1.84

6.89

2.9

2.4

10.15

7.40

ug/l

0.49

507

Traumatic ischaemia of muscle

300

2.18

6.82

2.8

2.4

11.57

7.81

ug/l

0.44

270

Other diseases of stomach and duodenum

249

1767

1.45

6.82

2.2

2.3

5.97

7.49

ug/l

0.80

220

1561

Dermatitis due to substances taken internally

195

1320

1.52

6.79

2.2

2.3

5.76

7.34

ug/l

0.88

167

1150

Oesophageal obstruction

157

1020

1.61

6.79

2.5

2.4

5.05

7.53

ug/l

2.12

137

898

Benign neoplasm: Skin of other and unspecified parts of face

441

3418

1.32

6.78

2.6

2.4

5.98

7.01

ug/l

0.38

353

2927

Inguinal hernia, bilateral

465

3633

1.31

6.77

2.4

8.41

8.51

ug/l

0.02

414

3216

Polymyositis

197

2.51

6.77

3.2

2.2

18.28

7.24

ug/l

2.02

174

Obstructive hydrocephalus

349

2.08

6.75

2.3

2.4

7.78

7.11

ug/l

0.07

308

Persons encountering health services in circumstances related to reproduction

1438

11239

0.86

6.75

2.0

2.1

9.36

8.33

ug/l

0.54

1310

10031

Anomalies of dental arch relationship, including avohilmo

509

3589

1.29

6.72

2.1

2.2

6.82

7.32

ug/l

0.15

439

3186

Inguinal or femoral hernia, bilateral

471

3690

1.31

6.71

2.4

8.42

8.48

ug/l

0.02

419

3264

Fibrosis and cirrhosis of liver

298

2189

1.41

6.70

2.6

2.4

9.54

7.07

ug/l

0.58

262

1932

Iridocyclitis

823

6835

1.22

6.70

2.5

2.3

5.16

7.41

ug/l

4.72

726

5942

Primary_lymphoid and hematopoietic malignant neoplasms

1007

8527

1.20

6.67

2.4

7.24

7.86

ug/l

0.29

851

7363

Primary_lymphoid and hematopoietic malignant neoplasms

1007

8533

1.20

6.65

2.4

7.24

7.17

ug/l

0.03

851

7335

Pneumonia due to Streptococcus pneumoniae

162

1061

1.58

6.65

3.0

2.2

5.46

7.50

ug/l

1.47

137

933

Other and/or unspecified nontoxic goitre

299

2196

1.40

6.64

2.4

2.3

6.36

6.12

ug/l

0.07

270

1888

Congenital malformations of the urinary system

192

1302

1.52

6.62

2.2

2.3

5.47

7.66

ug/l

2.02

172

1153

Other drug-induced secondary parkinsonism

232

2.38

6.61

3.3

2.5

5.02

6.86

ug/l

0.59

214

Mental and behavioural disorders due to cannabinoids

375

1.98

6.61

2.0

3.03

10.50

ug/l

6.79

341

Lichen ruber planus, wide definition including periferal and oral lichen planus

778

6444

1.23

6.58

2.2

2.3

5.95

7.26

ug/l

1.42

658

5609

Respiratory disorders in diseases classified elsewhere

326

2.11

6.55

3.0

2.3

14.01

6.68

ug/l

0.98

285

Dental pulpitis 3, only avohilmo

168

796

1.56

6.54

1.7

2.0

6.36

5.62

ug/l

0.17

136

671

Abnormal findings in nipple discharge synovial fluid wound secretions

332

2.09

6.54

2.2

2.3

13.21

7.55

ug/l

1.09

291

Sequelae of injuries of lower limb

321

2387

1.38

6.54

2.3

8.27

7.65

ug/l

0.14

286

2136

Open wound of hip and thigh

116

704

1.71

6.53

2.3

7.23

8.02

ug/l

0.14

637

Iliotibial band syndrome

192

2.44

6.52

2.1

2.2

5.60

6.97

ug/l

0.20

175

Suggestive for eosinophilic asthma

346

2608

1.36

6.50

2.4

2.2

6.21

8.12

ug/l

1.51

310

2313

Other salmonella infections

143

916

1.62

6.50

2.7

2.2

6.59

7.80

ug/l

0.32

117

807

Anxious personality disorder

269

2.17

6.49

2.7

2.2

4.18

8.31

ug/l

1.56

242

Optic atrophy

440

1.93

6.48

2.4

4.01

7.32

ug/l

2.80

388

Contusion of other and unspecified parts of foot

141

899

1.61

6.42

2.4

2.2

5.40

7.47

ug/l

1.04

128

807

Benign neoplasm of other and unspecified endocrine glands

470

3699

1.30

6.39

2.5

2.3

6.07

7.72

ug/l

0.95

415

3276

Other diseases of gallbladder

184

1252

1.53

6.37

2.5

2.4

6.19

6.90

ug/l

0.26

154

1077

Divergent concomitant strabismus

252

1810

1.43

6.37

2.2

2.3

7.53

7.10

ug/l

0.09

215

1616

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

978

8306

1.20

6.35

2.3

2.4

4.39

8.03

ug/l

10.86

857

7249

Stenosis and insufficiency of lacrimal passages

350

2653

1.35

6.34

2.4

2.3

5.42

6.64

ug/l

0.61

296

2292

Chronic viral hepatitis

149

965

1.58

6.33

2.3

2.2

11.90

8.73

ug/l

0.45

134

878

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

588

4760

1.26

6.33

2.7

2.4

8.54

8.12

ug/l

0.13

514

4211

Ptosis of eyelid

438

3429

1.31

6.30

2.5

2.3

5.39

7.34

ug/l

2.49

366

2986

Hypopituitarism

228

1613

1.45

6.29

2.4

2.3

6.62

7.86

ug/l

0.34

194

1460

Benign neoplasm of meninges

382

2937

1.33

6.28

2.5

6.34

7.13

ug/l

0.38

316

2509

Ankylosing spondylitis

288

2118

1.39

6.28

2.7

2.2

5.27

9.68

ug/l

3.67

247

1905

In situ neoplasms

1375

11423

1.16

6.26

2.3

2.4

6.23

6.81

ug/l

0.40

1188

9764

Nasal polyp

752

6240

1.22

6.25

2.2

2.3

7.26

7.98

ug/l

0.35

672

5497

Chronic laryngitis and laryngotracheitis

511

4071

1.28

6.25

2.4

2.3

6.67

7.54

ug/l

0.51

399

3547

Scleritis

249

2.23

6.22

2.4

4.00

6.28

ug/l

1.51

226

Assault by unspecified means

350

2.00

6.22

1.9

2.1

7.09

9.80

ug/l

0.36

321

Other disorders of breast

359

2731

1.34

6.22

2.1

2.2

3.61

5.73

ug/l

5.59

297

2329

Viral hepatitis

222

1566

1.45

6.21

2.3

10.25

7.71

ug/l

0.53

191

1418

Erosion of teeth

275

2.14

6.20

2.3

2.2

5.85

6.03

ug/l

0.06

248

Conjunctivitis

2618

20627

1.11

6.19

2.3

2.2

6.53

6.99

ug/l

0.41

2219

17952

Chronic nephritic syndrome

161

1073

1.56

6.19

2.6

2.4

5.25

7.76

ug/l

1.38

144

957

Dislocation, sprain and strain of joint and ligaments of hip

152

1002

1.58

6.18

2.6

2.5

5.53

6.93

ug/l

0.54

133

863

Adrenocortical insufficiency

128

810

1.64

6.15

3.2

2.4

5.34

7.12

ug/l

0.69

113

720

Hidradenitis suppurativa

103

615

1.73

6.12

2.2

2.1

6.54

8.01

ug/l

0.36

558

L02BG Aromatase inhibitors

732

8797

0.82

6.12

2.0

2.3

3.94

5.79

ug/l

6.55

606

7486

Unspecified nephritic syndrome

545

1.80

6.08

3.1

2.4

7.13

7.51

ug/l

0.06

484

Chronic tubulo-interstitial nephritis

150

987

1.58

6.07

2.3

2.4

5.41

6.57

ug/l

0.46

125

835

Erectile dysfunction

383

2971

1.33

6.06

2.7

2.4

21.16

7.80

ug/l

4.79

346

2608

Inflammatory disease of cervix uteri

223

1586

1.45

6.04

2.0

2.3

4.21

5.46

ug/l

1.03

176

1356

Prepatellar bursitis

182

1249

1.51

6.04

2.3

2.2

7.52

10.77

ug/l

1.23

159

1125

Viral infections of the central nervous system

244

1761

1.42

6.04

2.6

2.3

5.57

6.82

ug/l

0.74

204

1563

Rosacea

367

2818

1.33

6.02

2.4

2.3

8.19

6.74

ug/l

0.26

316

2486

Abnormal findings on diagnostic imaging of central nervous system

149

980

1.57

6.01

1.9

2.4

4.16

6.60

ug/l

2.88

131

864

Open wound of abdomen, lower back and pelvis

104

628

1.72

6.00

2.4

5.99

8.36

ug/l

1.03

567

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

128

2.87

5.99

3.0

2.4

3.27

7.53

ug/l

1.40

115

Emotional disorders and disorders of social functioning with onset specific to childhood

460

1.81

5.98

1.6

2.5

4.15

6.46

ug/l

0.96

385

Deviated nasal septum

1290

11222

1.16

5.96

2.4

2.3

9.44

8.70

ug/l

0.29

1125

10012

Other bursitis of hip

489

1.84

5.95

2.7

2.4

4.90

7.31

ug/l

0.75

421

Thrombocytopenia, unspecified

266

1957

1.40

5.94

2.3

2.4

8.31

7.31

ug/l

0.38

233

1716

Benign neoplasm of other and unspecified endocrine glands

470

3735

1.28

5.94

2.5

2.4

6.07

7.94

ug/l

1.15

415

3268

Other superficial mycoses

407

1.90

5.93

2.4

2.3

5.42

8.37

ug/l

1.07

367

Varicose veins of other sites

250

1821

1.41

5.92

2.6

2.3

6.76

8.25

ug/l

0.67

210

1632

Thyroiditis

233

1675

1.43

5.92

2.4

2.2

6.88

6.52

ug/l

0.07

203

1465

Evidence of alcohol involvement determined by level of intoxication

175

2.42

5.91

2.9

2.3

4.77

7.05

ug/l

1.04

158

Injury of eye and orbit

456

3608

1.28

5.87

2.5

2.2

6.27

8.50

ug/l

1.97

404

3232

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

369

1.99

5.87

2.6

2.4

3.23

4.80

ug/l

1.24

314

Other peripheral vascular diseases

274

2028

1.38

5.83

2.4

2.3

5.96

6.29

ug/l

0.16

231

1769

Other and unspecified coagulation defects

146

962

1.56

5.82

1.8

2.4

11.22

6.78

ug/l

0.95

127

851

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

229

2.24

5.82

2.9

2.4

5.72

ug/l

0.00

205

Benign neoplasm of meninges

382

2973

1.32

5.77

2.5

2.4

6.34

6.33

ug/l

0.00

316

2554

Haemorrhagic disorder due to circulating anticoagulants

336

2.04

5.77

3.0

2.5

6.19

6.46

ug/l

0.06

291

Cirrhosis of liver, NAS

207

1472

1.46

5.77

2.8

2.5

10.47

7.49

ug/l

0.49

188

1311

Other and unspecified disorders of skin and subcutaneous tissue

236

1711

1.42

5.76

2.3

2.4

5.85

7.03

ug/l

0.71

160

1508

Toxic effect of alcohol

508

1.80

5.76

3.1

2.3

4.70

8.94

ug/l

3.46

460

Car occupant injured in noncollision transport accident

119

751

1.64

5.76

2.4

2.3

7.22

7.96

ug/l

0.17

109

678

Nonalcoholic fatty liver disease

303

2282

1.36

5.74

2.2

2.3

6.87

8.05

ug/l

0.44

269

2037

Open wound of shoulder and upper arm

413

1.88

5.70

2.7

2.3

6.03

8.00

ug/l

0.51

365

Herpesviral keratitis and keratoconjunctivitis

168

1150

1.51

5.69

2.2

2.4

6.67

7.31

ug/l

0.15

142

1020

Superficial frostbite

142

2.62

5.68

2.0

2.2

5.44

12.02

ug/l

1.45

126

Idiopathic pulmonary fibrosis

336

2584

1.34

5.67

2.6

2.5

13.65

7.13

ug/l

5.13

295

2197

Vascular dementia

383

2889

1.31

5.65

2.5

2.6

4.37

5.80

ug/l

2.29

266

2381

Oral leukoplakia and related diseases, including avohilmo

333

2554

1.34

5.63

2.1

2.4

12.00

7.02

ug/l

0.84

284

2259

Oral leukoplakia and related diseases

230

1672

1.42

5.62

2.1

2.5

11.70

6.95

ug/l

0.61

200

1481

114

723

1.67

5.62

3.4

2.6

5.97

6.58

ug/l

0.20

625

Excessive attrition of teeth

1404

6659

1.15

5.62

2.3

6.38

6.19

ug/l

0.14

1226

5895

Diffuse brain injury

119

755

1.62

5.61

2.4

2.2

8.06

7.60

ug/l

0.12

691

Congenital iodine-deficiency syndrome/hypothyroidism

118

751

1.64

5.60

2.7

2.4

5.06

5.89

ug/l

0.37

639

Colitis due to radiation

276

2.13

5.60

2.8

2.6

5.71

8.73

ug/l

0.92

239

Carcinoma in situ of skin of ear and external auricular canal

436

1.89

5.59

2.3

2.8

4.65

6.52

ug/l

1.39

373

Nonspecific lymphadenitis

190

1331

1.46

5.58

1.9

2.2

5.53

8.24

ug/l

1.46

167

1197

Acute and subacute iridocyclitis

683

5683

1.22

5.55

2.6

2.3

5.38

7.58

ug/l

3.53

612

4988

Frostbite

241

2.18

5.54

2.2

5.54

9.78

ug/l

1.33

215

Neuromuscular dysfunction of bladder

338

2602

1.33

5.54

2.3

2.2

5.34

7.79

ug/l

2.23

274

2315

Type 1 diabetes, definitions combined

238

1726

1.39

5.53

2.0

7.92

7.64

ug/l

0.08

200

1541

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

355

2760

1.32

5.51

2.7

2.4

5.18

7.42

ug/l

2.57

308

2375

Other and unspecified rosacea

283

2125

1.36

5.51

2.5

2.3

9.43

6.80

ug/l

0.39

243

1881

Systemic sclerosis (FG)

531

1.75

5.46

2.5

2.4

17.22

6.95

ug/l

0.52

478

Other nonscarring hair loss

150

2.49

5.46

2.1

13.44

3.57

ug/l

0.66

128

Other fall from one level to another

751

6310

1.20

5.43

2.4

2.3

8.43

7.76

ug/l

0.28

665

5532

Primary open-angle glaucoma, strict

1163

10124

1.16

5.40

2.5

2.4

6.64

6.50

ug/l

0.06

969

8516

Benign neoplasm: Cerebral meninges

340

2631

1.32

5.40

2.4

2.5

6.70

6.97

ug/l

0.09

277

2247

Other renal tubulo-interstitial diseases

517

1.75

5.40

2.4

8.28

6.47

ug/l

0.38

447

Drug-induced hypoglycaemia without coma

415

1.87

5.39

2.1

2.5

7.92

7.79

ug/l

0.01

366

Coeliac disease

393

3093

1.29

5.36

2.1

2.3

5.98

6.69

ug/l

0.43

339

2708

Use of rivastigmine

636

5281

1.23

5.36

2.5

5.46

5.90

ug/l

0.29

466

4289

Benign neoplasm: Kidney

136

905

1.57

5.35

2.4

2.5

4.83

6.76

ug/l

1.37

115

798

IBD patients in KELA-register

718

6018

1.21

5.34

2.4

2.2

6.27

7.91

ug/l

1.57

636

5357

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

614

5089

1.23

5.33

2.2

2.4

7.79

7.99

ug/l

0.06

545

4452

Generalized skin eruption due to drugs and medicaments

140

936

1.55

5.32

2.4

2.5

5.97

6.92

ug/l

0.32

116

818

Adhesive middle ear disease

335

1.94

5.31

2.8

2.3

5.11

7.69

ug/l

0.80

299

Benign neoplasm: Cerebral meninges

340

2638

1.32

5.30

2.4

6.70

6.39

ug/l

0.11

277

2277

Implicit parasitic Sepsis

111

2.84

5.30

2.1

2.2

8.87

6.05

ug/l

0.43

Reactive arthropathies

294

2231

1.34

5.30

2.5

2.3

5.45

8.25

ug/l

3.37

249

1982

Other and unspecified intracranial injuries

116

746

1.62

5.29

2.4

6.50

7.40

ug/l

0.29

101

656

Atopic dermatitis, strict definition with reimbursement

748

6096

1.20

5.28

2.1

2.0

6.83

7.53

ug/l

0.39

653

5354

Muscle strain

107

674

1.64

5.27

2.1

5.58

8.00

ug/l

1.11

588

Seropositive rheumatoid arthritis, strict definition

543

4446

1.24

5.26

2.3

5.81

7.05

ug/l

1.47

486

3872

Complications following myocardial infarction

166

2.40

5.26

3.7

2.1

7.34

4.94

ug/l

0.60

132

Other abnormalities of plasma proteins

390

1.89

5.25

2.6

7.22

7.15

ug/l

0.01

342

Benign neoplasm of urinary organs

183

1295

1.46

5.24

2.4

2.5

4.39

7.13

ug/l

3.53

150

1135

Medicines for HER+ breast cancer

947

10703

0.85

5.23

2.0

2.3

3.74

5.78

ug/l

10.77

781

9097

Benign neoplasm of mouth and pharynx

408

3243

1.28

5.22

2.5

2.3

6.65

7.59

ug/l

0.46

341

2855

Type 1 diabetes, strict (exclude DM2)

235

1719

1.38

5.21

2.0

7.94

7.79

ug/l

0.04

198

1535

Schizotypal disorder

424

1.81

5.19

2.4

2.2

4.95

8.61

ug/l

2.52

390

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

211

1538

1.43

5.17

2.5

5.62

7.61

ug/l

1.17

186

1328

Crohn's disease of small intestine

206

1487

1.42

5.14

2.4

2.2

7.59

7.52

ug/l

0.01

184

1347

Exposure to other and unspecified inanimate mechanical forces

220

1607

1.40

5.13

2.1

2.3

5.82

8.02

ug/l

1.45

177

1451

Perforation of tympanic membrane

346

2699

1.31

5.13

2.3

2.4

5.79

7.13

ug/l

0.96

284

2367

Crohn disease (strict definition, all UC cases excluded)

153

1047

1.50

5.13

2.1

2.3

6.27

7.35

ug/l

0.25

132

946

Complications of genitourinary prosthetic devices, implants and grafts

564

1.70

5.12

2.7

2.4

5.13

6.76

ug/l

0.60

487

Acute nasopharyngitis (common cold)

380

2977

1.29

5.11

2.4

2.1

6.75

9.51

ug/l

2.59

341

2705

L04AC Interleukin inhibitors

146

991

1.51

5.11

2.2

4.72

8.00

ug/l

2.87

122

895

Dementia due to Parkinsons disease, excluding more controls

543

1.72

5.09

2.4

2.3

5.74

6.40

ug/l

0.20

482

Lung cancer and mesothelioma

762

5516

1.20

5.09

2.3

2.2

5.99

7.99

ug/l

1.92

669

4817

Campylobacter enteritis

102

643

1.65

5.08

2.7

2.3

4.95

7.72

ug/l

1.20

578

Burn and corrosion of hip and lower limb, except ankle and foot

496

1.74

5.07

1.9

2.4

4.47

8.59

ug/l

3.09

448

Oral leukoplakia

492

1.77

5.07

2.2

2.6

5.73

6.50

ug/l

0.12

427

Isolated proteinuria

107

683

1.63

5.06

2.7

2.4

6.69

7.55

ug/l

0.11

611

Disorders of refraction and accommodation

765

6454

1.19

5.06

2.1

2.2

7.85

7.47

ug/l

0.15

666

5650

Malignant neoplasm of vulva

252

2.12

5.05

2.4

2.5

3.36

4.34

ug/l

0.49

215

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

233

1727

1.39

5.03

2.5

3.41

6.17

ug/l

5.31

203

1464

Other Crohn's disease

205

1484

1.41

5.03

2.2

6.89

7.17

ug/l

0.07

183

1346

Contusion of toe(s) without damage to nail

376

1.84

5.03

2.3

2.1

7.25

6.72

ug/l

0.07

339

Other misadventures during surgical and medical care

507

1.74

5.01

2.3

2.4

6.72

7.59

ug/l

0.22

449

Hydrocele

516

4231

1.24

5.01

2.6

2.4

7.81

8.47

ug/l

0.36

458

3748

Acute generalized exanthematous pustulosis

156

1080

1.49

5.00

2.3

2.5

6.20

7.00

ug/l

0.26

130

940

Dislocation, sprain and strain of joints and ligaments of knee

2050

17216

1.11

5.00

2.1

2.2

7.29

7.93

ug/l

0.45

1791

15321

Intermittent heterotropia

146

993

1.50

5.00

2.3

8.91

6.73

ug/l

0.30

120

878

Benign neoplasm: Liver

438

1.79

4.99

2.0

2.4

7.73

6.15

ug/l

0.26

389

Abnormal findings on examination of urine, without diagnosis

161

1123

1.48

4.98

2.5

5.90

7.28

ug/l

0.29

137

987

Scleritis and episcleritis

188

1345

1.43

4.98

2.1

2.2

4.78

6.86

ug/l

1.47

172

1193

Injury of muscle and tendon at wrist and hand level

477

3879

1.25

4.95

2.2

2.3

6.52

8.47

ug/l

1.57

433

3488

Hordeolum and other deep inflammation of eyelid

177

1255

1.45

4.95

2.8

2.3

7.75

7.87

ug/l

0.02

154

1128

Molar incisor enamel hypoplasia, with caries

3.48

4.94

3.3

1.6

10.08

6.63

ug/l

0.33

Brain meningioma, excluding all cancers (controls excluding all cancers)

196

1419

1.43

4.94

2.0

2.5

5.27

6.95

ug/l

1.37

171

1234

Pleural plaque

454

3690

1.26

4.91

2.9

2.4

6.00

7.00

ug/l

0.85

385

3200

Crohn's disease of large intestine

158

1098

1.47

4.91

2.2

6.21

7.70

ug/l

0.51

137

997

Habit and impulse disorders

279

1.98

4.90

2.4

2.2

6.04

9.52

ug/l

0.90

257

Dental caries 2, only avohilmo

2544

18337

1.10

4.87

2.1

2.2

6.18

7.64

ug/l

3.93

2209

16198

Severe visual impairment, monocular

213

2.19

4.86

3.0

2.6

4.62

8.28

ug/l

1.04

189

Other diseases of peritoneum

163

1145

1.47

4.86

2.4

5.17

6.83

ug/l

0.67

133

1003

Lupus erythematosus

557

1.69

4.85

2.6

2.4

4.54

7.63

ug/l

2.21

490

Scabies

141

962

1.51

4.85

2.3

6.57

8.59

ug/l

0.86

124

868

Crohn disease (strict definition, require KELA)

182

1300

1.43

4.84

2.2

5.66

7.17

ug/l

0.46

155

1175

Speech therapy

1032

8994

1.16

4.84

2.1

2.4

7.91

7.05

ug/l

0.40

956

7725

Type1 diabetes, definitions combined, early onset

124

816

1.53

4.84

2.2

1.9

6.84

7.80

ug/l

0.27

104

724

Other facial nerve disorders

102

652

1.62

4.80

2.6

2.4

4.94

7.13

ug/l

0.92

571

Thyrotoxicosis with diffuse goitre

410

3288

1.26

4.79

2.2

8.54

6.13

ug/l

0.76

344

2849

Burns and corrosions confined to eye and internal organs

581

1.66

4.79

2.1

2.2

5.12

8.51

ug/l

2.21

525

Other forms of systemic lupus erythematosus

160

2.34

4.78

1.7

2.4

8.47

5.15

ug/l

0.52

141

Other intracranial haemorrhages

134

913

1.53

4.78

2.8

2.6

3.79

6.01

ug/l

3.18

117

789

IgA nephropathy (IgA glomerulonephritis)

552

1.68

4.77

2.4

2.3

3.88

8.67

ug/l

4.17

504

Crohn disease (strict definition, require KELA, min 2 HDR)

179

1279

1.43

4.76

2.2

5.64

7.22

ug/l

0.47

152

1155

Benign neoplasm: Other and unspecified parts of mouth

133

904

1.53

4.76

2.5

5.27

7.18

ug/l

1.32

110

811

Melanocytic naevi, other sites/unspecified

252

1904

1.35

4.76

2.5

2.3

8.04

7.77

ug/l

0.05

231

1699

Other and unspecified trigeminal disorders

341

1.88

4.76

2.5

6.71

7.39

ug/l

0.11

304

Psoriasis vulgaris

665

5608

1.20

4.75

2.5

2.3

6.61

7.80

ug/l

1.08

574

4969

Histrionic personality disorder

111

2.69

4.74

3.4

2.4

7.24

4.86

ug/l

0.19

Other congenital malformations of circulatory system

600

1.65

4.74

1.8

2.4

4.62

7.52

ug/l

1.68

543

Epidural haemorrhage

180

2.24

4.73

2.8

2.4

4.97

7.79

ug/l

0.77

160

Benign neoplasm of urinary organs

183

1321

1.43

4.73

2.4

2.5

4.39

7.41

ug/l

4.36

150

1155

Fall on same level involving ice and snow

2141

19481

1.11

4.73

2.4

2.3

7.56

7.07

ug/l

0.33

1779

16963

Melanocytic naevi

947

8210

1.16

4.72

2.4

2.3

8.78

7.62

ug/l

0.46

829

7185

Hypertrophy of breast in women and men

541

4473

1.22

4.71

2.2

4.52

6.66

ug/l

2.42

466

3910

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

139

955

1.51

4.70

2.5

5.00

7.00

ug/l

1.67

114

836

Papilloedema, unspecified

446

1.75

4.69

2.1

2.6

3.31

7.02

ug/l

3.69

398

Melanocytic naevi

947

8215

1.16

4.69

2.4

2.3

8.78

7.15

ug/l

0.73

829

7162

Anterior Iridocyclitis

717

6093

1.19

4.68

2.6

2.3

5.42

7.54

ug/l

3.50

636

5319

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1216

8408

0.87

4.65

2.4

2.5

7.22

9.47

ug/l

3.12

1043

7507

Supervision of high-risk pregnancy

390

1867

1.27

4.64

1.7

1.8

3.89

6.03

ug/l

2.39

346

1632

Other congenital malformations of skin

120

800

1.54

4.63

2.4

2.3

6.66

7.06

ug/l

0.10

110

714

Eosinophilic disease (BM)

322

1.89

4.62

2.6

2.2

20.34

7.58

ug/l

0.47

291

Allergic rhinitis

812

6896

1.17

4.61

2.1

2.2

6.60

7.40

ug/l

0.49

698

6095

Melanocytic naevi, other sites/unspecified

252

1914

1.34

4.60

2.5

2.3

8.04

7.16

ug/l

0.17

231

1716

Personal history of certain other diseases

187

2.15

4.60

1.9

2.2

4.42

5.33

ug/l

0.31

168

Benign neoplasm of mouth and pharynx

408

3296

1.26

4.59

2.5

2.4

6.65

8.00

ug/l

0.74

341

2876

Other disorders of gingiva or/and edentulous alveolar ridge

167

1190

1.44

4.59

2.2

2.3

5.38

7.00

ug/l

0.85

140

1044

Agranulocytosis

378

3026

1.27

4.59

2.2

2.3

7.65

7.04

ug/l

0.26

319

2669

Ehlers-Danlos syndrome

111

2.55

4.59

1.5

2.2

11.14

3.98

ug/l

0.50

Sudden idiopathic hearing loss

379

3038

1.27

4.58

2.4

2.3

6.73

7.58

ug/l

0.44

308

2678

Abscess of external ear

294

1.93

4.58

3.7

2.3

4.75

7.30

ug/l

0.69

266

Cysts of oral region, not elsewhere classified

156

1099

1.46

4.58

2.2

6.95

7.54

ug/l

0.14

137

989

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1205

8179

0.87

4.57

2.4

2.5

7.25

9.45

ug/l

3.00

1032

7295

Benign neoplasm: Kidney

136

938

1.51

4.57

2.4

2.6

4.83

7.41

ug/l

2.23

115

818

Benign neoplasm: Liver

450

1.74

4.56

2.0

2.4

7.73

6.59

ug/l

0.17

395

Residual foreign body in soft tissue

163

1158

1.44

4.54

2.3

4.19

9.86

ug/l

5.93

143

1044

Other and unspecified injuries of wrist and hand

113

747

1.56

4.54

2.0

2.3

7.33

6.82

ug/l

0.14

659

Abscess of anal and rectal regions

271

2082

1.33

4.54

2.2

9.62

9.07

ug/l

0.08

235

1893

Oral lichen ruber planus wide, hypothyreosis or thyroxin

191

1398

1.41

4.54

2.3

5.13

6.44

ug/l

0.54

157

1211

Superficial injury of neck

330

1.85

4.53

2.1

2.3

16.27

8.27

ug/l

0.29

301

ILD and respiratory illness in diseases classified elsewhere

127

2.55

4.51

3.2

2.3

9.62

9.41

ug/l

0.02

118

Primary open-angle glaucoma

1416

12341

1.13

4.49

2.4

6.38

6.50

ug/l

0.06

1161

10379

Achalasia of cardia

446

1.74

4.48

2.5

2.3

3.85

7.82

ug/l

3.10

388

Inflammatory bowel disease, strict (require KELA)

718

6120

1.18

4.48

2.4

2.2

6.27

7.77

ug/l

1.38

636

5435

Blindness or visual impairment, binocular

102

2.71

4.47

2.8

2.7

10.04

6.30

ug/l

0.35

Carcinoma in situ of oral cavity, oesophagus and stomach

147

2.42

4.47

2.3

2.8

3.18

5.50

ug/l

1.88

131

Recurring oral aphthae

156

1105

1.45

4.46

2.6

2.4

5.96

7.23

ug/l

0.53

126

978

Drug-induced adrenocortical insufficiency

379

1.80

4.43

2.9

2.4

7.42

8.09

ug/l

0.10

339

Bursitis of shoulder

586

1.63

4.43

2.3

5.78

7.60

ug/l

0.66

513

Juvenile arthritis (FINNGEN)

104

677

1.56

4.42

2.1

5.04

6.80

ug/l

0.87

598

Disorders of speech understanding and production

107

689

1.56

4.41

2.6

2.5

5.57

6.86

ug/l

0.34

599

Chronic diseases of tonsils and adenoids

2844

16590

1.09

4.41

2.3

2.2

6.36

7.90

ug/l

2.96

2499

14680

Other and unspecified injuries of lower leg

215

1605

1.37

4.40

2.3

6.71

6.85

ug/l

0.04

179

1430

Tonsillectomy and adenotomy

1524

9495

1.12

4.40

2.2

2.1

6.49

7.70

ug/l

1.04

1338

8441

Hyphaema and other vascular disorders of iris and ciliary body

495

1.70

4.40

2.6

2.4

5.19

7.37

ug/l

1.17

436

Erythema multiforme

509

1.68

4.39

2.9

2.5

6.89

7.15

ug/l

0.05

452

Other specified/unspecified inflammatory spondylopathies

123

832

1.51

4.39

2.2

2.0

10.94

7.86

ug/l

0.19

107

740

Hypoparathyroidism

137

953

1.49

4.39

2.5

2.4

7.39

6.00

ug/l

0.30

109

815

malignant neoplasm of male genital organs

1652

11627

0.89

4.39

2.3

2.5

6.91

8.44

ug/l

2.63

1396

10279

Other and unspecified injuries of ankle and foot

116

777

1.53

4.37

2.4

2.2

6.45

7.10

ug/l

0.18

101

691

Emotional disorders starting during childhood or adolescence

455

1.68

4.36

1.6

1.8

5.29

6.63

ug/l

0.36

394

Beningn neoplasm: Meninges, unspecified

413

1.77

4.34

2.4

2.6

4.53

6.09

ug/l

0.58

357

Amblyopia ex anopsia

115

771

1.53

4.33

2.3

6.79

6.68

ug/l

0.03

673

Emphysema

288

2254

1.31

4.31

2.9

2.3

9.94

8.05

ug/l

0.75

249

1934

Collapsed vertebra, not elsewhere classified

210

2.12

4.30

2.3

5.76

6.49

ug/l

0.14

176

Memory loss

376

3040

1.27

4.29

2.2

2.5

4.83

7.06

ug/l

4.17

308

2651

Lichen simplex chronicus

127

874

1.50

4.29

2.3

2.4

4.49

7.41

ug/l

2.76

111

779

Bullous pemphigoid

643

1.61

4.28

2.4

2.6

5.65

6.04

ug/l

0.09

554

Contact with hot air and gases

142

2.36

4.28

1.7

2.8

11.55

9.08

ug/l

0.27

127

Additional codes for the location of defect, injury or illness

190

1402

1.39

4.28

2.4

3.99

7.07

ug/l

6.09

179

1247

Benign neoplasm: Skin of lip

362

1.82

4.28

2.0

2.5

4.09

7.39

ug/l

2.05

320

Post-traumatic wound infection, not elsewhere classified

608

1.61

4.27

2.9

2.4

9.00

8.02

ug/l

0.13

550

Progressive vascular leukoencephalopathy

152

1089

1.46

4.24

1.8

2.5

4.50

5.49

ug/l

0.74

123

894

Infective bursitis

116

787

1.53

4.24

2.6

2.3

11.83

8.82

ug/l

0.18

708

Other specified and unspecified disorders of eye and adnexa

140

983

1.47

4.24

2.1

2.4

10.54

6.89

ug/l

0.46

114

859

Right hemicolectomy

244

1875

1.34

4.24

2.4

2.5

7.02

6.84

ug/l

0.04

213

1612

Carbimazole or st.post thyroidectomy, condition for graves disease

635

5387

1.19

4.24

2.3

10.07

6.60

ug/l

1.55

536

4682

Psoriasis

1019

8960

1.15

4.23

2.4

2.3

5.99

8.01

ug/l

4.22

888

7906

Systemic sclerosis, icd10

570

1.63

4.23

2.5

2.4

17.22

6.27

ug/l

0.57

506

Impacted teeth

335

2473

1.27

4.22

2.1

7.32

6.77

ug/l

0.14

300

2153

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

836

0.54

4.22

2.1

2.5

2.21

7.14

ug/l

13.64

719

In situ neoplasms

1375

12317

1.13

4.22

2.3

2.4

6.23

6.29

ug/l

0.03

1188

10441

Third [oculomotor] nerve palsy

502

1.68

4.21

2.3

2.4

4.83

6.92

ug/l

1.09

437

Autoimmune hyperthyroidism

183

1343

1.39

4.21

2.2

10.18

6.11

ug/l

0.62

146

1182

Intracranial and intraspinal abscess and granuloma

275

1.94

4.21

2.8

2.5

7.15

7.44

ug/l

0.04

242

Dystonia

180

1320

1.40

4.21

2.7

2.3

3.76

7.04

ug/l

7.32

155

1177

Specific development disorders of speech and language

134

894

1.47

4.20

2.4

2.3

5.65

6.98

ug/l

0.45

114

769

Other and unspecified nerve root and plexus disorders, also in other diseases

611

5173

1.20

4.20

2.4

2.2

6.41

8.31

ug/l

1.36

527

4582

Alzheimer’s disease (Early onset), excluding more controls

150

1005

1.44

4.20

2.6

2.3

6.64

6.54

ug/l

0.02

835

Disorders of optic nerve, not elsewhere classified

549

1.64

4.20

2.9

2.5

4.53

7.11

ug/l

1.76

486

Systemic sclerosis

571

1.62

4.19

2.5

2.4

17.22

6.24

ug/l

0.57

504

Perineal laceration during delivery

136

1725

0.70

4.18

1.6

1.9

4.63

5.28

ug/l

0.23

112

1493

Other interventions on the root canals of the tooth

347

1.80

4.18

2.0

2.2

9.48

7.46

ug/l

0.28

313

Malignant neoplasm of corpus uteri

317

2522

1.29

4.18

2.4

4.26

5.37

ug/l

1.12

265

2072

Benign neoplasm: Liver/bile ducts

508

1.65

4.17

2.0

2.3

7.22

6.35

ug/l

0.14

445

Pregnancy examination and test

265

1266

1.32

4.17

3.2

1.8

4.10

6.00

ug/l

1.13

234

1096

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1485

13471

0.89

4.16

2.0

2.2

5.93

6.88

ug/l

0.72

1297

11751

Other specified disorders of kidney and ureter

125

864

1.50

4.16

2.8

2.4

7.29

7.73

ug/l

0.10

114

757

Melanocytic naevi of trunk

371

2998

1.26

4.15

2.6

2.3

11.68

7.50

ug/l

1.00

337

2668

Brain meningioma

187

1386

1.39

4.15

2.0

2.5

5.42

6.57

ug/l

0.73

163

1200

Bicipital tendinitis

169

1231

1.41

4.14

2.1

2.2

9.09

9.51

ug/l

0.07

142

1107

Nonsuppurative otitis media

581

4224

1.20

4.13

2.1

2.2

6.28

6.72

ug/l

0.23

488

3693

Rash and other nonspecific skin eruption

320

2546

1.28

4.13

2.2

2.3

6.82

6.84

ug/l

0.01

287

2209

Other meningitis

320

1.83

4.08

2.1

2.3

4.70

6.75

ug/l

0.79

284

Endometriosis ASRM stages 1,2

409

3339

1.24

4.08

2.0

3.76

5.72

ug/l

2.84

348

2886

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

190

1410

1.37

4.08

2.2

5.55

7.15

ug/l

0.51

160

1275

Biological medication for rheuma

426

3496

1.23

4.07

2.1

2.2

5.94

7.67

ug/l

1.47

372

3131

Subacute thyroiditis

116

792

1.51

4.06

2.1

2.2

4.54

6.38

ug/l

1.13

102

698

Other and specified injuries of hip and thigh

577

1.61

4.05

2.7

2.6

4.88

6.81

ug/l

0.80

488

Cholesteatoma of external ear

194

2.13

4.05

2.2

2.6

3.82

6.32

ug/l

1.29

173

Other acute viral hepatitis

234

1.98

4.04

1.8

2.3

6.28

9.65

ug/l

0.92

212

Other encephalitis

616

1.58

4.03

2.4

2.5

4.59

7.85

ug/l

2.40

547

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

410

1.70

4.02

2.3

4.32

6.72

ug/l

1.20

363

Redundant prepuce, phimosis and paraphimosis

735

6311

1.17

4.02

2.3

2.2

8.39

9.39

ug/l

0.39

655

5694

Benign neoplasm: Other and unspecified parts of mouth

133

938

1.47

4.00

2.5

2.4

5.27

7.79

ug/l

2.06

110

829

Malignant neoplasm of prostate

1640

11419

0.90

4.00

2.3

2.5

6.80

8.40

ug/l

2.91

1386

10085

Lactose intolerance, other/unspecified

497

1.64

3.99

2.1

2.3

3.65

6.59

ug/l

2.38

431

Viral encephalitis, not elsewhere classified/unspecified

492

1.66

3.98

2.7

2.5

4.72

7.40

ug/l

1.42

436

Encephalitis

659

1.55

3.95

2.3

2.4

4.45

7.73

ug/l

2.61

580

Unspecified event, undetermined intent

523

1.62

3.95

2.3

10.68

7.45

ug/l

0.29

472

Other otitis externa (chronic)

216

1646

1.34

3.94

2.3

2.4

5.91

6.94

ug/l

0.60

150

1481

Adenocarcinoma of pancreas

819

0.55

3.94

2.1

2.5

2.21

6.56

ug/l

9.47

703

Complications predominantly related to the puerperium

571

4828

1.19

3.93

2.0

2.1

5.37

5.73

ug/l

0.15

508

4203

Other disorders of iris and ciliary body

103

694

1.54

3.93

2.7

2.4

5.90

6.91

ug/l

0.41

607

Other nonautoimmune haemolytic anaemias

3.63

3.92

2.1

2.0

9.46

7.17

ug/l

0.33

Convalescence

173

1276

1.39

3.92

2.2

2.3

8.57

6.22

ug/l

0.36

139

1134

Inflammatory disorders of male genital organs, not elsewhere classified

349

1.78

3.90

2.3

6.65

10.33

ug/l

0.89

310

Injury of urinary and pelvic organs

479

1.65

3.89

2.6

2.4

10.03

8.58

ug/l

0.15

425

Other specified and unspecified disorders of eyelid

350

1.78

3.87

3.1

2.5

4.55

7.80

ug/l

1.27

314

Acute alcohol intoxication ICD-9

141

1011

1.44

3.87

3.3

2.5

6.09

7.80

ug/l

0.48

126

898

Gingival hyperplasia

109

744

1.51

3.86

2.2

2.3

6.11

6.88

ug/l

0.21

665

Exposure to smoke, fire and flames

592

1.58

3.83

2.6

2.4

5.17

8.31

ug/l

2.22

531

124

2.43

3.82

3.2

2.3

10.34

8.77

ug/l

0.14

115

Aphakia

334

1.77

3.82

2.7

2.2

5.03

7.15

ug/l

0.82

291

Tuberculosis, wide

314

2525

1.27

3.79

2.6

2.5

5.27

6.79

ug/l

1.68

257

2123

Toxic liver disease

367

1.75

3.78

3.0

2.4

7.50

7.10

ug/l

0.07

325

Hyperfunction of pituitary gland

130

918

1.44

3.78

6.0

2.2

6.37

6.50

ug/l

0.03

111

816

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

733

7031

0.86

3.77

2.2

2.5

5.99

7.58

ug/l

1.33

638

6020

Portal vein thrombosis

368

1.74

3.75

2.5

2.4

4.05

7.41

ug/l

2.54

325

Acquired absence of organs, not elsewhere classified

263

1.88

3.74

2.5

4.98

5.58

ug/l

0.18

231

Long labour

300

3274

0.79

3.73

1.8

2.0

4.79

5.50

ug/l

0.27

259

2862

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

127

903

1.46

3.73

3.0

2.6

5.12

6.62

ug/l

0.92

100

773

Viral meningitis

100

674

1.52

3.73

2.1

2.2

5.85

7.48

ug/l

0.55

611

Osteonecrosis due to drugs

340

1.79

3.73

2.1

2.6

8.37

6.27

ug/l

0.27

300

Nephrotic syndrome

110

759

1.50

3.72

2.3

2.5

4.77

7.30

ug/l

1.47

674

Type 1 diabetes, strict definition, subgroup 1

142

1017

1.41

3.70

1.8

1.9

7.34

7.22

ug/l

0.02

122

906

Combined immunodeficiencies

257

1.89

3.70

3.2

2.3

3.26

6.64

ug/l

2.33

228

Dementia in other diseases classified elsewhere

181

1363

1.37

3.69

2.7

2.5

5.75

6.73

ug/l

0.41

1186

Other/unspecified enthesopathies, not elsewhere classified

309

2485

1.27

3.69

2.4

2.2

5.26

8.37

ug/l

3.95

264

2167

Other chondrocalcinosis

357

1.77

3.69

3.1

2.6

3.80

6.52

ug/l

1.63

315

Supervision of normal pregnancy

261

1902

0.78

3.68

1.5

1.8

4.37

6.25

ug/l

1.62

229

1660

Paraplegia, diplegia of upper limbs

550

1.59

3.68

3.6

2.3

6.44

8.02

ug/l

0.48

484

Other and unspecified mononeuropathies of upper limb

101

686

1.52

3.68

2.7

2.4

12.77

7.48

ug/l

0.47

613

Tuberculosis, IBD comorbidity

303

2437

1.27

3.67

2.6

2.5

5.33

6.74

ug/l

1.43

248

2054

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

159

1177

1.40

3.67

1.9

2.4

4.27

7.99

ug/l

5.64

131

1030

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

367

3015

1.24

3.65

2.4

2.5

4.48

5.85

ug/l

1.57

307

2497

Pediculosis, acariasis and other infestations

181

1361

1.36

3.64

2.3

6.93

8.77

ug/l

0.78

160

1235

Disorders of globe

100

682

1.52

3.63

2.6

2.4

6.51

6.34

ug/l

0.05

579

Benign neoplasm: Liver/bile ducts

527

1.59

3.63

2.0

2.3

7.22

6.80

ug/l

0.06

463

Lactose intolerance

557

1.56

3.63

2.1

2.2

3.65

6.88

ug/l

3.07

489

Enteropathic arthropathies

455

1.63

3.62

2.7

2.4

3.41

8.47

ug/l

4.03

408

Beningn neoplasm: Meninges, unspecified

435

1.67

3.61

2.4

2.5

4.53

7.22

ug/l

1.16

379

Procedures for purposes other than remedying health state

495

1.60

3.61

2.1

2.2

3.80

6.80

ug/l

2.03

445

Granulomatous disorders of skin and subcutaneous tissue

519

1.59

3.60

2.4

2.3

5.45

6.71

ug/l

0.47

453

Later onset COPD

1338

9489

1.12

3.60

2.8

2.5

5.62

6.74

ug/l

2.56

1077

8021

Other peripheral vertigo

327

2657

1.25

3.60

2.6

2.4

6.33

6.96

ug/l

0.25

270

2337

Other bullous disorders

101

691

1.51

3.60

2.4

2.5

7.25

6.76

ug/l

0.10

612

Melanocytic naevi of trunk

371

3051

1.23

3.58

2.6

2.3

11.68

7.69

ug/l

0.93

337

2679

Vasculitis limited to skin, not elsewhere classified

635

1.54

3.57

2.6

2.5

5.12

7.17

ug/l

1.17

553

Benign neoplasm: Larynx

125

892

1.45

3.57

3.0

2.6

5.03

7.20

ug/l

1.44

115

787

Vascular dementia (mixed)

437

1.66

3.56

2.0

2.8

5.33

6.30

ug/l

0.20

380

Hodgkin lymphoma, hilmo

667

1.52

3.56

2.2

2.3

6.76

7.72

ug/l

0.28

600

Hyperkinetic disorders (excl. ADHD)

177

2.01

3.55

2.0

1.8

7.86

9.12

ug/l

0.17

159

Monoplegia

366

1.72

3.55

2.9

2.4

6.96

7.70

ug/l

0.11

330

Lagophthalmos

329

1.77

3.55

2.8

2.6

5.12

6.00

ug/l

0.23

291

Contact with heat and hot substances

165

1230

1.37

3.53

2.4

2.3

6.94

7.71

ug/l

0.30

149

1104

Bacterial, viral and other infectious agents

262

2078

1.28

3.52

2.4

2.3

9.43

8.47

ug/l

0.21

230

1874

Primary biliary cholangitis (PBC)

500

1.60

3.50

2.0

2.3

5.47

5.96

ug/l

0.18

438

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

463

1.63

3.48

2.7

2.5

7.85

6.22

ug/l

0.19

403

Chronic hepatitis, not elsewhere classified

113

794

1.47

3.48

2.0

2.3

5.71

7.43

ug/l

0.77

101

702

Vulvovaginal ulceration/inflammation in other diseases

120

848

1.44

3.48

2.5

2.1

3.30

5.65

ug/l

2.37

754

Other lesions of median nerve

114

805

1.47

3.47

2.4

5.08

7.54

ug/l

1.62

683

Vascular dementia (multiple infarctions)

375

1.69

3.46

2.8

2.7

4.28

6.49

ug/l

1.38

320

Disorders of tooth development and eruption

110

745

1.46

3.45

2.2

2.1

12.38

9.19

ug/l

0.43

657

Carcinoma in situ of oral cavity, oesophagus and stomach

164

2.15

3.45

2.3

2.6

3.18

6.21

ug/l

2.28

140

Other and unspecified bullous disorders

219

1.94

3.45

2.1

2.7

8.68

4.98

ug/l

0.50

194

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1932

13860

1.10

3.45

2.2

2.4

5.12

7.99

ug/l

12.14

1625

12003

Other and unspecified injuries of thorax

400

1.66

3.43

3.0

2.6

3.71

7.69

ug/l

3.33

356

Livedoid vasculitis

2.70

3.41

1.8

2.4

6.31

7.13

ug/l

0.12

Recurrent dislocation and subluxation of joint

178

1346

1.34

3.41

2.0

2.2

5.71

8.25

ug/l

0.97

150

1206

Secondary and unspecified malignant neoplasm of lymph nodes

305

2478

1.26

3.40

2.2

2.4

9.80

7.43

ug/l

0.53

262

2175

Congenital deformities of feet

399

1.65

3.39

2.2

2.4

13.00

7.73

ug/l

0.37

361

Drug-induced osteoporosis

295

1.79

3.39

2.0

2.5

8.42

6.73

ug/l

0.23

258

Mental retardation, excluding more controls

619

1.51

3.39

2.4

2.2

5.58

9.11

ug/l

1.26

551

Ménière disease

352

2903

1.23

3.38

2.5

2.4

6.87

6.74

ug/l

0.04

300

2535

Immunodeficiency with predominantly antibody defects

544

1.55

3.37

2.5

2.2

5.39

6.60

ug/l

0.51

483

Primary angle-closure glaucoma

184

1410

1.34

3.37

2.9

2.5

4.81

6.80

ug/l

1.75

152

1196

Pneumonia derived septicemia

117

833

1.45

3.37

2.9

2.3

5.82

7.30

ug/l

0.75

728

Senility

234

1.87

3.36

3.7

2.2

4.42

6.00

ug/l

0.52

187

therapeutic use

113

802

1.46

3.36

2.3

2.5

6.47

6.33

ug/l

0.03

713

Hodgkin lymphoma

676

1.50

3.35

2.2

2.4

6.76

7.67

ug/l

0.28

597

Benign neoplasm: Skin of lip

389

1.68

3.35

2.0

2.4

4.09

7.40

ug/l

2.17

340

Syphilis

644

1.51

3.35

2.9

2.4

5.39

8.42

ug/l

2.39

581

Idiopathic thrombocytopenic purpura

103

718

1.48

3.34

2.4

4.59

6.63

ug/l

1.51

637

Other vitreous opacities

144

1065

1.39

3.33

2.4

4.91

7.22

ug/l

2.21

124

927

Type 1 diabetes, strict definition

152

1122

1.37

3.33

1.9

7.58

7.21

ug/l

0.09

130

996

Autism spe, excluding more controls

169

1.99

3.32

1.9

1.7

3.53

8.38

ug/l

1.82

144

Cerebral palsy

227

1.86

3.32

2.4

2.2

8.24

7.77

ug/l

0.06

208

Other specified/unspecified bacterial intestinal infections

223

1752

1.30

3.32

2.3

2.4

6.64

6.95

ug/l

0.09

187

1541

Injury of nerves at shoulder and upper arm level

244

1.86

3.31

3.1

2.2

15.09

7.50

ug/l

0.56

217

Mixed conductive and sensorineural hearing loss

463

3924

1.20

3.31

2.4

2.3

6.94

7.30

ug/l

0.14

367

3398

Filling of root of tooth

100

694

1.48

3.31

2.4

2.3

16.75

7.56

ug/l

0.89

625

Other and unspecified injuries of shoulder and upper arm

100

694

1.48

3.31

3.8

2.3

10.26

7.39

ug/l

0.34

615

Pilonidal cyst

228

1792

1.29

3.30

2.2

5.44

8.76

ug/l

2.66

199

1625

Other acute skin changes due to ultraviolet radiation

126

914

1.42

3.28

2.2

2.4

6.57

6.64

ug/l

0.02

103

800

Drug-induced obesity

165

2.04

3.27

2.1

2.6

3.85

5.34

ug/l

0.64

148

Polycystic ovarian syndrome, broad definition

162

1214

1.35

3.26

1.8

3.23

4.21

ug/l

0.77

140

1059

Degenerative conditions of globe

132

2.21

3.26

3.6

2.8

4.16

6.47

ug/l

0.65

111

Maternal care for known or suspected fetal abnormality and damage

139

1674

0.73

3.25

1.6

2.0

17.07

5.54

ug/l

1.19

115

1460

Hypertrophy of breast

418

3508

1.20

3.25

2.0

2.1

3.57

6.10

ug/l

7.20

351

3036

Benign neoplasm of major salivary glands

357

2962

1.23

3.24

2.6

2.4

5.77

7.27

ug/l

1.31

315

2584

Other/unspecified disorders of vestibular function

145

1079

1.38

3.24

2.6

2.4

6.39

7.20

ug/l

0.14

118

945

Osteonecrosis

207

1618

1.31

3.24

2.4

2.3

8.58

6.99

ug/l

0.27

173

1448

Wide developmental disorders, excluding more controls

240

1.80

3.23

1.7

1.8

3.71

7.92

ug/l

2.18

201

Lesion of plantar nerve

207

1618

1.31

3.22

2.4

2.3

3.81

6.71

ug/l

7.21

175

1402

Benign neoplasm: Larynx

125

911

1.42

3.20

3.0

2.5

5.03

8.00

ug/l

2.35

115

795

Malnutrition

464

1.59

3.19

3.1

2.6

6.00

6.84

ug/l

0.25

399

Sleep disorders, other/unspecified

566

1.52

3.18

2.6

2.3

5.34

6.95

ug/l

0.52

512

Pneumoconiosis due to asbestos and other mineral fibres

100

703

1.48

3.18

3.1

2.5

6.99

6.69

ug/l

0.07

600

Other lack of coordination

401

1.64

3.18

2.7

2.3

7.03

7.12

ug/l

0.01

348

Drug-induced neutropenia

234

1862

1.28

3.15

2.2

2.4

7.34

7.14

ug/l

0.06

204

1660

Benign neoplasm: Adrenal gland

265

2141

1.26

3.15

2.6

2.4

6.68

7.68

ug/l

0.29

235

1896

Other and unspecified mononeuropathies of lower limb

100

702

1.47

3.15

2.0

2.4

7.17

7.06

ug/l

0.01

616

Autonomic disorders

505

1.56

3.15

2.4

5.78

6.80

ug/l

0.24

444

Sixth [abducent] nerve palsy

127

931

1.41

3.14

2.6

2.5

7.12

7.34

ug/l

0.03

110

820

Benign neoplasm: Adrenal gland

265

2143

1.26

3.13

2.6

2.4

6.68

7.37

ug/l

0.19

235

1906

Other bacterial agents as the cause of diseases classified to other chapters

242

1.83

3.11

2.3

2.4

20.08

7.57

ug/l

0.60

211

Palmar fascial fibromatosis [Dupuytren]

641

5600

1.16

3.11

2.6

2.3

6.52

8.16

ug/l

1.39

530

4822

Pneumococcal septicemia

113

813

1.43

3.10

2.9

2.5

5.87

7.24

ug/l

0.64

715

Dysplasia of cervi uteri

528

3498

1.17

3.10

1.9

2.1

6.72

6.48

ug/l

0.05

461

3046

Hyperaldosteronism

105

748

1.45

3.09

2.4

12.53

6.97

ug/l

0.54

667

Injury of blood vessels of thorax

2.54

3.09

2.8

2.6

12.71

3.65

ug/l

0.65

Other/unspecified soft tissue disorders related to use, overuse and pressure

621

1.49

3.08

1.6

2.2

7.62

7.68

ug/l

0.01

555

Contusion of ankle

105

745

1.44

3.07

2.3

4.31

7.65

ug/l

2.24

666

Haemangioma and lymphangioma, any site

281

2288

1.25

3.06

2.3

2.4

4.50

6.62

ug/l

2.11

239

2029

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

505

1.53

3.06

1.9

2.2

9.44

8.18

ug/l

0.20

454

Benign neoplasm of middle ear and respiratory system

292

2391

1.24

3.06

2.5

2.4

8.82

7.87

ug/l

0.14

262

2108

Corneal scars and opacities

691

1.47

3.05

2.5

2.4

4.61

7.27

ug/l

1.95

606

Other congenital malformations of female genitalia

2.48

3.02

3.2

1.8

2.11

4.99

ug/l

1.63

Unspecified chronic bronchitis

138

1030

1.37

3.02

2.7

2.4

8.80

7.15

ug/l

0.16

113

880

Barrett oesophagus

177

1371

1.32

3.01

2.0

2.3

6.93

8.23

ug/l

0.46

146

1224

Intentional self-harm by crashing of motor vehicle

5.36

2.99

1.9

2.6

3.69

5.47

ug/l

—

Female infertility

660

3552

1.15

2.98

1.8

2.1

4.97

6.79

ug/l

2.03

572

3112

Benign neoplasm of bone and articular cartilage

249

2007

1.26

2.98

2.2

2.3

6.44

7.68

ug/l

0.51

216

1784

Use of levodopa decarboxylase inhibitor

551

4785

1.17

2.97

2.4

5.96

6.97

ug/l

0.96

408

4080

Atopic dermatitis, strict definition

688

5921

1.15

2.97

2.0

2.1

7.09

7.36

ug/l

0.12

607

5210

Sequelae of other and unspecified infectious and parasitic diseases

165

1265

1.33

2.97

2.2

9.60

8.11

ug/l

0.28

145

1138

Haemangioma and lymphangioma, any site

281

2297

1.24

2.97

2.3

4.50

7.28

ug/l

3.24

239

2007

Oesophageal varices

154

1174

1.35

2.96

2.3

2.4

5.57

7.74

ug/l

0.96

132

1053

Episcleritis

148

1118

1.35

2.96

2.0

2.2

5.02

7.01

ug/l

1.03

139

998

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

131

971

1.37

2.96

2.6

2.1

3.46

5.42

ug/l

2.33

121

854

Ectopic pregnancy

410

3467

1.19

2.95

1.9

2.1

4.42

5.89

ug/l

1.79

347

3047

Single delivery by forceps and vacuum extractor

140

1140

0.74

2.95

1.6

2.1

4.74

7.02

ug/l

1.23

119

979

Perichondritis of external ear

482

1.56

2.95

2.8

2.5

4.19

6.35

ug/l

1.28

431

Congenital malformations of the respiratory system

345

1.65

2.94

2.7

2.3

4.66

6.83

ug/l

1.08

304

Other symptoms and signs involving the urinary system

383

3231

1.20

2.94

2.3

8.11

7.78

ug/l

0.11

346

2865

Female infertility, cervigal, vaginal, other or unspecified origin

591

3429

1.16

2.93

1.8

2.1

4.85

6.77

ug/l

2.10

510

3003

Assault by blunt object

268

1.74

2.93

3.3

2.1

15.58

10.20

ug/l

0.20

245

Polyhydramnios

510

1.51

2.92

2.1

2.0

2.15

5.02

ug/l

5.41

443

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

754

0.60

2.92

2.4

2.6

4.31

7.07

ug/l

1.94

637

L01XE Protein kinase inhibitors

211

1679

1.29

2.92

2.2

2.5

8.95

7.18

ug/l

0.45

186

1497

Reactive arthropathies, FINNGEN

213

1691

1.28

2.92

2.5

2.3

5.68

7.97

ug/l

1.83

178

1509

Atopic dermatitis

1592

12480

1.09

2.91

2.3

2.1

6.50

7.65

ug/l

1.49

1365

10939

Benign neoplasm of bone and articular cartilage

249

2013

1.26

2.91

2.2

2.4

6.44

7.44

ug/l

0.39

216

1803

Disorders of myoneural junction and muscle in diseases classified elsewhere

188

1.92

2.91

2.1

2.4

3.68

6.17

ug/l

0.77

166

Other and unspecified myoneural disorders

2.41

2.91

2.9

2.2

4.29

4.64

ug/l

0.11

Intercostal neuropathy

188

1.92

2.91

2.4

2.5

5.33

6.07

ug/l

0.15

164

Pedestrian injured in collision with car, pick-up truck or van

580

1.49

2.91

2.3

2.5

6.20

6.80

ug/l

0.14

507

Other melanin hyperpigmentation

566

1.50

2.88

2.1

2.5

9.27

7.06

ug/l

0.39

492

Use of ropinirole

144

1094

1.36

2.88

3.0

2.5

6.13

7.29

ug/l

0.51

114

974

Calcification and ossification of muscle

2.81

2.88

2.7

2.1

2.17

8.57

ug/l

1.66

Contracture of joint

301

1.70

2.88

2.4

2.6

7.70

8.41

ug/l

0.12

263

Other psoriatic arthropathies

328

2732

1.22

2.88

2.2

2.3

5.00

8.20

ug/l

4.57

287

2450

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

207

1639

1.28

2.87

2.0

2.2

6.36

8.54

ug/l

0.82

175

1472

Biomechanical lesions, not elsewhere classified

163

1257

1.33

2.87

2.5

10.39

7.02

ug/l

0.55

140

1116

Nosocomial condition (hospital)

139

2.09

2.86

1.8

2.5

3.18

7.76

ug/l

1.55

124

All dysplastic lesions of the vulva

116

849

1.39

2.86

2.3

2.2

3.57

5.54

ug/l

1.56

104

732

Other and unspecified hydrocephalus

477

1.55

2.85

2.1

2.5

6.15

6.88

ug/l

0.08

417

Other disorders of bladder

459

3943

1.18

2.85

2.4

2.3

5.99

7.80

ug/l

1.86

374

3483

Endometriosis of ovary

422

3581

1.18

2.84

2.0

2.1

3.95

6.61

ug/l

5.58

345

3108

Hyperprolactinaemia

573

1.48

2.82

7.8

2.2

5.51

6.63

ug/l

0.21

519

Contact urticaria

2.92

2.82

2.0

2.8

2.61

6.15

ug/l

1.59

Benign neoplasm of major salivary glands

357

3006

1.21

2.82

2.6

2.4

5.77

7.79

ug/l

1.97

315

2620

Renal cell carcinoma of kidney

143

1088

1.35

2.82

3.0

2.5

4.18

6.50

ug/l

3.02

124

931

Other maltreatment syndromes

591

1.47

2.80

2.0

2.2

7.93

8.36

ug/l

0.09

542

Other disorders of prostate

148

1133

1.34

2.80

2.1

2.3

6.23

8.95

ug/l

1.92

142

1002

Prolapse and hernia of ovary and fallopian tube

178

1383

1.31

2.80

2.9

2.6

5.94

5.66

ug/l

0.06

147

1125

Melanocytic naevi of lower limb, including hip

125

930

1.37

2.80

2.2

2.3

6.48

6.97

ug/l

0.12

107

823

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

489

4231

1.17

2.79

2.5

2.4

5.00

7.54

ug/l

3.90

425

3659

Other diseases of spinal cord

703

1.43

2.77

2.4

5.61

7.19

ug/l

0.56

626

Benign neoplasm: Brain, supratentorial

351

1.63

2.77

3.1

2.4

7.04

6.40

ug/l

0.11

314

Presbyopia

191

1509

1.29

2.77

1.8

2.3

9.27

7.17

ug/l

0.43

172

1359

Impetigo

106

768

1.40

2.76

2.7

2.2

6.57

8.06

ug/l

0.22

684

Rheumatoid lung disease

114

2.23

2.76

4.1

2.4

3.52

5.34

ug/l

1.21

Cauda equina syndrome

297

1.69

2.76

3.5

2.4

7.43

6.21

ug/l

0.19

271

Burn and corrosion of head and neck

463

1.54

2.76

3.1

2.2

5.83

9.01

ug/l

1.28

417

Conductive hearing loss, unspecified

266

2182

1.24

2.75

2.3

5.97

7.20

ug/l

1.03

221

1928

Macular pucker

587

5153

1.16

2.75

2.7

2.4

6.49

7.12

ug/l

0.42

501

4459

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

125

937

1.37

2.73

2.7

2.6

4.11

6.14

ug/l

2.26

106

793

Urethritis and urethral syndrome

497

1.51

2.72

2.9

2.2

5.79

7.47

ug/l

0.29

442

Secondary uncertain malignant neoplasm

484

4192

1.17

2.72

2.2

2.4

7.69

7.26

ug/l

0.11

408

3613

Injury of nerves and spinal cord at neck level

590

1.47

2.71

2.1

2.2

11.70

7.15

ug/l

0.70

525

Systemic sclerosis,strict definition

177

1.90

2.71

2.8

2.4

31.91

7.44

ug/l

0.42

156

Ulcer of vagina/vulva

448

1.54

2.71

2.2

2.4

5.75

5.84

ug/l

0.02

389

Generalized epilepsy

110

806

1.39

2.70

1.9

2.2

7.34

7.59

ug/l

0.02

721

Eosinophilia

386

1.59

2.69

2.6

2.4

20.19

6.85

ug/l

0.51

345

Nonpyogenic thrombosis of intracranial venous system

170

1.91

2.69

1.4

2.3

6.75

8.38

ug/l

0.23

150

Benign neoplasm: other/unspecified salivary gland

105

768

1.41

2.69

2.4

2.6

5.59

7.01

ug/l

0.57

672

Vascular dementia (other)

172

1.95

2.69

2.9

2.7

4.05

6.47

ug/l

0.66

154

conjunctival degenerations and deposits

583

1.47

2.69

1.9

2.4

3.40

6.93

ug/l

3.19

511

Benign neoplasm of middle ear and respiratory system

292

2427

1.22

2.68

2.5

2.4

8.82

8.11

ug/l

0.10

262

2117

Benign neoplasm of other and unspecified sites

112

827

1.39

2.68

2.2

2.5

5.82

7.07

ug/l

0.38

101

732

Oral leukoplakia, including avohilmo

718

1.42

2.67

2.2

2.5

5.38

6.86

ug/l

0.34

630

Haemangioma, any site

260

2136

1.24

2.66

2.2

2.3

4.65

7.37

ug/l

2.77

221

1875

Urethral stricture

231

1879

1.26

2.66

2.3

2.4

6.59

8.24

ug/l

1.03

193

1669

Other nonthrombocytopenic purpura

224

1.80

2.66

3.5

2.5

6.90

7.21

ug/l

0.03

195

Psoriatic arthropathies, ICD10

334

2811

1.20

2.65

2.2

2.3

5.04

8.22

ug/l

4.64

291

2522

Vascular dementia (undefined)

156

1199

1.32

2.65

2.6

2.7

4.64

5.85

ug/l

0.61

101

977

Occupational exposure to risk-factors

119

890

1.37

2.64

3.2

2.4

8.28

8.03

ug/l

0.05

104

810

Other contact dermatitis

248

2028

1.24

2.64

2.3

4.76

6.89

ug/l

2.49

215

1784

Atlantoaxial subluxation

143

2.00

2.64

2.2

2.3

7.62

6.93

ug/l

0.10

132

Benign neoplasm: salivary glands, exclude unknown (D119)

307

2569

1.21

2.63

2.6

2.4

5.80

7.28

ug/l

1.13

274

2255

Juvenile osteochondrosis

557

1.46

2.63

2.3

2.2

5.11

8.23

ug/l

1.35

504

Other benign neoplasms of connective and other soft tissue

322

2705

1.21

2.62

2.3

4.91

7.37

ug/l

3.57

276

2367

L02BA Anti-estrogens

376

4406

0.84

2.61

2.1

2.3

3.18

5.91

ug/l

13.37

309

3745

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

147

1137

1.33

2.61

2.9

2.5

4.83

6.85

ug/l

1.74

119

978

Pedestrian injured in transport accident

222

1799

1.25

2.60

2.6

2.4

6.71

7.12

ug/l

0.12

190

1578

Other overlap syndromes

413

1.55

2.60

2.3

7.28

7.08

ug/l

0.03

359

Haemangioma, any site

260

2142

1.23

2.60

2.2

2.4

4.65

6.79

ug/l

1.90

221

1901

Other disorders of amniotic fluid and membranes

208

1652

1.26

2.58

1.7

2.1

4.24

5.83

ug/l

0.48

189

1437

Other and unspecified aplastic anaemias

264

1.71

2.58

2.3

2.4

6.87

6.30

ug/l

0.09

231

Exposure to unspecified smoke, fire and flames

218

1.78

2.57

3.0

2.4

5.14

9.70

ug/l

1.54

196

Tumor necrosis factor alpha inhibitors

361

3063

1.19

2.57

2.1

2.2

5.92

7.43

ug/l

1.06

319

2744

Abnormal findings on diagnostic imaging of breast

311

1.64

2.57

2.7

2.4

3.29

4.70

ug/l

0.94

270

Diseases of middle ear and mastoid

1822

13870

1.08

2.56

2.2

6.51

7.42

ug/l

0.80

1562

12093

Gestational diabetes (for exclusion)

609

3784

1.14

2.56

1.8

1.9

4.34

5.67

ug/l

0.96

543

3319

Inflammatory disorders of breast

132

1002

1.33

2.56

1.9

2.1

4.19

5.50

ug/l

0.85

111

880

Carcinoma in situ of breast, intraductal

164

2079

0.78

2.56

2.0

2.2

4.90

5.75

ug/l

0.31

133

1780

Malignant neoplasm of breast, HER2-negative

1448

11532

0.92

2.54

2.1

2.3

4.40

5.74

ug/l

4.10

1182

9752

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

143

1107

1.33

2.54

3.0

2.6

4.18

7.44

ug/l

5.13

124

949

Other and unspecified acute skin changes due to ultraviolet radiation

100

734

1.40

2.53

2.3

2.5

6.67

7.09

ug/l

0.10

635

Retinal detachment with retinal break

488

4256

1.16

2.52

2.4

7.26

7.82

ug/l

0.30

425

3704

CR(E)ST syndrome

336

1.61

2.52

2.5

2.3

24.14

5.21

ug/l

0.56

296

Distal bite

476

1.48

2.50

1.6

2.1

5.90

7.81

ug/l

0.57

412

Follow-up care involving plastic surgery

114

853

1.36

2.50

2.2

4.43

6.18

ug/l

0.86

755

Delivery

1116

6479

0.91

2.49

2.3

5.01

6.05

ug/l

1.76

989

5363

Polyarteritis nodosa and related conditions

313

1.63

2.49

4.2

2.2

5.74

6.95

ug/l

0.29

280

Other specified/unspecified disorders of bone/cartilage

701

1.41

2.49

2.4

2.3

6.02

7.52

ug/l

0.44

627

All dysplastic lesions of the cervix uteri, vagina or vulva

580

5073

1.14

2.49

2.0

5.91

5.61

ug/l

0.08

511

4383

Left hemicolectomy

695

1.41

2.48

2.3

2.5

8.82

6.48

ug/l

0.33

606

Disorders of synovium and tendon in diseases classified elsewhere

500

1.49

2.48

2.7

2.3

9.20

8.56

ug/l

0.07

443

Benign lipomatous neoplasm of other sites/unspecified

328

2779

1.20

2.47

2.2

2.4

6.27

6.89

ug/l

0.30

279

2401

Endometriosis ASRM stages 3,4

623

5518

1.14

2.47

2.1

2.2

5.41

5.70

ug/l

0.11

519

4695

Inflammation of lacrimal passages (chronic)

444

1.52

2.47

2.8

2.5

3.21

7.10

ug/l

3.64

383

Hypersplenism

2.25

2.46

3.2

2.4

17.28

9.45

ug/l

0.35

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

117

884

1.36

2.45

2.5

2.4

3.72

6.20

ug/l

2.01

104

763

Foreign body in respiratory tract

149

1161

1.31

2.45

2.7

2.5

5.69

6.96

ug/l

0.38

131

1024

Other benign neoplasms of connective and other soft tissue

322

2725

1.20

2.44

2.3

4.91

6.96

ug/l

2.60

276

2401

Cystic fibrosis, other manifestations/unspecified

3.61

2.43

2.1

2.8

13.68

8.73

ug/l

—

Premature rupture of membranes

247

2203

0.82

2.43

2.1

2.0

5.11

5.58

ug/l

0.15

215

1914

Femoral hernia

161

1272

1.29

2.41

3.6

2.4

7.36

7.04

ug/l

0.06

137

1110

Non-follicular lymphoma

362

3101

1.19

2.41

2.3

2.4

7.62

7.29

ug/l

0.07

304

2706

Flatulence and related conditions

199

1.78

2.41

1.9

2.3

3.59

9.08

ug/l

2.41

179

Injury of muscle and tendon at lower leg level

512

4492

1.15

2.41

2.4

2.3

11.53

8.55

ug/l

0.77

448

4050

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

467

4069

1.16

2.40

2.5

2.2

6.60

8.06

ug/l

0.96

419

3638

Serous carcinoma of ovary

117

888

1.35

2.39

2.5

2.3

3.72

5.85

ug/l

1.73

104

758

Folate deficiency anaemia

232

1.73

2.38

3.9

2.5

6.55

9.62

ug/l

0.71

205

Procreative management

668

6318

0.89

2.38

1.9

2.1

12.90

7.49

ug/l

2.38

584

5583

Congenital malformations of the nervous system

315

1.59

2.38

2.3

2.2

7.16

6.64

ug/l

0.06

282

Single spontaneous delivery

1108

6458

0.91

2.38

2.3

5.00

6.05

ug/l

1.79

980

5346

Inhalation and ingestion of other objects causing obstruction of respiratory tract

127

1.99

2.36

3.2

2.5

3.11

7.17

ug/l

2.70

114

Meningitis

154

1212

1.29

2.36

2.3

5.97

7.21

ug/l

0.49

132

1084

Abnormal findings on antenatal screening of mother

711

1.37

2.36

1.4

2.2

10.05

4.48

ug/l

0.34

606

Other and unspecified pemphigoid

265

1.69

2.35

2.1

2.8

4.81

6.14

ug/l

0.37

232

Adalimumab

225

1846

1.23

2.35

2.0

2.2

6.40

7.56

ug/l

0.46

195

1662

Congenital malformations of trachea and bronchus

217

1.74

2.34

3.2

2.3

6.02

5.54

ug/l

0.12

193

Other and unspecified vasculitis limited to skin

582

1.43

2.34

2.7

2.5

5.36

7.31

ug/l

0.96

506

Pollen allergy

381

3237

1.17

2.34

1.9

2.1

6.95

6.81

ug/l

0.05

319

2860

Benign lipomatous neoplasm

1068

9776

1.10

2.34

2.3

2.4

6.72

7.97

ug/l

0.95

941

8534

Other neurotic disorders

170

1357

1.28

2.34

2.2

2.3

5.90

7.20

ug/l

0.45

151

1197

Small cell lung cancer, helper endpoint

713

0.64

2.33

2.4

2.6

4.31

6.58

ug/l

1.34

600

Small cell lung cancer

713

0.64

2.33

2.4

2.6

4.31

6.58

ug/l

1.34

600

Benign neoplasm of ovary

544

4803

1.14

2.33

2.4

2.3

5.22

5.83

ug/l

0.38

467

4067

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

420

3651

1.17

2.33

2.6

2.4

5.18

7.57

ug/l

2.85

368

3167

Upper arm

2.80

2.32

2.8

2.3

1.88

5.40

ug/l

2.60

Spinal enthesopathy

116

880

1.34

2.32

2.9

2.3

5.11

6.20

ug/l

0.69

704

Mitochondrial myopathy

2.34

2.31

2.3

2.2

7.91

4.86

ug/l

0.71

Contact with blunt object, undetermined intent

114

2.03

2.30

3.0

2.1

6.17

6.39

ug/l

0.03

101

Impotence

212

1741

1.24

2.29

2.6

2.3

10.86

9.81

ug/l

0.12

193

1585

Glaucoma, exfoliation

467

4095

1.16

2.29

2.4

2.5

4.44

6.32

ug/l

5.31

375

3358

Other/unspecified crystal arthropathies

182

1.83

2.28

3.3

2.7

4.33

8.42

ug/l

0.94

153

Malignant neoplasm of oesophagus

100

750

1.38

2.27

1.8

2.7

4.05

7.63

ug/l

3.60

672

Abscess of mediastinum

2.80

2.26

2.8

3.63

6.48

ug/l

1.03

Other and unspecified psoriasis

218

1795

1.23

2.26

2.3

2.4

5.78

7.63

ug/l

1.50

191

1616

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

331

1.58

2.26

2.6

2.7

4.95

6.04

ug/l

0.51

286

Melanocytic naevi of lower limb, including hip

125

965

1.32

2.24

2.2

2.4

6.48

7.21

ug/l

0.19

107

846

Other deformities of toe(s)

114

870

1.34

2.24

2.5

2.4

3.60

6.78

ug/l

4.17

760

Benign lipomatous neoplasm

1068

9799

1.10

2.24

2.3

6.72

7.51

ug/l

0.50

941

8531

Puerperal sepsis

325

2772

1.18

2.24

2.1

5.74

6.08

ug/l

0.09

293

2415

Other disorders of white blood cells

180

1455

1.26

2.23

2.4

11.68

6.78

ug/l

0.54

153

1293

Other specified disorders of external ear

142

1119

1.30

2.23

2.3

2.5

7.55

7.62

ug/l

0.02

110

1020

Parkinson's disease, strict definition

575

5119

1.14

2.23

2.4

2.5

6.33

6.83

ug/l

0.36

426

4392

HSIL lesion of the cervix uteri, vagina or vulva

369

3176

1.17

2.23

1.9

2.0

6.36

5.50

ug/l

0.16

321

2761

Benign neoplasm: Lip

580

1.42

2.22

2.7

2.5

5.83

6.83

ug/l

0.27

512

Alzheimer’s disease (undefined)

333

0.49

2.22

2.1

2.6

15.03

5.55

ug/l

—

262

Injury of muscle and tendon at hip and thigh level

301

2556

1.19

2.22

2.5

2.3

9.80

8.58

ug/l

0.18

266

2301

Benign neoplasm: other/unspecified salivary gland

105

795

1.36

2.22

2.4

2.5

5.59

7.18

ug/l

0.68

691

Carcinoma in situ of breast, intraductal

164

2039

0.79

2.21

2.0

2.3

4.90

6.24

ug/l

0.53

133

1749

Sequelae of infectious and parasitic diseases

254

2126

1.21

2.21

2.4

7.82

7.35

ug/l

0.11

218

1838

Panniculitis, unspecified

236

1.68

2.21

2.9

2.2

4.42

6.90

ug/l

0.70

201

Carcinoma in situ of skin, other sites/unspecified

366

1.55

2.21

2.2

2.7

6.00

6.26

ug/l

0.04

317

Foreign body on external eye

474

4165

1.15

2.21

2.5

2.3

7.87

9.29

ug/l

0.57

435

3787

Complications following abortion and ectopic and molar pregnancy

104

785

1.35

2.20

2.0

2.3

9.04

5.77

ug/l

0.38

691

Embedded and impacted teeth

488

3640

1.14

2.20

2.1

7.46

6.57

ug/l

0.34

439

3185

Other specified/unspecified necrotizing vasculopathies

365

1.54

2.19

2.6

2.4

5.30

7.65

ug/l

0.84

324

Thyroiditis, unspecified

315

1.57

2.19

2.1

2.2

3.44

5.60

ug/l

1.83

278

Renal tubulo-interstitial disorders in diseases classified elsewhere

229

1.69

2.19

2.5

18.59

6.57

ug/l

0.46

201

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

529

4681

1.14

2.19

2.5

2.3

6.65

7.82

ug/l

0.81

476

4174

Non-follicular lymphoma, hilmo, excluding all cancers

362

3129

1.17

2.19

2.3

2.4

7.62

7.48

ug/l

0.03

304

2720

Disorders of eyelid in diseases classified elsewhere

102

769

1.36

2.18

3.0

2.4

5.22

6.88

ug/l

0.58

680

Dermatitis herpetiformis

464

1.47

2.18

2.5

6.22

6.91

ug/l

0.17

418

Benign neoplasm of ovary

544

4827

1.14

2.18

2.4

2.3

5.22

6.08

ug/l

0.59

467

4100

Anogenital herpesviral [herpes simplex] infection

129

1002

1.30

2.17

1.8

2.1

4.72

6.64

ug/l

1.09

895

Malignant neoplasm of breast

1494

11584

0.93

2.16

2.1

2.3

4.38

5.76

ug/l

4.39

1219

9804

Multifocal fibrosclerosis

177

1.80

2.16

2.2

2.5

7.71

4.88

ug/l

0.45

151

Vitamin A deficiency

2.10

2.15

20.3

2.4

4.96

8.73

ug/l

0.48

Benign neoplasm: Brain, supratentorial

374

1.52

2.15

3.1

2.5

7.04

6.96

ug/l

0.01

329

Mental disorders, not otherwise specified

193

1575

1.24

2.15

2.1

7.40

7.14

ug/l

0.05

171

1401

Ulcerative rectosigmoiditis

242

2022

1.21

2.14

2.8

2.2

5.03

7.97

ug/l

3.12

218

1821

Drug-induced tremor

147

1.88

2.14

1.7

2.4

6.18

8.44

ug/l

0.30

135

Poisoning by medicine, drug-induced

277

1.60

2.14

2.2

4.33

7.96

ug/l

1.18

255

Nezelof syndrome

111

2.04

2.14

3.6

2.5

2.78

6.33

ug/l

2.41

Burn and corrosion confined to eye and adnexa

490

1.44

2.13

2.0

2.3

4.34

8.55

ug/l

3.19

446

Oral lichen ruber planus, hypothyreosis or thyroxin

359

1.53

2.13

2.1

2.2

7.02

4.37

ug/l

0.32

315

Ulcerative colitis (strict definition, require KELA)

483

4259

1.14

2.12

2.5

2.3

6.57

7.96

ug/l

0.94

435

3805

Benign mammary dysplasia

456

4010

1.15

2.12

2.3

4.71

5.84

ug/l

1.16

379

3359

Benign neoplasm: Lip

586

1.41

2.11

2.7

2.5

5.83

7.11

ug/l

0.37

505

Ulcerative proctitis

168

1356

1.26

2.10

2.1

2.2

4.47

7.63

ug/l

3.76

142

1221

Infection due to other mycobacteria

410

1.49

2.10

3.0

2.5

8.73

7.46

ug/l

0.23

352

Diffuse large B-cell lymphoma

165

1335

1.26

2.09

2.4

2.5

13.84

7.11

ug/l

0.85

131

1172

Allergic purpura

645

1.38

2.08

2.5

2.3

4.77

7.40

ug/l

1.46

568

Acute nephritic syndrome

545

1.42

2.07

2.7

2.4

3.88

7.73

ug/l

4.33

490

Sexual assault by bodily force

3.27

2.07

1.7

13.66

4.07

ug/l

—

Occlusion and stenosis of arteries, not leading to stroke

378

1.51

2.06

3.0

2.6

6.86

6.75

ug/l

0.01

323

Fall on and from ladder

286

2441

1.19

2.05

2.6

2.4

6.33

8.32

ug/l

1.73

258

2186

Vitamin B12 deficiency anaemia

413

3620

1.15

2.05

2.5

2.4

5.41

6.82

ug/l

0.96

331

3071

Unspecified lump in breast

448

3943

1.15

2.05

2.2

3.64

6.01

ug/l

7.11

379

3347

Other benign neoplasm of uterus: Other parts/unspecified

116

1479

0.77

2.05

2.1

2.6

10.27

5.70

ug/l

0.93

1198

Other infective otitis externa

183

1497

1.24

2.05

1.9

2.4

6.05

7.36

ug/l

0.65

146

1346

Erythema nodosum

682

1.36

2.05

3.4

2.3

5.01

6.29

ug/l

0.52

603

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

882

7831

0.91

2.04

2.0

2.3

3.84

5.87

ug/l

8.79

725

6675

Tuberculosis

253

2138

1.20

2.04

2.7

2.5

5.00

6.67

ug/l

1.74

204

1799

Abnormal serum enzyme levels

1261

11556

1.09

2.04

2.5

2.4

7.32

8.18

ug/l

0.94

1156

10208

Protein-energy malnutrition of moderate and mild degree

203

1.71

2.03

2.8

4.44

8.03

ug/l

0.84

182

Torticollis

264

1.59

2.03

2.5

2.2

7.19

8.71

ug/l

0.24

239

Malignant neoplasm of pancreas

164

2012

0.80

2.03

2.1

2.5

3.01

7.16

ug/l

11.21

139

1718

Benign lipomatous neoplasm of other sites/unspecified

328

2832

1.17

2.03

2.2

2.4

6.27

7.08

ug/l

0.41

279

2433

Other and unspecified disorders of adult personality and behaviour

2.16

2.02

1.4

2.3

9.38

6.76

ug/l

—

Other disorders of cornea

305

2618

1.18

2.02

2.3

2.4

8.66

7.37

ug/l

0.31

256

2303

Spondylopathies in diseases classified elsewhere

307

1.56

2.01

3.0

2.2

6.91

7.74

ug/l

0.11

266

Acute lymphadenitis

153

1229

1.26

2.00

2.2

7.66

7.69

ug/l

0.00

135

1088

Exposure to other and unspecified forces of nature

106

1.99

1.6

2.0

3.29

5.59

ug/l

1.58

Chronic Coagulation defects

429

1.45

1.99

2.3

2.4

6.94

6.99

ug/l

0.01

386

Purulent endophthalmitis

159

1.81

1.98

2.7

2.6

9.73

5.55

ug/l

0.72

135

Need for other prophylactic measures

177

1450

1.24

1.98

1.8

2.4

10.13

7.50

ug/l

0.68

149

1297

Triptan medication for migraine, min. 3 purchases

1414

10390

1.08

1.97

2.0

2.1

6.43

7.09

ug/l

0.37

1237

9161

Ulcerative enterocolitis

686

1.35

1.97

2.5

2.3

3.91

7.81

ug/l

3.40

620

Female infertility, tubal origin

649

1.35

1.97

1.9

5.21

7.30

ug/l

0.47

581

Asthma mixed form (mode), excluding more controls

143

1142

1.27

1.97

2.1

2.0

4.20

7.00

ug/l

3.29

127

987

Carcinoma in situ of skin of trunk

120

945

1.31

1.96

2.2

2.6

5.96

ug/l

0.00

100

813

Malignant neoplasm of urinary organs

380

3327

1.16

1.96

2.7

2.4

5.28

7.22

ug/l

1.77

334

2890

Childhood allergy (age < 16)

177

1186

1.23

1.96

1.7

1.9

6.97

5.84

ug/l

0.32

148

1008

Lymphoid leukaemia

199

1653

1.23

1.96

2.3

2.5

7.38

7.11

ug/l

0.05

159

1444

Bilateral sagittal split ramus osteotomy operation

557

1.39

1.95

1.8

2.1

4.19

7.37

ug/l

2.02

512

Human immunodeficiency virus [HIV] disease

444

0.59

1.95

1.7

2.1

8.72

9.45

ug/l

0.06

413

Benign neoplasm of other and unspecified sites

112

873

1.31

1.94

2.2

2.5

5.82

7.64

ug/l

0.63

101

772

Diastasis of muscle

136

1.84

1.94

2.5

2.2

2.14

9.61

ug/l

2.80

121

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

243

2060

1.20

1.92

2.3

2.4

6.03

7.58

ug/l

0.65

212

1764

Symptoms and signs involving appearance and behaviour

159

1.76

1.92

2.6

2.4

2.72

6.78

ug/l

2.83

137

Other and unspecified erythematous conditions

734

1.34

1.91

2.1

2.5

7.15

7.38

ug/l

0.05

639

Universal erythroderma, KELA reimbursement

352

1.50

1.89

2.4

2.6

7.51

8.43

ug/l

0.14

315

Benign neoplasm: Appendix

271

1.58

1.89

2.2

2.7

15.04

7.87

ug/l

0.36

238

Cyst of kidney

250

2128

1.19

1.89

2.3

2.5

6.18

7.41

ug/l

0.72

220

1869

Tuberculosis of other organs, strict

746

1.34

1.89

2.6

5.89

5.58

ug/l

0.09

623

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

520

4645

1.13

1.88

2.5

5.22

7.80

ug/l

4.79

429

3997

Atypical virus infections of central nervous system

223

1.63

1.88

2.4

2.3

5.84

7.91

ug/l

0.47

200

Injury of muscle and tendon at forearm level

453

1.43

1.87

2.0

2.4

14.77

8.46

ug/l

0.36

409

Malignant neoplasm of kidney, except renal pelvis

347

3031

1.16

1.87

2.7

2.4

5.34

7.38

ug/l

1.69

305

2644

Other disorders of pigmentation

136

1091

1.27

1.86

2.0

2.4

7.67

7.08

ug/l

0.14

120

961

Motorcycle rider injured in other and unspecified transport accidents

147

1187

1.25

1.86

2.1

2.2

5.62

8.47

ug/l

2.38

131

1073

FESS (DNB20)

372

3260

1.15

1.86

2.1

2.3

7.34

8.02

ug/l

0.16

325

2938

Malignant neoplasm of bladder

287

2474

1.18

1.86

2.3

2.5

4.58

7.20

ug/l

3.71

236

2109

Other degenerative diseases of the basal ganglia

456

1.44

1.85

2.1

2.7

9.35

6.85

ug/l

0.38

406

Endocrine disorders, other/unspecified

450

0.61

1.85

1.7

2.4

6.85

6.47

ug/l

0.06

401

Multiple myeloma and malignant plasma cell neoplasms

176

1456

1.23

1.84

2.9

2.5

5.28

6.91

ug/l

0.72

152

1261

Fistulae involving female genital tract

312

1.51

1.84

3.0

2.3

3.18

6.67

ug/l

2.89

274

Benign neoplasm of brain and other parts of central nervous system

209

1754

1.21

1.84

2.6

2.4

5.59

6.98

ug/l

0.99

183

1557

Erythema elevatum diutinum

4.80

1.84

2.6

1.5

7.84

3.77

ug/l

—

Respiratory tuberculosis, confirmed and not-confirmed

211

1774

1.21

1.84

2.7

2.5

4.99

6.63

ug/l

1.58

172

1505

Respiratory tuberculosis

211

1775

1.21

1.83

2.7

2.5

4.99

6.62

ug/l

1.58

172

1506

Multiple myeloma and malignant plasma cell neoplasms

176

1458

1.23

1.82

2.9

2.5

5.28

7.61

ug/l

1.20

152

1256

Secondary malignant neoplasm of other and unspecified sites

373

1.48

1.82

2.3

2.7

4.01

6.72

ug/l

1.45

327

Carcinoma in situ, bladder

131

1054

1.28

1.82

2.8

2.5

6.52

8.23

ug/l

0.60

115

914

Carcinoma in situ of skin of scalp and neck

744

1.33

1.82

2.4

2.8

6.35

6.52

ug/l

0.04

642

HSIL lesion of the vulva

364

1.47

1.80

2.1

2.3

2.19

4.45

ug/l

3.56

317

Hirsutism in women

200

1.63

1.80

1.6

2.0

8.16

4.40

ug/l

0.41

178

Disorders of orbit

130

1042

1.27

1.80

2.2

2.3

6.14

7.59

ug/l

0.71

107

930

Torsion of ovary, ovarian pedicle and fallopian tube

280

1.52

1.80

2.6

2.2

1.30

6.82

ug/l

8.01

252

Otitis media, unspecified

245

1917

1.18

1.79

2.0

2.3

5.92

6.39

ug/l

0.18

206

1686

Migraine, single triptan purchase ok & required. ICD-code if available is included

2422

15571

1.06

1.79

2.1

2.2

6.50

7.55

ug/l

1.22

2127

13741

Triptan medication for migraine, single purchase ok

2422

15571

1.06

1.79

2.1

2.2

6.50

7.55

ug/l

1.22

2127

13741

Other benign neoplasms of uterus

146

1783

0.80

1.78

2.0

2.5

9.07

6.00

ug/l

0.75

1458

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

165

1362

1.24

1.78

2.4

2.5

13.84

7.83

ug/l

0.72

131

1182

Diffuse large B-cell lymphoma, helper endpoint

165

1362

1.24

1.78

2.4

2.5

13.84

7.83

ug/l

0.72

131

1182

Other abnormal findings of blood chemistry

135

1089

1.26

1.78

2.8

2.4

11.38

7.06

ug/l

0.87

122

964

Benign neoplasm of brain and other parts of central nervous system

209

1761

1.20

1.78

2.6

2.3

5.59

7.53

ug/l

1.63

183

1555

Leiomyoma of uterus

1412

7431

1.07

1.78

2.1

2.2

5.55

6.02

ug/l

0.51

1161

6420

Ankylosing spondylitis, ICD10

267

2294

1.18

1.77

2.7

2.3

5.35

8.06

ug/l

1.72

228

2067

Rare circulating lymphoid malignancy

105

823

1.30

1.77

1.9

2.6

7.78

6.91

ug/l

0.12

728

Other erythematous conditions

106

831

1.30

1.77

2.1

2.5

7.14

7.54

ug/l

0.09

726

Carcinoma in situ of skin of scalp and neck

747

1.33

1.77

2.4

2.7

6.35

7.29

ug/l

0.27

643

Special screening examination for infectious and parasitic diseases

452

2996

1.13

1.77

1.6

1.9

11.90

8.81

ug/l

0.79

352

2699

Carcinoma in situ of skin of other and unspecified parts of face

322

2814

1.16

1.77

2.4

2.5

6.12

6.36

ug/l

0.13

273

2330

HSIL lesion of the cervix uteri

309

2679

1.16

1.77

1.8

1.9

7.09

5.18

ug/l

0.34

271

2337

Striking against or struck by other objects

998

9229

1.09

1.77

2.6

2.2

9.51

8.07

ug/l

0.84

839

8165

Acute appendicitis, with complications

681

6201

1.11

1.76

2.1

2.3

7.04

7.63

ug/l

0.42

601

5444

Carcinoma in situ of skin, other sites/unspecified

385

1.47

1.76

2.2

2.6

6.00

6.13

ug/l

0.02

333

Multiple myeloma, excluding all cancers (controls excluding all cancers)

177

1473

1.23

1.76

2.9

2.5

5.26

7.58

ug/l

1.21

153

1271

Fatigue fracture of vertebra

104

1.93

1.76

2.2

2.6

4.37

5.79

ug/l

0.69

Parkinson's disease

610

5535

1.11

1.75

2.4

6.30

6.80

ug/l

0.37

458

4743

Frontotemporal dementia, wide, incl. Pick's disease

189

1.68

1.74

3.5

2.4

7.94

8.84

ug/l

0.08

167

Benign neoplasm: Spinal cord

342

1.48

1.74

2.7

2.5

4.82

6.74

ug/l

0.52

304

Actinomycosis

2.02

1.74

1.7

2.3

7.60

6.98

ug/l

0.04

Embedded teeth, including avohilmo

166

1367

1.22

1.74

2.2

2.3

7.62

6.63

ug/l

0.29

153

1201

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1044

0.75

1.73

2.2

2.6

2.15

7.39

ug/l

20.61

900

Medical abortion

1955

10036

1.06

1.73

2.4

2.2

5.91

5.49

ug/l

0.44

1650

8536

Other benign neoplasm of uterus: Other parts/unspecified

116

1445

0.79

1.73

2.1

2.4

10.27

5.34

ug/l

1.04

1174

Accidental poisoning by and exposure to alcohol

333

1.47

1.73

3.4

2.4

5.52

8.39

ug/l

0.84

294

Maternal care for known or suspected abnormality of pelvic organs

334

2639

0.87

1.72

1.9

2.0

4.87

5.45

ug/l

0.25

293

2300

Carcinoma in situ, bladder

131

1062

1.27

1.72

2.8

2.5

6.52

7.35

ug/l

0.24

115

947

LeFortI or BSSRO operation

692

1.32

1.72

1.7

2.1

4.33

7.21

ug/l

2.23

628

Other appendicitis

253

2172

1.18

1.71

2.3

8.38

7.54

ug/l

0.16

223

1945

Other surgical follow-up care

676

1.32

1.71

2.2

2.3

16.50

6.35

ug/l

0.85

600

Lymphoid leukaemia

199

1679

1.21

1.70

2.3

2.5

7.38

7.78

ug/l

0.08

159

1443

Von Willebrand disease

212

1.60

1.70

2.4

2.2

4.29

5.64

ug/l

0.30

188

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

519

4678

1.12

1.70

2.3

2.4

7.11

7.64

ug/l

0.16

445

4048

Hypoplasia of dental enamel , including avohilmo

224

1.56

1.70

2.4

1.8

14.66

4.88

ug/l

0.97

193

Calculus of lower urinary tract

202

1708

1.20

1.69

2.8

2.4

6.48

7.38

ug/l

0.32

158

1503

Abrasion of teeth

895

6068

1.09

1.69

2.1

2.3

5.98

6.20

ug/l

0.11

781

5393

Malignant neoplasm of breast, HER-negative

579

6375

0.90

1.68

2.2

2.4

5.27

5.85

ug/l

0.44

466

5334

Secondary polycythaemia

619

1.34

1.68

2.6

2.3

10.23

7.72

ug/l

0.26

555

Cyst of Bartholin Gland

669

1.32

1.67

2.0

2.1

4.36

5.62

ug/l

0.51

594

Other localized connective tissue disorders

429

1.41

1.67

2.3

2.2

26.22

6.10

ug/l

0.65

373

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

286

1.50

1.67

2.6

2.1

11.04

6.67

ug/l

0.33

248

Vasomotor rhinitis (mode)

222

1892

1.19

1.66

1.9

2.4

4.93

6.83

ug/l

1.77

190

1680

Carcinoma in situ of skin of upper limb, including shoulder

692

1.33

1.66

2.2

2.6

4.73

6.42

ug/l

1.09

596

Use of entacapone

248

0.50

1.66

1.8

2.6

3.35

7.01

ug/l

2.18

214

Alcohol induced polyneuropathy

272

1.53

1.66

2.4

5.14

9.70

ug/l

1.31

242

Malignant immunoproliferative diseases

273

1.53

1.64

2.4

2.8

15.91

7.35

ug/l

0.38

239

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

427

3813

1.13

1.64

2.4

2.3

6.70

7.77

ug/l

0.35

375

3376

Other inflammation of vagina/vulva

497

1.36

1.64

2.0

4.61

4.85

ug/l

0.05

444

Myeloid leukaemia

692

1.32

1.63

2.2

2.6

4.22

6.78

ug/l

1.63

605

Benign neoplasm: Skin of scalp and neck

595

1.34

1.63

2.1

2.5

6.16

7.01

ug/l

0.21

532

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

427

3815

1.13

1.63

2.4

6.70

7.92

ug/l

0.41

375

3355

Other sexually transmitted chlamydial diseases

768

0.72

1.62

1.5

1.8

12.70

7.35

ug/l

0.46

675

Poor fetal growth

171

1423

1.21

1.62

1.7

4.30

4.56

ug/l

0.10

157

1234

Impacted maxillary molar

566

1.34

1.62

1.7

2.5

4.67

6.71

ug/l

0.81

500

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

709

1.31

1.62

2.5

2.3

5.01

7.14

ug/l

1.17

635

LSIL lesion of the vulva

534

1.35

1.61

2.2

4.37

5.02

ug/l

0.21

468

Use of biperiden

167

1394

1.22

1.60

2.7

2.4

4.51

8.17

ug/l

4.67

140

1247

Benign neoplasm: Parotid gland

267

2319

1.17

1.60

2.6

2.4

5.98

7.25

ug/l

0.76

236

2046

Infections with a predominantly sexual mode of transmission

699

6396

1.10

1.59

2.1

8.41

7.09

ug/l

0.53

580

5642

Carcinoma in situ of skin of upper limb, including shoulder

697

1.32

1.59

2.2

2.5

4.73

6.50

ug/l

1.29

589

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

135

1106

1.24

1.59

2.0

2.5

7.87

7.16

ug/l

0.13

120

989

Mental retardation

727

1.30

1.58

2.4

2.3

5.58

8.25

ug/l

0.87

643

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

259

1.54

1.58

2.9

2.6

7.46

7.91

ug/l

0.06

221

Gastrointestinal stromal tumor and sarcoma

317

1.48

1.58

2.1

2.6

3.62

5.11

ug/l

1.15

279

Osteopathy in diseases classified elsewhere

170

1.66

1.57

2.2

2.1

4.43

7.35

ug/l

0.84

155

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

599

1.33

1.57

2.5

3.41

7.44

ug/l

3.55

527

Tuberculosis of other organs

644

1.32

1.57

2.6

6.34

6.00

ug/l

0.08

542

Benign neoplasm: Prostate

211

1.60

1.57

1.8

2.5

4.96

7.79

ug/l

0.84

182

Cerebral arteritis

2.22

1.57

3.2

2.7

3.67

3.95

ug/l

0.08

All dysplastic lesions of the cervix uteri

457

4092

1.12

1.57

1.9

2.0

6.31

5.54

ug/l

0.18

407

3567

Macular hole

193

1639

1.20

1.57

2.5

2.4

5.13

6.92

ug/l

2.06

168

1425

Cholesteatoma of middle ear

187

1583

1.20

1.56

2.4

2.5

5.58

7.48

ug/l

1.47

157

1390

Drug-induced dystonia

2.20

1.56

2.0

2.2

1.54

5.90

ug/l

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

105

839

1.28

1.56

1.9

2.5

7.78

7.34

ug/l

0.06

729

Carcinoma in situ of skin of other and unspecified parts of face

322

2844

1.15

1.55

2.4

2.6

6.12

6.59

ug/l

0.29

273

2361

Other disorders of bone density and structure

538

1.34

1.55

2.5

2.3

6.80

7.53

ug/l

0.17

483

Ovarian dysfunction

113

906

1.26

1.55

2.0

6.34

4.39

ug/l

0.37

102

783

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

260

1.53

1.55

1.7

2.6

10.69

7.55

ug/l

0.17

222

Injury of nerves at wrist and hand level

107

856

1.27

1.55

2.3

7.03

7.88

ug/l

0.23

100

776

Vascular dementia (subcortical)

117

949

1.26

1.54

2.3

2.7

4.86

6.34

ug/l

0.99

799

Hypermetropia

186

1572

1.20

1.54

2.4

2.3

6.99

7.42

ug/l

0.07

166

1385

Injury of nerves at ankle and foot level

139

1.72

1.54

2.3

2.1

15.15

8.24

ug/l

0.35

125

Contact with lifting and transmission devices, not elsewhere classified

462

1.38

1.54

2.4

2.2

7.95

8.53

ug/l

0.10

419

Deficiency of other B group vitamins

540

1.35

1.54

2.8

2.5

3.87

6.89

ug/l

2.57

469

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

893

8062

0.92

1.53

2.3

2.5

6.25

8.05

ug/l

1.71

779

6938

Personality and behavioural disorders due to brain disease, damage and dysfunction

368

1.42

1.53

2.5

2.4

4.30

8.74

ug/l

1.71

326

Benign neoplasm: Parotid gland

267

2328

1.16

1.53

2.6

2.3

5.98

7.50

ug/l

1.01

236

2036

Causalgia

326

1.44

1.52

1.9

2.3

3.27

7.79

ug/l

3.60

295

Adult respiratory distress syndrome

336

1.45

1.51

2.8

2.5

8.36

7.66

ug/l

0.06

293

Other and unspecified iridocyclitis

125

1021

1.24

1.51

2.4

3.97

7.98

ug/l

6.20

112

911

Carcinoma in situ of skin of trunk

120

980

1.26

1.51

2.2

2.6

5.96

7.36

ug/l

0.45

100

831

Open bite

670

1.30

1.51

1.8

2.0

5.05

6.65

ug/l

0.59

595

Unspecified dementia

441

3580

1.12

1.49

2.7

2.5

5.93

5.91

ug/l

0.01

322

2942

Ethmoidectomy

385

3440

1.13

1.49

2.1

2.3

7.51

8.01

ug/l

0.11

337

3088

Other benign neoplasms of uterus

146

1746

0.82

1.49

2.0

2.4

9.07

5.38

ug/l

0.99

1440

140

1.69

1.49

2.1

2.3

6.11

7.12

ug/l

0.12

126

Mental retardation, wide definition

101

806

1.27

1.48

2.3

5.91

8.33

ug/l

0.79

712

Alcoholic liver disease

361

3220

1.13

1.47

2.6

2.4

6.77

8.61

ug/l

1.27

313

2893

Carcinoma in situ of other and unspecified sites

137

1137

1.23

1.47

2.9

2.5

6.35

8.15

ug/l

0.69

121

985

Golimumab

595

1.31

1.47

2.1

5.97

7.37

ug/l

0.36

538

Astigmatism

159

1332

1.21

1.46

2.1

2.3

8.33

7.29

ug/l

0.27

133

1185

Perioral dermatitis

345

1.42

1.46

2.4

2.2

4.02

5.43

ug/l

0.60

307

Other acquired deformities of ankle and foot

181

1.60

1.46

2.7

2.6

8.41

7.19

ug/l

0.16

161

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

529

5470

0.90

1.46

2.2

2.5

4.94

7.49

ug/l

4.68

468

4681

Dysplastic lesion of unknown severity of the cervix uteri

133

1.70

1.46

2.0

2.4

1.83

4.05

ug/l

2.40

118

Other specified/unspecified deforming dorsopathies

363

1.41

1.45

2.2

36.59

7.55

ug/l

0.88

320

Oral lichen ruber planus

590

1.32

1.44

1.7

2.4

5.33

6.86

ug/l

0.60

521

Benign neoplasm: Other parts of oropharynx

206

1.56

1.44

1.8

2.4

2.42

5.95

ug/l

4.67

188

Melanocytic naevi of upper limb, including shoulder

502

1.34

1.44

2.8

2.4

10.70

6.39

ug/l

0.28

446

Thyrotoxicosis with toxic multinodular goitre

200

1717

1.18

1.44

2.5

2.4

5.27

6.28

ug/l

0.44

176

1452

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

181

1.58

1.43

3.3

2.4

2.61

4.46

ug/l

1.15

159

Other obstructed labour

153

1280

1.21

1.43

1.8

2.0

10.59

5.64

ug/l

0.44

133

1126

Horner syndrome

289

1.46

1.43

1.8

2.3

6.01

8.28

ug/l

0.39

263

Benign neoplasm: Skin of trunk

129

1065

1.23

1.43

2.6

2.4

10.77

7.03

ug/l

0.43

102

941

Adenomyosis (Endometriosis of uterus)

365

3260

1.13

1.42

2.0

2.2

5.67

6.32

ug/l

0.29

304

2814

Hypertrichosis

246

1.48

1.42

1.5

2.0

7.53

4.55

ug/l

0.35

215

Other factor of the environment

264

1.48

1.42

2.4

6.13

6.60

ug/l

0.07

240

Arthropathic psoriasis

343

3055

1.13

1.42

2.3

5.37

8.06

ug/l

3.62

294

2739

Human immunodeficiency virus [HIV] disease resulting in other conditions

384

0.64

1.41

1.8

2.1

9.12

9.34

ug/l

0.02

360

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

723

1.28

1.41

1.9

2.3

5.63

7.34

ug/l

0.77

651

Other disorders affecting eyelid function

209

0.51

1.41

3.1

2.4

2.57

7.16

ug/l

2.69

191

Antepartum haemorrhage, not elsewhere classified

125

1026

1.23

1.41

1.7

1.9

4.53

6.18

ug/l

0.52

109

890

Inflammation of lacrimal passages (acute and unspecified)

400

1.38

1.41

2.3

2.4

5.14

6.04

ug/l

0.31

350

Benign neoplasm: Skin of trunk

129

1067

1.23

1.41

2.6

2.4

10.77

7.50

ug/l

0.36

102

942

Exposure to other and unspecified animate mechanical forces

494

1.34

1.41

2.1

2.3

5.93

7.41

ug/l

0.49

446

Nontoxic single thyroid nodule

209

1802

1.17

1.40

2.1

2.3

6.98

6.33

ug/l

0.18

174

1565

Delivery, wide proxy

978

5578

0.93

1.40

2.3

2.4

5.02

5.63

ug/l

0.70

846

4567

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

135

1123

1.22

1.40

2.0

2.4

7.87

7.35

ug/l

0.09

120

1004

Acquired pure red cell aplasia [erythroblastopenia]

113

1.77

1.39

2.2

11.43

5.04

ug/l

0.57

Inguinal hernia, unilateral

727

1.28

1.38

2.8

2.4

9.52

6.97

ug/l

0.37

631

Femoral hernia, unilateral

727

1.28

1.38

2.8

2.4

9.52

6.97

ug/l

0.37

631

Inguinal of femoral hernia, unilateral

727

1.28

1.38

2.8

2.4

9.52

6.97

ug/l

0.37

631

Abscess of Bartholin gland

400

1.37

1.38

1.9

2.1

3.72

5.38

ug/l

0.95

360

Other congenital malformations of ear

112

1.72

1.37

1.7

1.9

11.30

5.10

ug/l

0.27

103

Iridocyclitis in diseases classified elsewhere

437

1.36

1.37

1.9

2.5

4.30

7.82

ug/l

1.95

394

Other conjunctival vascular disorders and cysts

586

1.31

1.37

2.6

2.3

10.19

7.08

ug/l

0.26

511

Other bursitis, not elsewhere classified

242

1.49

1.36

2.2

2.5

2.90

8.91

ug/l

3.09

210

Parkinson's disease, including avohilmo

627

5778

1.09

1.36

2.4

6.21

6.76

ug/l

0.43

472

4954

Nontoxic diffuse goitre

791

1.26

1.36

2.2

2.3

5.23

5.93

ug/l

0.20

680

Benign neoplasm: Appendix

293

1.45

1.36

2.2

2.7

15.04

7.74

ug/l

0.37

258

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

671

6200

1.09

1.36

2.0

2.5

5.19

7.91

ug/l

3.24

574

5396

Benign neoplasm: Floor of mouth

1.94

1.36

1.6

2.5

3.29

7.47

ug/l

1.98

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.93

1.35

2.1

2.3

2.61

4.57

ug/l

0.93

Carcinoma in situ of other and unspecified sites

137

1149

1.22

1.34

2.9

2.6

6.35

7.14

ug/l

0.24

121

1021

Certain conditions originating in the perinatal period

131

962

1.21

1.34

2.1

2.3

11.16

6.01

ug/l

0.89

114

828

Molar incisor enamel hypoplasia

244

1.46

1.34

2.5

1.8

14.21

4.84

ug/l

0.96

210

Burn and corrosion of shoulder and upper limb, except wrist and hand

482

1.33

1.34

3.0

2.2

8.40

7.78

ug/l

0.08

436

Other/unspecified reactive arthropathies

187

1606

1.18

1.34

2.5

2.3

5.62

7.14

ug/l

1.05

156

1441

Respiratory tuberculosis, confirmed

509

1.33

2.6

6.73

6.93

ug/l

0.04

441

Use of rotigotine

294

1.44

1.33

2.6

2.5

6.88

6.19

ug/l

0.11

264

Adenocarcinoma and ductal carcinoma of pancreas

1003

0.78

1.33

2.2

2.5

2.15

6.62

ug/l

14.00

867

Malignant neoplasm of lip

219

1.52

1.32

2.5

2.6

3.99

7.15

ug/l

1.41

189

Erectile dysfunction, exclusion

1.84

1.32

2.3

2.4

11.79

11.11

ug/l

0.04

Other acquired deformities of musculoskeletal system and connective tissue

145

1222

1.20

1.31

2.0

2.4

10.36

7.62

ug/l

0.34

122

1079

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

115

1.73

1.31

1.8

2.5

5.86

6.42

ug/l

0.09

108

Pregnancy with abortive outcome

2044

10201

1.05

1.30

2.3

2.2

5.61

5.49

ug/l

0.11

1724

8643

Juvenile rheumatoid arthirtis

310

1.41

1.30

2.1

5.50

7.02

ug/l

0.34

277

Melanocytic naevi of other and unspecified parts of face

164

1398

1.19

1.29

2.0

2.3

5.01

6.84

ug/l

1.06

136

1233

Donors of organs and tissues

219

1.49

1.29

1.7

2.0

18.57

8.41

ug/l

0.48

199

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

653

6779

0.92

1.29

2.2

2.3

5.09

5.83

ug/l

0.69

522

5715

Frontotemporal dementia

164

1.61

1.29

3.2

2.4

8.83

9.15

ug/l

0.02

147

Prolonged pregnancy

154

1657

0.84

1.29

1.4

2.0

2.40

5.65

ug/l

6.19

126

1436

Carcinoma in situ of skin

301

2685

1.14

1.29

2.4

2.5

5.95

6.66

ug/l

0.46

264

2278

Unspecified abortion

106

867

1.23

1.28

2.0

2.1

5.23

5.80

ug/l

0.09

784

Other and unspecified degenerative diseases of nervous system

709

1.27

1.28

2.3

2.5

7.16

5.51

ug/l

0.47

611

Benign neoplasm: Prostate

222

1.51

1.28

1.8

2.6

4.96

8.30

ug/l

1.07

191

Malignant neoplasm of floor of mouth

124

1.70

1.28

2.8

2.7

8.66

7.81

ug/l

0.07

112

Benign neoplasm: Spinal cord

365

1.38

1.27

2.7

2.4

4.82

7.43

ug/l

0.78

323

Drug phototoxic response

2.96

1.27

2.2

2.4

17.64

2.60

ug/l

—

Retained placenta and membranes, without haemorrhage

265

2341

1.14

1.27

2.0

4.26

5.93

ug/l

1.53

234

2017

Use of selegiline

171

1470

1.18

1.26

2.3

2.5

5.06

6.94

ug/l

1.57

116

1277

Simple and mucopurulent chronic bronchitis

147

1247

1.19

1.25

3.1

2.4

4.70

6.96

ug/l

1.60

121

1070

Dyshidrosis [pompholyx]

271

1.43

1.25

1.8

2.2

3.99

7.85

ug/l

1.60

241

Injury of nerves at hip and thigh level

1.80

1.24

2.0

2.5

3.66

5.15

ug/l

0.34

All dysplastic lesions of the vagina

470

1.32

1.24

2.5

2.2

4.14

6.09

ug/l

0.96

421

Drug-induced polyneuropathy

206

1.51

1.23

2.2

2.6

11.00

8.29

ug/l

0.19

182

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

622

1.28

1.23

2.5

3.41

7.63

ug/l

4.43

551

Malignant immunoproliferative diseases

291

1.43

1.23

2.4

2.7

15.91

7.70

ug/l

0.36

255

Hereditary corneal dystrophies

106

875

1.23

2.0

2.5

8.93

7.63

ug/l

0.16

769

Retinoschisis and retinal cysts

677

1.27

1.23

2.3

2.5

6.27

6.65

ug/l

0.07

596

Contact with other sharp object(s)

110

1326

0.82

1.23

2.4

2.3

4.66

7.33

ug/l

3.00

1198

Atopic conjunctivitis

106

873

1.23

1.22

2.3

2.2

7.33

6.93

ug/l

0.06

100

768

Presbycusis

480

5208

0.91

1.22

2.2

2.4

5.13

6.35

ug/l

1.80

375

4307

Autism

238

1.44

1.22

1.9

1.8

3.73

7.24

ug/l

1.38

206

Non-small cell lung cancer

529

5744

0.91

1.21

2.2

2.4

4.94

6.84

ug/l

2.99

468

4878

Myeloid leukaemia

723

1.26

1.21

2.2

2.5

4.22

7.48

ug/l

2.55

630

Infectious mononucleosis

145

1229

1.19

1.21

2.0

2.3

4.25

6.52

ug/l

1.86

129

1090

Other noninflammatory disorders of cervix uteri

139

1177

1.20

1.21

1.9

2.3

4.97

6.69

ug/l

1.15

116

1012

Benign neoplasm: Peripheral nerves and autonomic nervous system

386

1.35

1.20

2.1

2.5

5.76

7.36

ug/l

0.30

343

Personal history of allergy to drugs, medicaments and biological substances

182

1.52

1.19

2.0

2.4

4.76

6.63

ug/l

0.44

163

Respiratory tuberculosis, bacteriologically and histologically confirmed

528

1.30

1.18

2.6

2.5

6.67

6.96

ug/l

0.06

454

Benign neoplasm: Skin of scalp and neck

626

1.27

1.18

2.1

2.4

6.16

7.13

ug/l

0.26

542

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

574

1.28

1.17

2.0

2.5

3.93

6.90

ug/l

1.94

498

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

144

1230

1.19

1.16

2.3

2.5

11.48

7.59

ug/l

0.50

125

1070

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

494

1.31

1.16

2.5

2.7

9.53

7.06

ug/l

0.29

421

Morphin

441

1.32

1.16

3.5

2.3

4.62

6.84

ug/l

0.65

389

Other congenital malformations of peripheral vascular system

225

1.45

1.15

1.7

2.3

2.54

5.93

ug/l

2.95

201

Other and unspecified immunodeficiencies with predominantly antibody defects

234

1.44

1.15

2.3

2.2

6.23

5.82

ug/l

0.07

205

Other infiltrative disorders of skin and subcutaneous tissue

104

1.71

1.14

2.4

4.15

7.08

ug/l

1.24

Leiomyoma of uterus

2014

10976

1.05

1.14

2.1

2.2

5.58

ug/l

0.00

1643

9385

Wide developmental disorders

318

1.36

1.14

1.7

2.0

3.71

8.28

ug/l

2.43

276

Other and unspecified types of non-Hodgkin lymphoma, hilmo

144

1233

1.19

1.14

2.3

2.5

11.48

7.17

ug/l

0.57

125

1079

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

539

1.28

1.14

2.2

2.4

3.54

6.06

ug/l

2.00

471

Medical treatment for female infertility

243

2734

0.88

1.14

1.6

1.8

4.22

5.49

ug/l

0.80

213

2394

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

339

1.37

1.13

2.1

2.7

3.62

6.65

ug/l

2.06

297

Noise effects on inner ear

103

1234

0.82

1.13

1.7

2.4

6.84

8.77

ug/l

0.78

1132

Other bursitis of elbow

202

1.49

1.13

2.6

2.3

37.63

10.05

ug/l

0.46

175

Respiratory tuberculosis, clinically confirmed

362

0.67

1.12

2.4

2.6

4.96

7.33

ug/l

0.57

310

Autism spe

234

1.43

1.12

1.9

3.53

7.55

ug/l

1.63

208

Ulcerative ileocolitis

873

0.79

1.12

2.1

2.2

9.52

7.96

ug/l

0.27

789

Melanocytic naevi of other and unspecified parts of face

164

1419

1.17

1.11

2.0

2.3

5.01

7.01

ug/l

1.22

136

1240

Deaf mutism, not elsewhere classified

129

1.62

1.11

2.4

2.5

3.80

6.13

ug/l

0.50

114

Other disorders of penis

334

3025

1.11

1.10

2.8

2.4

7.97

9.57

ug/l

0.40

286

2716

Separation of retinal layers (serosa)

130

1107

1.19

1.10

2.0

2.3

6.50

7.92

ug/l

0.51

108

1001

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

235

2089

1.14

1.10

2.4

8.47

7.37

ug/l

0.30

213

1808

Benign neoplasm: Other parts of oropharynx

220

1.45

1.10

1.8

2.4

2.42

6.06

ug/l

5.07

196

Anomalies of pupillary function

409

1.32

1.09

2.5

2.2

5.47

7.31

ug/l

0.62

369

Acute poliomyelitis

358

1.35

1.09

3.0

2.5

5.64

7.19

ug/l

0.42

312

Peroneal tendinitis

279

1.39

1.09

1.9

2.3

17.79

6.97

ug/l

0.41

255

Chorioretinal inflammation

670

1.24

1.07

2.6

2.4

8.64

7.64

ug/l

0.17

598

Iron deficiency

245

1.40

1.07

2.7

2.3

15.10

5.57

ug/l

0.49

217

Dementia due to Parkinson's disease

736

1.24

1.07

2.4

2.7

5.74

5.92

ug/l

0.05

628

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

375

3423

1.10

1.07

2.4

6.18

8.14

ug/l

1.62

325

2977

Benign neoplasm: Oesophagus

316

1.37

1.06

2.0

2.5

4.86

8.28

ug/l

1.44

278

Benign neoplasm: Rectosigmoid junction

141

1214

1.18

1.06

2.4

2.5

6.18

7.16

ug/l

0.50

115

1073

Alzheimer’s disease (undefined), excluding more controls

256

0.63

1.06

2.1

2.3

15.03

5.29

ug/l

—

206

Congenital lens malformations

1.79

1.06

2.0

3.1

25.70

5.01

ug/l

—

Other disorders of Eustachian tube

653

1.24

1.06

1.8

2.4

6.14

6.79

ug/l

0.16

586

Use of donepezil

836

7574

1.07

1.05

2.3

2.5

6.35

5.74

ug/l

0.34

572

6206

Vertigo of central origin

395

1.32

1.05

1.9

2.4

4.35

5.39

ug/l

0.41

348

Congenital malformations of eye, ear, face and neck

142

1220

1.17

1.05

2.1

2.3

7.44

7.35

ug/l

0.02

115

1090

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

248

1.42

1.05

2.0

2.6

2.77

6.53

ug/l

2.59

220

Atypical mycobacterium lung infection

317

1.36

1.05

2.0

2.6

8.11

7.42

ug/l

0.10

276

Thrombotic microangiopathy

139

1.57

1.05

3.5

2.4

3.00

7.61

ug/l

1.61

122

Other menopausal disorders

752

4056

1.07

1.04

2.1

2.2

4.52

6.72

ug/l

3.30

663

3548

Benign neoplasm: Pituitary gland, craniopharyngeal duct

145

1251

1.17

1.04

2.2

2.4

6.68

6.92

ug/l

0.05

121

1120

Benign neoplasm: Cornea

2.15

1.04

2.4

2.7

5.74

8.52

ug/l

—

Ankylosing spondylitis, strict definition

110

927

1.20

1.04

3.2

2.2

7.34

8.04

ug/l

0.12

840

Colon adenocarcinoma

453

4178

1.09

1.04

2.4

4.70

6.95

ug/l

2.61

382

3552

Acute epiglottitis

334

1.34

1.04

4.1

2.2

3.83

8.71

ug/l

3.14

300

Benign neoplasm: Conjunctiva

819

1.21

1.04

2.3

2.4

6.05

7.45

ug/l

0.56

717

Circumscribed brain atrophy

575

1.26

1.04

3.4

2.6

8.31

6.74

ug/l

0.20

499

Rheumatic fever without mention of heart involvement

1.80

1.03

2.0

2.2

3.53

7.49

ug/l

1.64

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

537

4987

1.08

1.03

2.3

2.4

7.50

7.47

ug/l

0.01

460

4316

Orthopaedic devices associated with adverse incidents

495

1.28

1.03

2.1

2.5

5.90

5.99

ug/l

0.01

431

Hypertrophy of tongue papillae

283

1.38

1.02

2.5

2.6

3.49

6.76

ug/l

1.80

254

Leiomyosarcoma

190

1.48

1.02

1.6

2.5

13.72

6.98

ug/l

0.28

167

Wegener granulomatosis

388

1.32

1.02

2.1

2.4

4.79

6.55

ug/l

0.49

346

Spirochaetal infections, other/unspecified

254

2279

1.12

1.02

2.1

2.4

6.74

7.30

ug/l

0.27

208

2032

Benign leiomyoma with endometriosis

414

4502

0.91

1.02

1.9

2.4

6.74

5.92

ug/l

0.26

327

3815

Fluid overload

1.84

1.02

2.9

2.1

40.82

4.99

ug/l

0.45

Ulcerative colitis (strict definition, all Crohn cases excluded)

398

3650

1.10

1.01

2.5

2.2

6.36

7.89

ug/l

1.00

360

3264

Psoriasis (vulgaris), strict definition

757

1.22

1.01

2.4

4.76

7.81

ug/l

2.76

684

Asthma mixed form (mode)

143

1235

1.17

1.01

2.1

4.20

7.39

ug/l

4.11

127

1074

Generalized epilepsy, mode (most common among epilepsy diagnosis)

593

1.24

1.01

1.8

2.3

3.72

8.13

ug/l

4.52

527

Glaucoma secondary to eye trauma

174

1.49

1.00

3.0

2.7

4.41

5.99

ug/l

0.60

154

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

470

1.28

1.00

2.2

2.4

3.63

6.68

ug/l

1.88

400

Helminthiases

398

1.31

1.00

2.1

2.3

9.32

7.39

ug/l

0.25

350

Other secondary coxarthrosis

105

888

1.20

0.99

2.5

2.4

8.86

7.39

ug/l

0.17

782

LSIL lesion of the cervix uteri, vagina or vulva

258

2318

1.12

0.99

2.0

4.95

5.33

ug/l

0.21

228

2026

Malignant neoplasm of other and unspecified parts of tongue

400

1.31

0.98

2.2

2.5

5.51

7.03

ug/l

0.45

351

Benign neoplasm: Conjunctiva

824

1.21

0.98

2.3

2.4

6.05

7.20

ug/l

0.42

724

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

255

2827

0.89

0.98

2.3

2.4

3.53

7.33

ug/l

11.65

214

2417

Benign neoplasm: Peripheral nerves and autonomic nervous system

400

1.30

0.98

2.1

2.6

5.76

7.54

ug/l

0.34

348

Malignant neoplasm of mesothelium and soft tissue

148

1289

1.16

0.97

2.6

2.5

8.96

6.63

ug/l

0.50

136

1128

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

158

1383

1.16

0.97

2.3

2.4

6.42

8.00

ug/l

0.77

142

1217

Malignant neoplasm of ovary

137

1187

1.17

0.96

2.4

3.95

5.62

ug/l

1.44

119

1016

Other, unspecified and serous retinal detachments

100

845

1.20

0.96

2.3

2.5

5.64

7.35

ug/l

0.78

735

Multiple myeloma

736

1.22

0.96

2.4

2.6

6.36

6.16

ug/l

0.03

633

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

736

1.22

0.96

2.4

2.6

6.36

6.16

ug/l

0.03

633

Crossbite

127

1011

1.17

0.96

2.1

14.21

7.45

ug/l

0.80

108

896

Other and unspecified corneal deformities and disorders

762

1.21

0.96

2.3

9.63

7.52

ug/l

0.21

676

Bacterial meningitis

100

845

1.20

0.95

2.4

6.54

7.82

ug/l

0.31

762

Mucosal proctocolitis

332

3032

1.10

0.95

2.6

2.2

7.15

8.32

ug/l

0.49

295

2742

Pemphigus foliaceus

2.28

0.94

1.7

2.9

16.33

7.11

ug/l

—

Gluteal tendinitis

735

1.21

0.94

2.5

2.2

3.53

7.04

ug/l

4.93

642

Benign neoplasm: Oesophagus

323

1.33

0.94

2.0

2.4

4.86

7.17

ug/l

1.02

275

Dental caries 2 and operation codes, only avohilmo

2400

15402

0.96

0.94

2.2

2.3

6.34

7.35

ug/l

1.99

2090

13618

Malignant neoplasm of colon

569

5323

1.08

0.93

2.3

2.4

4.81

6.85

ug/l

2.71

475

4526

Polyarteritis nodosa

177

1.46

0.93

6.5

2.3

7.57

5.45

ug/l

0.35

158

Hip and thigh

1.89

0.92

1.6

2.7

7.26

4.67

ug/l

—

Use of antiglaucoma preparations and miotics

309

2822

1.11

0.92

2.3

2.5

7.63

6.63

ug/l

0.22

246

2347

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

232

2087

1.12

0.92

2.2

2.4

5.08

7.73

ug/l

3.50

198

1827

Melanocytic naevi of scalp and neck

529

1.25

0.91

2.8

2.5

9.69

6.98

ug/l

0.30

476

Other disorders of binocular movement

385

1.29

0.91

2.5

2.2

4.14

6.66

ug/l

1.57

342

Respiratory tuberculosis, not confirmed

150

1315

1.15

0.91

2.7

2.5

4.25

6.24

ug/l

2.40

125

1111

Use of interferon beta-1a

348

0.71

0.91

1.5

2.1

4.81

7.22

ug/l

0.49

323

Other protozoal intestinal diseases

280

1.35

0.91

2.9

2.1

4.06

7.93

ug/l

1.20

250

Postpartum hemorraghe, parous women as controls

357

3405

0.92

0.91

1.8

7.38

5.03

ug/l

0.49

323

3001

Torsion of testis

315

1.32

0.90

2.0

2.1

6.43

10.98

ug/l

1.15

282

Anisometropia and aniseikonia

716

0.80

0.90

2.2

2.4

7.07

6.72

ug/l

0.07

633

Carcinoma in situ of skin

301

2751

1.11

0.90

2.4

2.5

5.95

7.24

ug/l

1.06

264

2332

Benign neoplasm: Pituitary gland, craniopharyngeal duct

145

1269

1.15

0.90

2.2

2.4

6.68

7.66

ug/l

0.26

121

1127

Nutritional marasmus

2.11

0.90

1.0

1.9

2.73

4.86

ug/l

—

Myeloproliferative diseases

289

2635

1.11

0.89

2.3

2.4

5.24

7.14

ug/l

2.04

229

2294

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

669

1.22

0.89

2.3

2.6

5.85

7.71

ug/l

0.66

587

Benign neoplasm of breast

280

3075

0.91

0.89

2.0

2.3

6.14

5.61

ug/l

0.25

227

2594

Congenital deformities of hip

237

1.37

0.89

2.2

2.3

15.84

5.44

ug/l

0.62

211

Myasthenia gravis

433

1.27

0.89

3.5

2.5

3.85

6.27

ug/l

1.26

394

Melanoma in situ of lip

0.00

0.88

0.0

1.9

—

3.50

—

Rubella [German measles]

107

918

1.18

0.88

2.2

2.3

8.78

11.79

ug/l

0.79

848

Melanocytic naevi of scalp and neck

532

1.24

0.88

2.8

2.4

9.69

6.81

ug/l

0.33

466

Exfoliative dermatitis

274

1.35

0.88

2.2

2.8

9.28

8.11

ug/l

0.15

251

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

506

1.25

0.87

2.1

2.5

4.55

7.35

ug/l

1.80

443

Hereditary ataxia

318

1.32

0.87

2.8

2.4

3.95

7.52

ug/l

2.02

278

Other puerperal infections

102

869

1.18

0.87

1.7

1.8

3.14

4.66

ug/l

1.17

756

Guttate psoriasis

300

1.32

0.87

2.5

2.3

7.18

8.05

ug/l

0.18

270

Disorders of other and unspecified cranial nerves

129

1.52

0.87

3.4

2.5

4.20

8.00

ug/l

0.88

113

Lifestyle-related condition

248

1.36

0.87

2.1

2.4

6.74

6.62

ug/l

0.01

225

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

101

865

1.19

0.86

2.5

2.6

6.70

7.73

ug/l

0.23

751

Benign neoplasm: Rectosigmoid junction

141

1238

1.15

0.86

2.4

2.5

6.18

7.48

ug/l

0.74

115

1081

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

258

1.36

0.86

2.0

2.6

2.77

7.08

ug/l

3.15

220

Tooth eruption problems

220

1959

1.12

0.85

2.1

7.99

6.75

ug/l

0.31

200

1704

Oral lichen ruber planus, including avohilmo

167

1482

1.14

0.85

2.0

2.3

7.65

6.84

ug/l

0.19

140

1302

Benign neoplasm: Floor of mouth

1.64

0.85

1.6

2.6

3.29

7.54

ug/l

1.99

Other specified and unspecified disorders of lens

232

1.37

0.85

2.2

2.1

18.23

6.87

ug/l

0.48

191

Benign neoplasm: Long bones of lower limb

681

1.20

0.84

2.0

2.2

5.73

7.66

ug/l

0.70

609

Alcoholic cardiomyopathy

139

1.50

0.84

4.3

2.6

8.71

8.17

ug/l

0.04

123

Postpartum haemorrhage due to anatomy

1135

0.85

0.84

1.6

1.7

5.68

4.23

ug/l

0.31

1004

Melanoma in situ

105

1215

0.85

0.84

1.9

2.6

7.33

6.72

ug/l

0.15

1050

Disorders of male genital organs in diseases classified elsewhere

147

1.47

0.84

2.1

2.4

10.70

11.23

ug/l

0.03

136

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.83

0.0

2.3

—

4.22

—

Other and unspecified disorders of white blood cells

120

1044

1.16

0.83

2.3

2.4

7.26

6.76

ug/l

0.14

925

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

739

0.81

0.83

2.5

9.27

8.17

ug/l

0.17

657

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

453

4226

1.08

0.83

2.4

2.5

4.70

6.92

ug/l

2.61

382

3599

Family history of certain disabilities and chronic diseases leading to disablement

644

1.20

0.83

2.1

2.0

11.79

6.04

ug/l

0.53

565

Benign neoplasm of breast

280

3061

0.91

0.83

2.0

2.3

6.14

5.99

ug/l

0.06

227

2594

Lichen nitidus

0.00

0.83

0.0

2.5

—

6.57

—

Other and unspecified glaucoma

251

2285

1.11

0.83

2.4

2.5

5.79

6.59

ug/l

0.53

198

1927

Melanocytic naevi of upper limb, including shoulder

546

1.23

0.82

2.8

2.5

10.70

6.44

ug/l

0.28

477

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1116

10331

1.05

0.82

2.2

2.5

5.28

7.83

ug/l

5.71

930

8881

Postpartum care and examination

150

1086

0.88

0.82

1.8

4.72

5.95

ug/l

0.25

130

930

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

123

0.55

0.82

2.3

2.5

4.84

6.18

ug/l

—

111

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

340

1.29

0.81

1.7

2.5

5.14

6.98

ug/l

0.59

288

Hirsutism, drug-induced

0.00

0.81

0.0

3.3

—

4.63

—

Cerebral amyloid angiopathy

124

1.53

0.80

1.7

2.3

4.79

5.76

ug/l

0.23

107

Allergic contact dermatitis due to drugs in contact with skin

521

1.23

0.79

1.9

2.4

4.66

6.27

ug/l

0.57

454

Malignant neoplasm of oral cavity

115

1003

1.16

0.79

2.3

2.5

6.88

7.30

ug/l

0.12

103

888

Benign leiomyoma with endometriosis

414

4442

0.93

0.79

1.9

2.3

6.74

5.68

ug/l

0.36

327

3773

Other abnormal products of conception

545

3405

1.07

0.78

1.7

1.9

3.94

5.40

ug/l

1.51

475

3028

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

460

1.25

0.78

1.7

2.5

6.56

7.53

ug/l

0.15

401

Other abnormal findings in urine

414

1.26

0.78

2.1

2.6

4.19

7.47

ug/l

1.81

360

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

153

1361

1.13

0.77

2.1

2.4

4.64

8.00

ug/l

3.91

135

1201

Carcinoma in situ of skin of lower limb, including hip

598

1.21

0.77

2.3

2.6

8.11

6.54

ug/l

0.29

508

Mandibular retrognathia

100

1152

0.86

0.77

1.9

2.1

5.00

6.91

ug/l

1.24

1031

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

262

1.32

0.77

2.2

4.91

8.84

ug/l

1.44

234

Colorectal cancer

923

8817

1.05

0.77

2.2

2.4

5.22

7.10

ug/l

3.23

777

7534

Mild mental retardation

468

1.23

0.76

2.1

2.4

6.46

8.11

ug/l

0.27

413

Fasciculation

245

1.33

0.76

1.9

2.3

4.80

6.46

ug/l

0.52

218

Melanoma in situ

105

1204

0.86

0.76

1.9

2.5

7.33

7.57

ug/l

0.05

1040

HSIL lesion of the vagina

263

1.31

0.75

2.6

2.4

2.35

4.72

ug/l

2.38

235

Benign neoplasm: Vagina

290

1.30

0.75

2.1

2.3

3.65

4.92

ug/l

0.60

254

Adrenomedullary hyperfunction

1.66

0.75

3.2

2.5

3.46

6.06

ug/l

—

Non-Hodgkin lymphoma, all

140

1244

1.14

0.74

1.9

2.6

5.00

6.45

ug/l

0.62

116

1070

Radiodermatitis

1.65

0.74

2.9

2.3

11.27

5.55

ug/l

—

Pyogenic granuloma

362

1.26

0.74

2.4

2.3

3.63

8.60

ug/l

2.39

312

Diabetes insipidus

194

1.37

0.74

3.1

2.5

3.38

5.48

ug/l

1.30

173

Abscess of lung

381

1.26

0.73

3.0

2.6

10.54

8.82

ug/l

0.22

339

Benign neoplasm: Other and unspecified parts of small intestine

454

1.23

0.73

1.6

2.5

4.36

6.90

ug/l

1.34

395

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

750

7138

1.06

0.73

2.3

2.5

4.67

7.62

ug/l

6.50

619

6099

Adenocarcinoma and Papillary adenocarcinoma of kidney

310

1.29

0.73

2.7

2.6

5.91

8.78

ug/l

0.91

282

Corneal degeneration

345

1.27

0.73

1.5

2.3

10.03

7.48

ug/l

0.26

300

Other disorders of male genital organs

112

981

1.15

0.73

2.1

2.2

11.98

9.45

ug/l

0.22

890

Parapsoriasis

417

1.24

0.73

2.4

2.5

5.52

7.36

ug/l

0.55

372

Malignant neoplasm of heart, mediastinum and pleura

355

1.27

0.73

2.5

2.6

6.65

8.19

ug/l

0.46

310

Carcinoma in situ of skin of lower limb, including hip

602

1.20

0.72

2.3

2.6

8.11

6.57

ug/l

0.29

516

Gonococcal infection

711

1.18

0.72

2.2

5.96

7.85

ug/l

0.95

644

Malignant melanoma of skin

391

3652

1.08

0.72

2.4

7.42

7.12

ug/l

0.10

333

3172

Other hearing loss

1074

10132

1.05

0.72

2.2

2.4

6.31

6.98

ug/l

0.52

872

8620

Benign neoplasm: Carotid body

1.61

0.72

2.3

1.9

5.09

5.72

ug/l

—

Generalized epilepsy, strict definition

399

1.24

0.72

2.0

2.2

11.97

7.88

ug/l

0.19

359

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

125

1105

1.14

0.71

2.3

4.96

7.32

ug/l

1.39

117

987

Other ulcerative colitis

147

1312

1.13

0.71

2.6

2.2

5.34

7.65

ug/l

1.14

137

1188

Congenital ichthyosis

1.70

0.71

2.6

2.1

18.81

4.63

ug/l

—

Etanercept

145

1294

1.13

0.70

2.3

2.2

6.60

7.13

ug/l

0.15

128

1166

Colour vision deficiencies

1.60

0.70

2.5

1.8

3.19

7.06

ug/l

1.60

L02BB Anti-androgens

313

3370

0.92

0.70

2.5

2.4

6.17

7.19

ug/l

0.48

273

2893

Deep bite

242

1939

1.10

0.70

2.1

2.2

5.14

7.23

ug/l

2.06

203

1720

Uterine polyps

228

2085

1.10

0.70

2.3

2.2

6.64

6.70

ug/l

0.01

190

1812

Malignant neoplasm of other connective and soft tissue

650

1.19

0.70

2.4

2.5

6.21

6.51

ug/l

0.07

575

Loose body in joint

631

1.19

0.70

2.4

2.5

5.87

8.44

ug/l

1.10

569

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

503

1.21

0.69

2.2

2.5

7.60

6.99

ug/l

0.05

433

Myeloproliferative diseases (CML excluded)

259

2387

1.09

0.69

2.3

2.4

5.11

7.09

ug/l

2.03

200

2078

Chronic suppurative otitis media, including avohilmo

228

2088

1.10

0.69

2.3

2.4

6.45

7.11

ug/l

0.22

197

1835

Other bursitis of knee

330

1.26

0.69

2.2

2.3

18.77

9.99

ug/l

0.72

289

Benign neoplasm: Trachea

1.90

0.69

1.6

2.7

127.18

6.37

ug/l

—

Injury of muscle and tendon at ankle and foot level

521

1.20

0.68

2.0

2.3

11.68

7.75

ug/l

0.35

469

Melanoma in situ of other and unspecified parts of face

360

0.76

0.68

2.0

2.5

7.59

6.53

ug/l

0.09

310

Other endocrine disorders

924

0.86

0.67

2.0

2.3

5.33

7.07

ug/l

0.88

812

Benign neoplasm: Pancreas

727

1.17

0.67

2.6

4.88

6.33

ug/l

0.67

637

Foreign body entering into or through eye or natural orifice

226

2072

1.10

0.67

2.4

8.50

8.27

ug/l

0.04

191

1869

Benign neoplasm: Connective and other soft tissue, unspecified

304

0.74

0.67

1.3

2.5

14.99

6.88

ug/l

0.65

264

Crushed, pushed or stepped on by crowd or human stampede

148

1327

1.12

0.67

2.1

2.2

8.06

7.40

ug/l

0.17

130

1191

Pedal cyclist injured in noncollision transport accidents

258

2796

0.92

0.67

2.2

2.3

9.26

7.77

ug/l

0.26

221

2506

Melanoma in situ of lip

0.00

0.65

0.0

1.5

—

2.40

—

Autoimmune hepatitis

155

1.38

0.65

2.0

2.3

3.33

4.59

ug/l

0.46

134

Crowding of teeth, including avohilmo

128

939

1.13

0.65

1.9

7.39

7.15

ug/l

0.02

117

812

Toxic effect of contact with venomous animals

102

897

1.15

0.65

2.2

2.4

5.22

7.21

ug/l

1.35

795

Burn and corrosion of ankle and foot

324

1.26

0.64

3.3

2.5

5.31

8.64

ug/l

0.93

292

Benign neoplasm: Vagina

297

1.27

0.64

2.1

2.3

3.65

5.32

ug/l

0.81

259

Myelodysplastic syndrome

235

1.31

0.64

2.3

2.7

2.32

7.04

ug/l

3.40

203

Abnormal findings in peritoneal fluid saliva

1.60

0.64

2.7

2.2

2.52

5.70

ug/l

2.03

Obstructed labour due to maternal pelvic abnormality

359

3359

1.07

0.64

2.2

2.1

7.19

6.31

ug/l

0.29

313

2924

Benign neoplasm: Testis

139

0.63

0.64

2.1

2.5

6.90

9.28

ug/l

—

123

Benign neoplasm: Spinal meninges

271

1.28

0.64

3.0

2.5

3.77

4.95

ug/l

0.66

240

Colorectal adenocarcinoma

771

7378

1.05

0.64

2.2

2.5

5.14

7.00

ug/l

2.91

651

6300

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

771

7376

1.05

0.64

2.2

2.5

5.14

7.69

ug/l

4.85

651

6308

Allergic contact dermatitis

334

3118

1.08

0.64

2.2

6.15

6.65

ug/l

0.24

285

2730

Laparoscopic right hemicolectomy

189

1727

1.10

0.63

2.1

2.5

3.53

7.01

ug/l

9.83

160

1515

Epiphora

554

1.19

0.63

2.5

2.4

7.58

7.64

ug/l

0.01

481

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

205

1879

1.10

0.63

2.4

9.60

7.38

ug/l

0.51

188

1679

Otosclerosis

204

2223

0.91

0.63

2.4

2.3

8.30

7.12

ug/l

0.27

172

1971

Disease of thymus, other/unspecified

1.72

0.63

1.4

2.0

3.10

6.49

ug/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

227

1.30

0.62

2.0

2.7

5.24

7.71

ug/l

0.47

202

Other degenerative disorders of eyelid and periocular area

1.60

0.62

5.4

2.6

3.30

5.91

ug/l

1.23

Alopecia areata

490

1.19

0.62

2.5

2.2

7.71

7.65

ug/l

0.01

437

Benign neoplasm of other and unspecified female genital organs

116

1034

1.13

0.61

2.4

2.3

4.82

5.87

ug/l

0.56

896

Kissing spine

1.58

0.61

3.8

2.6

4.79

5.91

ug/l

—

Degeneration of nervous system due to alcohol

641

1.17

0.61

3.0

2.5

5.97

8.41

ug/l

1.22

573

Failure in dosage during surgical and medical care

1.82

0.61

4.3

2.5

3.25

4.99

ug/l

—

Benign neoplasm of eye and adnexa

312

2916

1.08

0.60

2.5

2.3

7.78

7.14

ug/l

0.21

254

2563

Degeneration of the brain due to alcohol

642

1.17

0.60

3.0

2.5

5.97

8.32

ug/l

1.15

573

Obstructed labour due to malposition and malpresentation of fetus

353

3117

1.07

0.60

1.9

5.03

5.48

ug/l

0.17

308

2738

Accidental poisoning by and exposure to pesticides

1.53

0.59

1.9

2.3

1.83

5.41

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

917

0.87

0.59

1.6

1.8

11.39

4.60

ug/l

0.88

810

Other articular cartilage disorders

642

1.17

0.59

2.2

2.4

6.58

8.13

ug/l

0.28

568

Recurrent cholesteatoma of postmastoidectomy cavity

0.56

0.59

2.2

2.5

15.20

5.67

ug/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

320

1.25

0.59

2.7

2.8

5.91

8.31

ug/l

0.81

281

Burn and corrosion of wrist and hand

763

1.15

0.59

2.2

2.3

5.00

8.55

ug/l

1.77

691

Benign neoplasm: Bladder

256

1.28

0.59

2.4

2.5

4.56

8.90

ug/l

1.30

223

Dental caries 1 and operation codes, only avohilmo

1082

5243

1.04

0.58

2.4

7.53

7.38

ug/l

0.08

964

4584

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

644

1.17

0.58

2.5

2.7

5.83

7.98

ug/l

0.43

556

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

133

1.40

0.58

1.8

2.5

2.77

3.72

ug/l

0.67

115

Postpolio syndrome

1.60

0.57

3.4

2.4

3.23

4.83

ug/l

—

Complications of the puerperium, not elsewhere classified

484

1.18

0.57

1.8

1.9

3.60

5.10

ug/l

0.83

435

Disorders of adrenal gland, other and/or unspecified

107

1.44

0.57

2.0

2.4

11.03

4.48

ug/l

0.56

Essential (haemorrhagic) thrombocythaemia

124

1117

1.12

0.57

2.6

2.5

5.05

7.62

ug/l

1.64

108

977

Benign neoplasm: Connective and other soft tissue of abdomen

1.58

0.57

3.6

2.1

5.07

5.00

ug/l

—

Other corneal oedema

213

1.30

0.57

3.3

2.3

3.87

7.30

ug/l

1.36

191

Maternal care related to the fetus and amniotic cavity and possible delivery problems

851

5215

0.96

0.56

1.9

2.0

3.99

6.13

ug/l

4.04

763

4562

Traumatic amputation of shoulder and upper arm

1.62

0.55

6.5

2.3

2.70

4.92

ug/l

—

Other and unspecified disease of Bartholin gland

646

1.16

0.55

1.9

2.3

4.73

6.38

ug/l

0.74

562

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

855

0.87

0.55

2.4

2.5

4.80

7.19

ug/l

1.00

730

Congenital retinoschisis

1.50

0.55

2.3

2.7

4.71

7.83

ug/l

—

Benign neoplasm of other and unspecified female genital organs

116

1043

1.12

0.55

2.4

2.3

4.82

5.49

ug/l

0.33

897

Malignant neoplasm of eye, brain and central nervous system

125

1129

1.12

0.55

2.0

2.3

3.97

7.75

ug/l

5.81

105

1000

Vertical strabismus

788

1.14

0.54

2.0

2.4

10.51

7.17

ug/l

0.35

698

Malignant neoplasm of brain

826

1.14

0.54

1.8

2.4

3.58

7.49

ug/l

5.96

741

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

101

903

1.13

0.54

2.0

2.6

7.21

7.33

ug/l

0.02

781

Benign neoplasm: Other and unspecified parts of small intestine

471

1.19

0.54

1.6

2.5

4.36

6.91

ug/l

1.56

404

Malignant melanoma, excluding all cancers (controls excluding all cancers)

634

6073

1.05

0.54

2.2

2.4

7.52

7.77

ug/l

0.11

539

5247

Malignant neoplasm of pyriform sinus, excluding all cancers (controls excluding all cancers)

1.57

0.53

1.5

2.9

6.68

12.45

ug/l

—

Polycystic ovarian syndrome

525

1.17

0.53

2.4

1.9

5.53

4.09

ug/l

0.31

450

Malignant neoplasm of eye and adnexa

224

1.28

0.53

1.8

2.3

5.56

6.60

ug/l

0.19

199

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

144

1.35

0.53

2.4

5.74

8.23

ug/l

0.34

125

Migraine, unspecified, drug-induced

135

1.36

0.52

3.2

2.0

8.02

4.23

ug/l

0.51

119

Benign neoplasm: Carotid body

1.42

0.52

2.3

2.0

5.09

6.14

ug/l

—

Melanoma in situ of other and unspecified parts of face

345

0.80

0.51

2.0

2.5

7.59

6.55

ug/l

0.09

302

Pedal cyclist injured in other and unspecified transport accidents

305

2868

1.07

0.51

2.2

2.3

11.69

7.63

ug/l

0.62

251

2546

Convergent concomitant strabismus

120

1085

1.11

0.51

2.2

7.19

7.42

ug/l

0.05

105

975

Bitten or struck by other mammals

247

2306

1.08

0.51

2.0

2.3

6.14

6.81

ug/l

0.36

218

2052

Antenatal screening

373

1982

1.06

0.51

1.7

1.8

4.72

6.25

ug/l

0.87

340

1730

Follicular lymphoma, hilmo

134

1222

1.11

0.50

2.1

2.5

5.28

7.20

ug/l

0.38

117

1070

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

354

1.21

0.50

2.6

2.8

3.33

7.39

ug/l

3.43

304

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

199

1.29

0.50

2.0

2.8

7.57

7.96

ug/l

0.04

170

Chronic suppurative otitis media

195

1807

1.08

0.50

2.2

2.4

6.96

6.94

ug/l

0.01

166

1598

Dental caries 3 and operation codes, only avohilmo

1217

5927

1.03

0.50

2.3

2.4

7.02

7.24

ug/l

0.13

1088

5194

Benign neoplasm: Long bones of lower limb

718

1.14

0.50

2.0

2.3

5.73

7.39

ug/l

0.60

641

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

212

1973

1.08

0.50

2.6

2.4

5.61

7.71

ug/l

1.47

167

1687

Benign neoplasm: Spinal meninges

281

1.23

0.50

3.0

2.4

3.77

5.38

ug/l

0.97

242

Neuroendocrine tumor and carcinoma of pancreas

146

1.33

0.49

2.4

2.5

5.74

8.08

ug/l

0.33

127

Ovarian dysfunction, other/unspecified

1.47

0.49

1.5

1.9

3.01

3.91

ug/l

0.34

Maxillary retrognathism

244

1.24

0.49

1.5

2.3

3.11

9.03

ug/l

3.19

218

Other specified and unspecified disorders of iris and ciliary body

1.45

0.48

2.9

2.4

6.05

5.50

ug/l

0.06

Other diseases of blood and blood-forming organs

207

1928

1.08

0.48

2.5

2.4

8.03

7.19

ug/l

0.19

173

1714

Use of rasagiline

769

1.13

0.48

2.6

2.5

6.83

7.04

ug/l

0.06

682

Benign neoplasm: Pancreas

750

1.13

0.48

2.6

4.88

7.32

ug/l

1.35

660

Carcinoma in situ of cervix uteri

145

1329

1.09

0.48

1.9

2.0

10.37

5.13

ug/l

0.50

133

1150

Benign neoplasm: Short bones of upper limb

337

1.20

0.48

1.8

2.3

3.52

7.83

ug/l

2.75

306

Benign neoplasm: Cranial nerves

802

0.88

0.48

2.7

2.5

6.24

7.76

ug/l

0.78

709

Diseases caused by chlamydiae

155

1.31

0.47

2.3

2.67

4.77

ug/l

1.08

137

Osteomyelitis of vertebra

1.47

0.47

3.1

2.6

6.77

10.32

ug/l

0.42

Acute myeloid leukaemia and myelodysplastic syndromes

487

1.16

0.47

2.5

2.7

3.31

6.22

ug/l

2.23

425

Caught, crushed, jammed or pinched in or between objects

118

1074

1.11

0.46

2.1

2.4

5.25

7.59

ug/l

1.90

102

968

Suppurative otitis media, unspecified

524

1.15

0.46

1.8

2.4

10.35

6.30

ug/l

0.60

462

UC patients in KELA-register (code 208), prior to 1994

138

1267

1.10

0.46

3.0

2.3

7.54

7.26

ug/l

0.07

128

1141

Neurofibromatosis, type 1

103

1.38

0.46

1.8

2.7

9.71

5.66

ug/l

0.33

Lesion of medial popliteal nerve

1.43

0.46

4.8

2.6

6.05

8.10

ug/l

0.21

Congenital malformation of biliary tract

1.43

0.46

1.7

2.6

8.60

5.64

ug/l

—

Carcinoma in situ of cervix uteri

145

1333

1.09

0.46

1.9

2.0

10.37

5.00

ug/l

0.52

133

1156

Follicular lymphoma

134

1231

1.10

0.45

2.1

2.4

5.28

7.65

ug/l

0.50

117

1083

Contraceptive management

1038

7522

0.97

0.45

2.0

2.1

7.83

8.30

ug/l

0.21

938

6766

Postpartum haemorrhage due to retained placenta

153

1658

0.92

0.45

1.8

9.12

4.81

ug/l

0.39

138

1469

Peripheral retinal degeneration

772

1.12

0.45

2.5

2.4

6.17

7.36

ug/l

0.28

675

Benign neoplasm: Bladder

266

1.22

0.45

2.4

2.7

4.56

7.95

ug/l

1.06

225

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

125

1145

1.10

0.44

2.3

2.4

4.96

7.24

ug/l

1.36

117

1014

Malignant neoplasm of head and neck

284

2684

1.06

0.44

2.3

2.4

5.91

7.72

ug/l

1.50

246

2336

Endometriosis diagnosis and infertility diagnosis occurring together

175

1625

1.08

0.44

1.8

2.0

3.87

4.89

ug/l

0.55

147

1434

Polycythaemia vera

120

1099

1.10

0.44

2.1

2.5

4.65

7.47

ug/l

2.34

958

Generalized pustular psoriasis

0.62

0.44

5.0

2.7

5.25

6.48

ug/l

—

Carcinoma in situ of larynx

1.44

0.44

1.6

2.7

4.29

5.80

ug/l

—

Phantom limb syndrome with pain

1.44

0.43

1.4

2.5

2.98

5.94

ug/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1568

15053

1.03

0.43

2.1

2.2

7.53

6.73

ug/l

0.49

1305

13083

Other predominantly sexually transmitted diseases, not elsewhere classified

330

3131

1.06

0.43

1.9

2.1

11.81

6.31

ug/l

1.57

281

2761

Congenital malformations of ovaries, fallopian tubes and broad ligaments

829

0.89

0.43

1.6

2.0

3.09

5.49

ug/l

2.29

731

Erosion and ectropion of cervix uteri

632

1.13

0.43

1.8

2.3

5.12

6.38

ug/l

0.60

550

Optic neuritis

822

1.11

0.43

2.1

2.2

6.25

7.33

ug/l

0.30

735

Acrodermatitis continua

1.55

0.42

1.8

2.7

2.22

6.36

ug/l

—

Carcinoma in situ of other and unspecified digestive organs

751

0.88

0.42

2.2

2.5

6.72

7.28

ug/l

0.09

657

L02BX Other hormone antagonists and related agents

173

1853

0.93

0.42

2.8

2.4

4.67

8.18

ug/l

5.25

152

1635

Benign neoplasm: Nasopharynx

241

1.22

0.42

2.4

2.5

6.93

6.63

ug/l

0.05

209

Benign neoplasm: Nasopharynx

241

1.22

0.42

2.4

6.93

7.83

ug/l

0.14

207

Use of riluzole

102

0.67

0.41

1.4

2.6

48.79

7.29

ug/l

—

Clear cell adenocarcinoma of kidney

151

1402

1.09

0.41

2.2

2.5

6.30

7.57

ug/l

0.32

135

1251

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

807

1.11

0.41

2.3

2.6

6.35

7.87

ug/l

0.50

717

Frostbite with tissue necrosis

1.45

0.41

1.5

2.2

7.22

12.70

ug/l

—

Use of cabergoline

270

0.81

0.40

1.9

2.4

6.21

7.92

ug/l

0.28

245

Graves disease, strict definition

224

2109

1.07

0.40

2.1

2.2

5.36

6.43

ug/l

0.60

186

1858

Benign neoplasm: Connective and other soft tissue of abdomen

1.40

0.40

3.6

2.2

5.07

4.89

ug/l

—

Benign neoplasm: Skin of lower limb, including hip

665

1.12

0.40

2.5

2.4

6.00

7.35

ug/l

0.36

587

Benign neoplasm: Connective and other soft tissue, unspecified

280

0.81

0.39

1.3

2.5

14.99

7.16

ug/l

0.62

246

Pseudopolyposis of colon

1.37

0.39

4.8

2.1

16.53

5.53

ug/l

—

Adenocarcinoma and papillary adenocarcinoma of stomach

831

0.90

0.39

2.4

2.6

4.80

7.03

ug/l

0.87

714

Hypospadias

1.37

0.39

4.3

2.1

5.84

5.36

ug/l

—

Syndrome of inappropriate secretion of antidiuretic hormone

152

1.28

0.39

3.1

2.6

5.06

5.07

ug/l

0.00

135

Sequelae of tuberculosis

581

1.13

0.39

3.1

2.6

4.16

5.85

ug/l

0.65

478

Injury of blood vessels at lower leg level

125

1.31

0.38

2.4

2.1

13.42

5.66

ug/l

0.44

106

Struck by thrown, projected or falling objec

119

1097

1.09

0.38

2.3

8.16

8.15

ug/l

0.00

106

990

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

205

1930

1.07

0.38

2.4

2.3

9.60

8.28

ug/l

0.26

188

1720

Postpartum haemorrhage

357

3254

0.95

0.38

1.8

1.9

7.38

5.47

ug/l

0.38

323

2845

Chronic iridocyclitis

128

1185

1.09

0.38

2.5

2.4

4.48

7.70

ug/l

3.82

106

1047

Other congenital malformations of urinary system

1.32

0.38

1.7

2.3

4.80

4.68

ug/l

—

Hepatocellular carcinoma

602

1.13

0.37

2.3

2.7

7.67

7.20

ug/l

0.06

523

Motor neuron disease (with DMD)

412

1.15

0.37

2.8

2.2

14.37

7.20

ug/l

0.51

370

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

126

1360

0.92

0.37

2.1

2.0

12.19

4.85

ug/l

1.24

110

1206

Benign neoplasm of eye and adnexa

312

2977

1.05

0.37

2.5

2.4

7.78

7.39

ug/l

0.12

254

2577

Malignant neoplasm of other and ill-defined digestive organs

208

1.22

0.37

1.7

2.8

3.19

7.16

ug/l

1.72

183

Non-small cell lung cancer, squamous, helper endpoint

147

1574

0.93

0.36

2.2

2.6

6.06

6.67

ug/l

0.16

130

1335

Non-small cell lung cancer, squamous

147

1574

0.93

0.36

2.2

2.6

6.06

6.67

ug/l

0.16

130

1335

Malignant neoplasm, without specification of site

102

938

1.10

0.36

2.0

2.6

4.29

6.46

ug/l

1.16

785

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

1.40

0.36

2.1

2.5

6.49

5.34

ug/l

—

Premenstrual syndrome

108

1.31

0.35

2.0

2.2

2.56

6.67

ug/l

—

Malignant neoplasm of digestive organs

1567

15123

1.02

0.35

2.2

2.5

4.83

7.21

ug/l

9.57

1317

12882

Other obstetric trauma

613

1.11

0.35

1.7

1.8

4.41

5.23

ug/l

0.29

533

Chronic myeloproliferative disease

403

0.86

0.34

2.3

2.4

4.56

6.86

ug/l

0.84

354

Intrahepatic Cholestasis of Pregnancy (ICP)

878

0.91

0.34

1.6

1.8

11.39

4.77

ug/l

0.85

772

Bus occupant injured in other and unspecified transport accidents

136

1.27

0.34

3.2

2.1

3.82

7.57

ug/l

0.93

120

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

1.40

0.34

1.8

2.6

5.75

5.58

ug/l

—

Malignant neoplasm of small intestine

616

1.11

0.34

2.1

2.5

3.97

6.65

ug/l

2.13

542

Benign neoplasm: Cranial nerves

781

0.90

0.34

2.7

2.4

6.24

6.98

ug/l

0.30

691

Villonodular synovitis (pigmented)

173

1.23

0.34

2.6

2.5

3.20

8.71

ug/l

2.30

153

Diseases of thymus

1.32

0.33

1.3

2.6

3.12

5.28

ug/l

—

Other nutritional anaemias

275

1.18

0.33

2.5

2.6

4.17

5.32

ug/l

0.39

237

Normotensive glaucoma

292

2792

1.05

0.33

2.3

2.5

5.76

6.50

ug/l

0.67

241

2374

Contact with nonpowered hand tool

123

1145

1.08

0.33

2.1

2.3

9.64

8.47

ug/l

0.28

109

1046

Other specified/unspecified diseases of inner ear

132

0.74

0.33

4.1

2.2

3.48

5.45

ug/l

—

116

Alzheimer’s disease (Early onset)

153

1436

1.07

0.33

2.6

2.5

6.59

6.22

ug/l

0.07

100

1169

Carcinoma in situ of other and unspecified digestive organs

738

0.90

0.33

2.2

2.6

6.72

7.40

ug/l

0.11

650

Unspecified renal colic

146

1.25

0.33

2.0

2.5

14.69

7.66

ug/l

0.33

134

Other specified/unspecified hearing loss

250

2381

1.05

0.33

2.2

2.4

7.69

7.40

ug/l

0.05

222

2063

Bacterial sepsis of newborn

1.31

0.33

4.2

2.8

17.08

7.33

ug/l

—

Bullous keratopathy

248

1.19

0.33

2.0

2.6

5.74

6.54

ug/l

0.16

220

Qualitative platelet defects

1.35

0.33

3.6

2.7

6.36

4.88

ug/l

0.13

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

151

1418

1.07

0.33

2.2

2.4

6.30

8.15

ug/l

0.52

135

1251

Pedestrian injured in collision with pedal cycle

789

1.10

0.33

3.0

2.4

8.96

7.53

ug/l

0.22

705

Maternal care for known or suspected malpresentation of fetus

211

1661

0.95

0.33

1.6

2.0

3.74

5.45

ug/l

1.01

183

1434

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

1.39

0.33

4.0

3.0

5.37

9.30

ug/l

—

Rapidly progressive nephritic syndrome

1.38

0.32

2.1

2.4

3.89

5.88

ug/l

—

Malignant neoplasm of gallbladder

131

0.75

0.32

2.9

2.6

1.67

6.72

ug/l

—

114

6-mercaptopurine

507

0.88

0.32

2.1

7.98

7.30

ug/l

0.04

463

Sequelae of other accidents

379

0.86

0.32

3.0

2.5

5.91

7.69

ug/l

0.47

331

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

400

1.14

0.31

2.4

2.6

4.62

6.03

ug/l

0.33

342

Eustachian salpingitis and obstruction

132

1410

0.93

0.31

1.8

2.1

6.72

6.38

ug/l

0.08

115

1264

Ulcerative colitis (strict) with PSC

142

0.77

0.31

1.4

2.2

1.81

8.26

ug/l

2.55

133

Cervical root disorders

166

1.22

0.31

1.9

2.8

3.84

7.45

ug/l

1.25

149

LSIL lesion of the vagina

240

1.18

0.31

2.4

2.2

5.49

5.54

ug/l

0.01

211

Pustulosis palmaris et plantaris

106

986

1.08

0.30

2.4

2.3

3.44

6.93

ug/l

6.62

876

Benign neoplasm: Skin, unspecified

111

1035

1.08

0.30

2.0

2.3

6.81

7.17

ug/l

0.09

920

Malignant neoplasm of tongue

554

1.11

0.30

2.2

2.5

6.01

7.58

ug/l

0.45

491

1005

0.92

0.30

1.4

1.7

8.13

3.95

ug/l

1.19

867

Congenital malformations of breast

174

0.80

0.30

1.6

2.3

13.46

4.95

ug/l

0.35

153

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1292

8606

0.98

0.30

2.1

2.2

4.47

6.06

ug/l

4.33

1053

7348

Carcinoma in situ of larynx

1.34

0.30

1.6

2.2

4.29

8.95

ug/l

—

Adenocarcinoma of small intestine

1.36

0.29

1.8

2.1

5.75

6.05

ug/l

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

488

1.12

0.29

2.3

2.4

5.44

6.93

ug/l

0.53

421

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1292

8605

0.98

0.29

2.1

2.2

4.47

6.06

ug/l

4.33

1053

7347

Benign neoplasm: Choroid

160

1691

0.94

0.29

2.5

2.4

6.78

7.45

ug/l

0.21

128

1480

Allergic conjunctivitis

1644

15909

1.02

0.29

2.1

2.2

7.56

6.71

ug/l

0.56

1376

13815

Benign neoplasm: Tongue

738

1.09

0.29

2.3

2.5

8.72

7.04

ug/l

0.27

648

Benign neoplasm: Thymus

1.28

0.28

1.3

2.8

31.79

7.54

ug/l

—

Benign neoplasm: Testis

118

0.75

0.28

2.1

2.3

6.90

8.94

ug/l

—

104

Unequal limb length (acquired)

103

1.27

0.28

2.3

4.96

7.05

ug/l

0.30

Pulmonary eosinophilia, not elsewhere classified

318

1.14

0.28

2.9

2.4

6.86

7.15

ug/l

0.04

278

Benign neoplasm: Choroid

160

1688

0.94

0.28

2.5

2.4

6.78

6.92

ug/l

0.04

128

1489

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

122

1.25

0.28

2.0

2.2

5.73

8.00

ug/l

0.33

108

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

147

1554

0.94

0.28

2.2

2.4

6.06

7.07

ug/l

0.29

130

1306

Mumps

636

0.91

0.27

2.4

2.3

5.93

6.99

ug/l

0.32

572

Benign neoplasm: Vertebral column

1.23

0.27

2.6

2.1

3.35

6.12

ug/l

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

262

1.16

0.27

1.8

2.5

4.58

6.11

ug/l

0.36

229

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

281

1.15

0.27

1.9

2.7

6.15

7.68

ug/l

0.25

242

Benign neoplasm: Skin, unspecified

111

1040

1.07

0.27

2.0

2.4

6.81

7.51

ug/l

0.18

924

Pedestrian injured in other and unspecified transport accidents

262

1.16

0.27

2.8

2.3

2.51

7.00

ug/l

2.55

238

Unspecified multiple injuries

1.23

0.27

1.8

2.3

8.82

4.30

ug/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

152

1440

1.06

0.27

2.2

2.6

5.32

6.60

ug/l

0.49

132

1242

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

886

1.08

0.27

2.1

2.5

5.27

8.11

ug/l

1.70

779

Malignant neoplasm of liver and intrahepatic bile ducts

105

984

1.07

0.26

2.3

2.7

6.09

6.57

ug/l

0.10

859

Localized scleroderma [morphea]

310

1.14

0.26

1.9

2.2

44.25

5.22

ug/l

0.69

266

Myopia

259

2488

1.04

0.26

1.9

2.2

8.28

7.01

ug/l

0.38

228

2207

Benign neoplasm: Anus and anal canal

791

1.08

0.26

2.2

2.6

7.72

6.73

ug/l

0.25

691

Benign neoplasm: Extrahepatic bile ducts

0.71

0.25

1.8

2.1

1.63

6.14

ug/l

—

Hereditary hypogammaglobulinemia

1.18

0.25

2.2

2.4

7.62

4.95

ug/l

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

437

4495

0.97

0.24

2.0

2.5

6.38

7.44

ug/l

0.61

372

3908

Carcinoma in situ of bronchus and lung

1.36

0.24

2.2

2.7

2.62

7.88

ug/l

—

Macular cyst

746

1.08

0.24

2.8

2.6

4.96

6.60

ug/l

1.10

646

Hydrocephalus in other diseases

134

1.21

0.23

1.5

2.3

8.30

5.17

ug/l

0.24

116

Chronic mastoiditis

766

1.08

0.23

2.0

2.6

4.56

6.39

ug/l

1.02

677

Overexertion and strenuous or repetitive movements

268

2585

1.04

0.23

2.3

11.71

8.03

ug/l

0.54

229

2314

Varicella [chickenpox]

109

1028

1.06

0.23

2.4

2.3

12.96

10.02

ug/l

0.31

102

937

Sunburn

1.30

0.23

1.4

1.9

2.04

5.79

ug/l

—

Use of amantadine

400

0.89

0.23

2.0

2.5

4.88

7.06

ug/l

0.79

354

Infections of breast associated with childbirth

447

1.10

0.23

2.0

9.68

5.10

ug/l

0.35

403

Malignant neoplasm of oropharyng

1.28

0.23

2.0

2.7

3.64

8.41

ug/l

—

Carcinoma in situ of bronchus and lung

1.25

0.23

2.2

2.62

9.76

ug/l

—

Testicular dysfunction

101

952

1.07

0.23

2.9

2.2

9.15

9.99

ug/l

0.13

868

Benign neoplasm: Short bones of upper limb

362

1.11

0.22

1.8

2.4

3.52

7.87

ug/l

3.02

326

Crushing injury of shoulder and upper arm

0.00

0.22

0.0

4.2

—

9.02

—

Refsum disease

0.00

0.22

0.0

3.8

—

6.62

—

Other fluke infections

0.00

0.22

0.0

2.1

—

5.15

—

Digeorge syndrome

0.00

0.22

0.0

4.8

—

6.85

—

Other diseases of appendix

296

1.12

0.22

2.2

2.4

11.19

6.85

ug/l

0.59

261

Cholangitis (primary sclerosing, PSC), with reimbursement 202

363

1.11

0.21

1.9

2.3

1.85

7.52

ug/l

6.76

330

Benign neoplasm: Vulva

502

0.91

0.21

2.0

2.4

4.39

6.30

ug/l

0.95

442

Leprosy [Hansen's disease]

0.00

0.21

0.0

4.9

—

2.89

—

Defect, injury or illness of skull

0.00

0.21

0.0

2.2

—

4.02

—

Other complications of labour and delivery, not elsewhere classified

105

1070

0.94

0.21

1.6

2.0

3.11

4.73

ug/l

0.84

921

Crushing injuries involving multiple body regions

0.00

0.21

0.0

2.7

—

4.26

—

Other secondary gonarthrosis

154

1473

1.05

0.21

2.4

5.07

7.50

ug/l

2.44

138

1300

Other and unspecified disorders of lacrimal system

1.30

0.21

2.8

2.9

3.33

3.47

ug/l

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

712

1.07

0.21

2.3

2.4

3.85

6.03

ug/l

1.25

615

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

126

1324

0.95

0.21

2.1

2.0

12.19

5.09

ug/l

1.18

110

1173

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

0.00

0.21

0.0

2.1

—

4.30

—

Papillary adenocarcinoma of thyroid gland

129

1229

1.05

0.21

2.0

2.3

6.76

6.86

ug/l

0.02

111

1082

Open bite that required surgery (Lefort1 or BSSRO)

117

1.20

0.21

1.2

2.0

3.44

6.54

ug/l

0.87

108

Butylpyrazolidines

0.00

0.21

0.0

3.7

—

15.34

—

LSIL lesion of the cervix uteri

176

1689

1.04

0.20

1.8

2.0

4.94

5.00

ug/l

0.02

157

1472

Multiple delivery

138

1445

0.95

0.20

1.9

2.0

4.73

7.10

ug/l

1.29

128

1235

Effects of other deprivation

1.19

0.20

1.3

1.9

1.43

4.77

ug/l

—

Maternal care for other known or suspected fetal problems

310

1929

1.03

0.19

1.7

1.9

3.82

5.46

ug/l

1.31

280

1664

Postpartum hemorraghe, all women as controls

357

3652

0.97

0.19

1.8

1.9

7.38

5.23

ug/l

0.44

323

3207

Maternal care for known or suspected disproportion

541

0.92

0.19

1.4

1.9

3.64

5.49

ug/l

0.82

472

Mandibular prognathia

260

1.12

0.19

1.7

2.1

6.51

8.95

ug/l

0.28

233

Malignant neoplasm of rectosigmoid junction

453

1.09

0.19

2.1

2.6

9.40

7.04

ug/l

0.22

397

Contact with venomous snakes and lizards

232

1.13

0.19

1.9

2.3

6.39

5.41

ug/l

0.13

201

Pedal cyclist injured in transport accident

596

6079

0.98

0.19

2.2

2.3

9.05

7.57

ug/l

0.38

498

5338

Other endophthalmitis

147

1.17

0.19

1.7

2.5

7.21

5.72

ug/l

0.27

127

Benign neoplasm: Anus and anal canal

804

1.06

0.18

2.2

2.5

7.72

7.56

ug/l

0.03

703

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

631

0.93

0.18

2.5

6.74

8.22

ug/l

0.34

568

Other osteochondropathies

178

1715

1.04

0.18

2.7

2.3

14.21

8.27

ug/l

0.75

156

1546

Hypothyroidism, autoimmune, DX-based

1.22

0.18

1.6

2.3

2.17

4.71

ug/l

—

Brain glioblastoma

339

1.10

0.18

1.4

2.3

2.51

7.34

ug/l

5.06

304

Benign neoplasm: Vertebral column

1.21

0.17

2.6

2.3

3.35

4.92

ug/l

—

Colorectal neuroendocrine tumor and carcinoma

330

1.10

0.17

2.8

2.3

9.01

6.46

ug/l

0.30

292

L01XX Other antineoplastic agents

169

1751

0.96

0.17

2.4

2.5

4.34

7.02

ug/l

3.51

136

1525

Other or unspecified immunodeficiency

0.72

0.17

2.8

2.2

18.68

5.56

ug/l

—

Malignant neoplasm of stomach

167

1611

1.04

0.17

2.5

5.04

7.10

ug/l

1.43

131

1377

Benign neoplasm: Skin of lower limb, including hip

699

1.06

0.17

2.5

6.00

7.34

ug/l

0.37

617

Benign neoplasm: Thymus

1.18

0.17

1.3

3.0

31.79

7.32

ug/l

—

Benign neoplasm: Tongue

758

1.06

0.17

2.3

2.5

8.72

7.82

ug/l

0.13

671

Retinal breaks without detachment

476

4857

0.98

0.17

2.3

7.25

7.41

ug/l

0.07

411

4265

Contact with machinery

350

3418

1.03

0.17

2.7

2.4

8.09

8.79

ug/l

0.29

316

3077

Defect, injury or illness of neck

1.21

0.16

1.7

2.4

4.51

5.40

ug/l

0.31

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1066

8486

0.99

0.16

1.8

2.1

5.40

5.87

ug/l

0.23

928

7337

Labour and delivery complicated by fetal stress [distress]

286

1960

0.97

0.16

1.6

1.9

5.00

5.38

ug/l

0.10

251

1698

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

172

0.86

0.16

1.9

2.3

8.63

7.85

ug/l

0.06

151

Failed induction of labour

556

0.93

0.16

1.5

2.4

3.93

4.74

ug/l

0.23

476

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.77

0.16

2.0

2.4

10.13

9.64

ug/l

—

Disorder of the sleep-wake schedule

322

1.09

0.16

2.8

2.4

2.50

6.64

ug/l

4.61

290

Calcaneal spur

274

1.10

0.15

1.9

2.1

16.59

6.86

ug/l

0.45

239

Personal history of malignant neoplasm

751

1.06

0.15

2.6

2.2

3.43

5.44

ug/l

1.98

651

Osteosarcoma, excluding all cancers (controls excluding all cancers)

1.12

0.15

2.0

3.1

3.19

6.27

ug/l

—

Other spirochaetal diseases

779

7902

0.98

0.15

2.1

2.3

6.77

7.25

ug/l

0.36

641

6933

Abnormalities of forces of labour

149

1543

0.96

0.15

1.8

1.9

6.40

5.73

ug/l

0.11

132

1368

Malignant neoplasm of gum

112

1.18

0.15

3.5

2.8

3.65

7.77

ug/l

1.31

102

Malignant neoplasm of anus and anal canal

131

1.16

0.15

1.9

2.6

5.10

ug/l

—

119

Spermatocele

268

2744

0.97

0.14

2.5

2.4

7.22

8.76

ug/l

1.03

235

2446

Contact with sharp glass

705

0.95

0.14

1.9

2.2

6.70

8.40

ug/l

0.55

636

Traumatic amputation of wrist and hand

130

1256

1.04

0.13

2.4

8.70

8.32

ug/l

0.09

120

1140

Malignant melanoma

506

4979

1.02

0.13

2.3

2.4

7.47

6.99

ug/l

0.21

429

4301

Amoebiasis

132

1.15

0.13

1.7

2.2

3.39

5.75

ug/l

0.97

116

Chronic myeloid leukaemia

108

0.82

0.13

1.4

2.8

5.20

8.73

ug/l

—

MS-disease / Multiple Sclerosis

137

1416

0.97

0.13

2.0

2.1

5.47

7.11

ug/l

1.01

116

1257

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

214

2195

0.97

0.13

2.2

2.3

6.07

7.50

ug/l

0.72

188

1924

Disorders of lacrimal system and orbit in diseases classified elsewhere

530

1.06

0.13

2.0

2.3

6.31

6.02

ug/l

0.06

468

Non-small cell lung cancer, adenocarcinoma, helper endpoint

198

2032

0.97

0.13

2.1

2.5

3.63

7.36

ug/l

8.20

175

1750

Non-small cell lung cancer, adenocarcinoma

198

2032

0.97

0.13

2.1

2.5

3.63

7.36

ug/l

8.20

175

1750

Malignant neoplasm of tonsil

396

0.93

0.13

2.5

2.6

8.51

8.09

ug/l

0.05

347

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

229

1.10

0.13

1.9

2.9

8.11

8.38

ug/l

0.02

200

Other demyelinating diseases of the central nervous system

642

0.95

0.13

1.8

2.2

7.31

6.92

ug/l

0.06

579

Meningococcal infection

142

1.13

0.13

1.9

2.3

2.76

8.89

ug/l

—

127

Motor neuron disease

404

1.07

0.12

3.0

2.2

13.46

7.21

ug/l

0.37

363

Spontaneous abortion

1065

7320

0.99

0.12

2.0

2.1

4.29

5.81

ug/l

3.22

933

6346

Laparoscopic left hemicolectomy

473

1.06

0.12

2.5

2.6

3.97

8.08

ug/l

2.87

418

Lyme disease

772

7811

0.99

0.12

2.1

2.3

6.78

7.29

ug/l

0.39

635

6860

Infliximab

126

0.87

0.11

2.2

1.70

7.41

ug/l

3.86

119

Dislocation, sprain and strain of joints and ligaments of elbow

132

1281

1.03

0.11

2.2

6.00

7.13

ug/l

0.53

118

1147

Biological medicines for asthma

240

1.09

0.11

2.2

2.3

2.35

7.91

ug/l

3.88

218

Family history of malignant neoplasm

197

1924

1.03

0.11

1.5

2.0

4.57

5.25

ug/l

0.36

166

1690

Benign neoplasm of male genital organs

622

1.05

0.11

2.0

2.5

7.39

8.70

ug/l

0.35

557

Sequelae of injuries of upper limb

247

2520

0.98

0.11

2.1

2.3

8.73

7.91

ug/l

0.12

207

2258

Malignant neoplasm of endocrine gland

178

1823

0.97

0.11

2.0

2.3

6.09

6.67

ug/l

0.15

154

1610

Other and unspecified papulosquamous disorders

144

1.12

0.10

2.9

2.4

8.69

5.29

ug/l

0.27

128

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

515

0.95

0.10

2.6

2.5

7.46

8.61

ug/l

0.20

462

Erosion of teeth, including avohilmo

510

4861

1.01

0.10

2.3

2.2

7.16

6.28

ug/l

0.59

428

4363

Use of levodopa decarbox-comt-inhibitor

104

1008

1.04

0.10

2.7

2.6

6.77

6.52

ug/l

0.07

879

Benign neoplasm: Vulva

484

0.95

0.10

2.0

2.3

4.39

6.15

ug/l

0.85

416

Malignant neoplasm of oropharynx

443

0.94

0.10

2.5

2.6

7.79

8.43

ug/l

0.09

393

Exophthalmic conditions

261

1.08

0.10

2.0

2.3

6.68

6.29

ug/l

0.08

238

Thoracic root disorders

1.15

0.10

1.6

2.1

3.84

6.55

ug/l

—

Cholera

114

1107

1.03

0.10

2.1

2.2

8.01

6.39

ug/l

0.39

102

957

Maternal care for cervical incompetence

748

0.96

0.10

2.3

2.2

7.00

5.76

ug/l

0.14

660

Other parasitologically confirmed or unspecified malaria

1.09

0.10

2.2

21.50

5.56

ug/l

—

Pterygium

879

0.96

0.10

4.0

2.5

8.55

6.98

ug/l

0.31

773

Knuckle pads

1.07

0.09

1.0

2.4

4.70

10.53

ug/l

—

Haemophilus septicemia

1.07

0.09

2.4

2.9

4.28

5.68

ug/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

1.07

0.09

1.6

2.6

3.72

4.13

ug/l

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

198

2020

0.98

0.09

2.1

2.4

3.63

7.54

ug/l

9.60

175

1734

Brain glioblastoma and astrocytoma

409

1.06

0.09

1.5

2.3

3.78

7.05

ug/l

2.12

372

Pregnancy, childbirth and the puerperium

963

5082

0.99

0.09

2.4

2.3

5.13

5.48

ug/l

0.32

808

4091

Malignant neoplasm of palate

1.12

0.09

1.7

2.6

2.30

6.88

ug/l

—

Crystalline deposits in vitreous body

257

0.93

0.09

3.6

2.5

4.26

8.30

ug/l

1.58

224

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

214

2179

0.98

0.08

2.2

2.3

6.07

6.90

ug/l

0.36

188

1943

Traumatic cerebral oedema

1.06

0.08

2.2

2.5

9.65

8.58

ug/l

—

Undefined dementia

450

4088

1.01

0.08

2.6

2.5

5.92

5.79

ug/l

0.05

328

3238

Benign neoplasm: Lymph nodes

1.10

0.08

1.9

2.4

5.71

4.90

ug/l

—

Benign neoplasm: Lymph nodes

1.05

0.08

1.9

2.6

5.71

6.15

ug/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

336

3403

0.99

0.08

2.0

2.4

5.63

7.22

ug/l

1.24

285

2954

Benign neoplasm: Extrahepatic bile ducts

0.84

0.08

1.8

2.0

1.63

4.96

ug/l

—

Phantom limb syndrome

1.10

0.08

1.4

2.5

2.98

6.37

ug/l

—

Meningitis, viral

0.82

0.08

1.7

1.9

5.67

2.59

ug/l

—

Glaucoma secondary to drugs

1.04

0.07

1.9

2.4

8.30

6.01

ug/l

—

Pustular psoriasis

115

1124

1.02

0.07

2.5

2.3

3.52

6.88

ug/l

6.93

998

Malignant neoplasm of adrenal gland

1.09

0.07

3.0

2.9

3.43

6.70

ug/l

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

448

0.96

0.07

1.5

2.5

3.78

7.90

ug/l

3.01

398

Other specified and unspecified disorders of choroid

1.02

0.07

3.7

2.7

27.94

4.85

ug/l

—

Viral conjunctivitis

383

1.05

0.07

2.3

11.86

6.28

ug/l

0.47

346

Chronic lymphocytic leukaemia, helper endpoint

878

1.03

0.07

2.2

2.5

5.32

7.85

ug/l

0.94

766

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

878

1.03

0.07

2.2

2.5

5.32

7.85

ug/l

0.94

766

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

163

1602

1.02

0.06

2.0

2.3

7.98

7.06

ug/l

0.15

140

1405

Keratoconus

528

0.96

0.06

2.0

2.3

7.57

8.22

ug/l

0.12

481

Graves ophthalmopathy, strict

477

0.96

0.06

2.2

2.4

7.09

5.73

ug/l

0.27

423

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

474

1.04

0.06

1.9

2.4

4.24

7.00

ug/l

1.54

410

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

178

1.07

0.06

1.3

2.4

2.36

7.70

ug/l

2.73

161

Desensitization to allergens

759

0.97

0.06

1.7

2.0

4.23

7.19

ug/l

1.83

682

Malignant neoplasm of thyroid gland

167

1695

0.98

0.05

2.0

2.3

6.16

6.71

ug/l

0.13

143

1499

Benign neoplasm of male genital organs

633

1.03

0.05

2.0

2.5

7.39

9.19

ug/l

0.55

562

Chronic lymphocytic leukaemia

881

1.02

0.05

2.2

2.6

5.32

6.69

ug/l

0.41

771

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

196

1935

1.01

0.05

2.0

2.3

7.82

6.95

ug/l

0.17

169

1689

Secondary malignant neoplasm of respiratory and digestive organs

384

0.96

0.05

1.9

2.6

1.92

7.13

ug/l

5.66

338

Benign neoplasm of thyroid gland

843

1.02

0.05

2.3

2.4

4.89

7.12

ug/l

0.74

733

Foreign body in ear

367

1.04

0.04

3.2

2.3

4.84

7.57

ug/l

1.18

331

Tooth agenesis EXCLUDE clefts and syndromes

423

0.97

0.04

1.9

2.0

8.98

6.62

ug/l

0.44

365

Pedal cyclist injured in collision with motor vehicle

675

0.98

0.04

2.0

2.3

4.79

7.65

ug/l

2.14

604

Placenta praevia

507

1.03

0.04

1.9

2.0

3.80

5.11

ug/l

0.59

444

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

350

3523

0.99

0.04

2.0

2.4

6.09

7.50

ug/l

0.94

297

3075

Other congenital malformations of face and neck

547

1.03

0.04

2.1

2.3

5.21

7.70

ug/l

0.59

492

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

125

1234

1.01

0.03

2.3

2.5

7.11

7.43

ug/l

0.09

111

1076

Single delivery by caesarean section

265

1521

1.01

0.03

1.7

2.0

2.86

7.47

ug/l

7.99

235

1307

Drowning and submersion while in natural water

112

1.08

0.03

3.3

2.4

4.61

8.10

ug/l

1.07

100

Polypectomy (DHB20)

201

2026

0.99

0.03

2.2

2.4

6.11

8.67

ug/l

1.70

190

1826

Other and unspecified diseases of blood and blood-forming organs

641

0.98

0.02

2.2

2.4

7.51

6.85

ug/l

0.15

561

Benign neoplasm: Bronchus and lung

359

0.97

0.02

2.4

2.7

6.39

7.70

ug/l

0.36

308

Crushing injury of wrist and hand

401

1.02

0.02

2.0

2.3

5.51

7.25

ug/l

0.51

360

Carcinoma in situ of skin of lip

1.08

0.02

3.1

2.7

12.13

6.07

ug/l

—

Chondromalacia

669

0.99

0.01

1.7

2.3

6.80

7.09

ug/l

0.05

602

Testicular hypofunction

841

1.01

0.01

2.7

2.2

10.23

10.12

ug/l

0.01

772

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

341

3397

1.00

0.01

2.0

2.4

6.20

7.46

ug/l

0.77

289

2965

Disorders of parathyroid gland, other and/or unspecified

187

0.96

0.01

2.9

2.4

2.46

4.84

ug/l

3.39

164

Graves ophthalmopathy

548

0.98

0.01

2.1

2.3

6.30

5.80

ug/l

0.10

485

Other disorders of choroid

373

1.02

0.01

2.9

2.4

12.94

7.31

ug/l

0.38

328

Malignant neoplasm of larynx

463

1.02

0.01

2.1

2.7

3.25

7.55

ug/l

4.35

402

Complications of labour and delivery

1567

8744

1.00

0.01

2.0

2.1

5.04

5.98

ug/l

1.36

1388

7516

Foreign body or object entering through skin

154

1532

1.01

0.01

2.1

2.4

6.49

7.51

ug/l

0.46

130

1377

Demyelinating diseases of the central nervous system

176

1752

1.00

0.01

2.0

2.2

5.96

6.91

ug/l

0.42

150

1559

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

147

1476

0.99

0.01

2.1

2.5

4.02

7.16

ug/l

3.63

123

1257

Twin gestation

115

1157

0.99

0.00

1.9

5.85

6.20

ug/l

0.07

108

1009

Melanoma in situ of trunk

406

0.98

0.00

1.5

2.5

8.97

7.32

ug/l

0.26

347

Malignant neoplasm of rectum

322

3226

1.00

0.00

1.9

2.4

5.72

7.30

ug/l

1.26

277

2790

Multiple gestation

120

1206

0.99

0.00

1.9

5.72

6.16

ug/l

0.09

112

1053

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

217

2164

1.00

0.00

2.1

2.3

7.41

7.08

ug/l

0.06

189

1885

Carrier of infectious disease

496

1.01

0.00

2.6

2.5

4.79

5.71

ug/l

0.26

440

Adenocarcinoma and papilloma adenocarcinoma of rectum

324

3241

1.00

0.00

1.9

2.4

5.78

7.32

ug/l

1.13

274

2815

Cleft palate

128

1.02

0.00

1.9

7.37

6.09

ug/l

0.16

117

Systemic atrophies primarily affecting the central nervous system

117

1166

1.00

0.00

2.8

2.5

7.60

7.02

ug/l

0.07

104

1009

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

362

0.99

0.00

2.8

2.4

9.01

6.72

ug/l

0.26

314

Congenital malformations of genital organs

146

1456

1.00

0.00

2.3

2.0

5.66

5.85

ug/l

0.05

119

1278

Benign neoplasm: Bronchus and lung

349

1.00

0.00

2.4

2.6

6.39

8.29

ug/l

0.52

307

Glaucoma-related operations

178

1782

1.00

0.00

2.4

2.5

4.94

6.20

ug/l

1.24

149

1511

Other papulosquamous disorders

263

0.99

0.00

2.7

2.4

7.47

8.18

ug/l

0.07

228

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

187

1.02

0.00

1.3

2.4

2.36

7.96

ug/l

2.86

161

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

366

1.01

0.00

1.4

2.5

2.51

7.64

ug/l

5.64

322

Malaria

105

0.95

0.00

1.6

2.4

11.95

8.27

ug/l

—

Unspecified early complication of trauma

0.00

0.0

1.6

—

6.80

—

Carcinoma in situ of rectosigmoid junction

0.00

0.0

1.6

—

6.04

—

Carcinoma in situ of rectosigmoid junction

0.00

0.0

2.0

—

2.62

—

Pseudomembranous colitis, drug-induced

0.00

0.0

2.9

—

9.24

—

Yellow fever

0.00

0.0

2.8

—

12.40

—

Other disorders originating in the perinatal period

0.90

0.00

2.1

2.4

9.51

6.87

ug/l

—

Birth injury to scalp

0.00

0.0

4.3

—

2.37

—

Major histocompatibility complex class I deficiency

0.00

0.0

2.2

—

8.12

—

Drug-induced folate deficiency anaemia

0.00

0.0

4.0

—

11.85

—

Neonatal aspiration syndromes

0.00

0.0

2.6

—

1.86

—

Other disorders of intestinal carbohydrate absorption

0.00

0.0

2.8

—

8.30

—

Psoriatic arthropathies, strict definition

0.00

0.0

1.7

—

2.36

—

Use of metixene

0.00

0.0

2.7

—

3.20

—

Polyglandular hyperfunction

0.00

0.0

2.0

—

2.98

—

Disorders of glycosaminoglycan metabolism, other/unspecified

0.00

0.0

1.2

—

4.70

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

0.0

2.0

—

2.80

—

Smallpox

0.00

0.0

2.7

—

8.00

—

Brain astrocytoma

0.88

0.00

2.0

2.3

10.13

6.20

ug/l

—

Heredofamilial amyloidosis, unspecified

0.00

0.0

1.8

—

7.02

—

Lichen planopilaris

0.92

0.00

1.5

2.8

1.57

4.45

ug/l

—

Multiple sites

0.00

0.0

1.1

—

2.13

—

Pinta [carate]

0.00

0.0

3.0

—

14.20

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.97

0.00

4.2

2.5

7.96

9.22

ug/l

—

Other birth injuries

0.00

0.0

2.3

—

4.34

—

Carcinoma in situ of skin of lip

100

1.00

0.00

3.1

2.6

12.13

9.47

ug/l

—

Disorders of other visual pathways

0.00

0.0

1.7

—

9.22

—

Melanoma in situ of trunk

400

1.00

0.00

1.5

2.5

8.97

7.67

ug/l

0.19

361

Epiphyseal arrest

0.00

0.0

3.3

—

6.60

—

Microcephaly

0.00

0.0

5.0

—

4.60

—

Other specified/unspecified disorders of ear

1.00

0.00

2.1

4.86

9.15

ug/l

—

Hereditary angioödema type 2

0.00

0.0

2.3

—

3.07

—

Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers

0.00

0.0

5.0

—

4.70

—

Congenital hydrocephalus

1.02

0.00

2.5

1.7

8.67

4.05

ug/l

—

Toxic liver disease with cholestasis, drug-induced

0.00

0.0

2.7

—

9.73

—

Acquired keratosis follicularis

0.00

0.0

2.1

—

6.40

—

Air embolism (traumatic)

0.00

0.0

1.7

—

3.83

—

Plasmodium falciparum malaria

1.00

0.00

1.0

2.6

2.40

6.11

ug/l

—

Adenosine deaminase [ADA] deficiency

0.00

0.0

2.4

—

4.36

—

Chorioretinal scars

0.93

0.00

3.2

2.6

4.53

8.46

ug/l

—

Atrophoderma of Pasini and Pierini

0.00

0.0

1.8

—

2.14

—

Benign neoplasm of thyroid gland

860

1.00

0.00

2.3

2.4

4.89

7.16

ug/l

0.78

749

Hypervitaminosis D

0.00

0.0

2.5

—

8.97

—

Anthrax

0.00

0.0

3.0

—

2.89

—

Maple-syrup-urine disease

0.00

0.0

4.0

—

6.36

—

Gastric ulcer - Acute with haemorrhage, drug-induced

0.85

0.00

2.4

2.1

4.36

4.92

ug/l

—

Carcinoma in situ of penis

0.88

0.00

2.8

2.9

2.14

7.28

ug/l

—

Pityriasis rubra pilaris

0.87

0.00

3.0

2.5

8.66

5.53

ug/l

—

Dietary calcium deficiency

0.00

0.0

3.1

—

7.39

—

Relapsing panniculitis [Weber-Christian]

0.00

-0.00

0.0

1.5

—

4.15

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Creatine kinase.MB [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS